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1ABSTRACT
The acute phase response is a cascade of events which occurs immediately after 
an injury or infection. It is a non-specific, non-immune defence mechanism 
which consists of a local and a systemic response that vary from species to 
species. The aim of the work described here was to increase our understanding 
of the systemic acute phase response (APR) in cattle.
An established experimental model for bovine pneumonic pasteurellosis 
in which calves were inoculated intra-tracheally with P. haemolytica A1 or with 
lipopolysaccharide (LPS) extracted from the organism was used in these studies 
of the APR. Serum amyloid A (SAA), a major acute phase protein in cattle was 
monitored in an indirect enzyme-linked immunosorbent assay developed using a 
commercially available rabbit anti-human SAA antibody. The assay was 
standardized using a pool of acute phase bovine serum which was quantified with 
purified bovine SAA (b-SAA) prepared by hydrophobic interaction 
chromatography and gel filtration. This allowed b-SAA concentrations in serum 
to be estimated in SI units with the detection limit of the assay being 3|ig ml-1.
The APR induced with P. haemolytica was characterised within 24 hours 
by the clinical signs of fever, anorexia, tachypnoea and a dull demeanour and 
was associated with a marked neutrophilic leukocytosis, hypoferraemia and 
hypozincaemia. During the same period the endocrine system was affected with 
an elevation of cortisol and a reduction of thyroxine being detected. The acute 
phase protein response was manifested by an increase in both SAA and 
haptoglobin (Hp) concentrations within 24 hours of inoculation and the 
concentration of both proteins reached a peak at 48 hours post inoculation. 
However, in studies comparing the effect of different isolates of P. haemolytica, 
on the acute phase protein response only the SAA levels correlated with the 
pathogenicity of the infectious organism. Frequent sampling during the initial 
phase of the APR indicated an earlier rise in SAA compared to Hp. In addition, 
a rise in fibrinogen was found at 24 hours, but there were no clear increases in 
ceruloplasmin or copper concentrations. Most results from a comprehensive 
biochemical analysis of sera from infected animals were within the normal range, 
but plasma concentration of bilirubin was increased and glutamate 
dehydrogenase activity was decreased.
Animals treated with P. haemolytica LPS intra-venously demonstrated an 
APR which was comparable to that observed when the whole organism was 
challenged intra-tracheally. In studies to determine the role of bovine cytokines 
in the infection, both P. haemolytica and LPS elicited a tumour necrosis factor 
(TNFa) response which peaked 2 hours after challenge and returned to non- 
detectable levels after a further 4 hours. Unsuccessful attempts were made to 
measure the plasma concentration of Interleukin 1 and Interleukin 6.
It is concluded that the APR in bovine pneumonic pasteurellosis is 
characterised by clinical changes and a wide array of pathophysiological 
alterations which include leukocytosis, mineral redistribution, endocrine and 
metabolic changes, and an acute phase protein response. The APR varied with 
the isolate of P. haemolytica and appears to correlate with the pathogenicity of 
the organism. Furthermore, the marked response in TNFa concentrations
implicates this cytokine as a major mediator of the APR in cattle.
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1.1 General introduction
The acute phase response (APR) is a cascade of events initiated by the host as an 
immediate response to infection, injury or neoplasia. It is a non-specific and a 
non-immune response which can be divided into two phases; the local response 
and the systemic response (Gordon and Koj 1985; Whicher and Evans 1992). The 
local acute phase or inflammatory response which occurs at the site of infection is 
characterised by dilation of blood vessels, release of lysosomal enzymes and 
infiltration of inflammatory cells which then produce mediators to induce the 
systemic APR. This phase encompasses pain, fever, endocrine changes, mineral 
redistribution and alterations in serum protein concentrations characterised by 
modified production of liver-derived acute phase proteins (APP) such as 
fibrinogen, haptoglobin and serum amyloid A (Fig. 1.1) (Kushner 1982; Myers et 
al. 1984; Besadovsky et al. 1986; Atkins 1989; Pepys 1989; Sipe 1990). The 
APR also includes systemic metabolic changes such as increased protein 
catabolism, increased gluconeogenesis and a negative nitrogen balance that 
facilitate or modulate the local processes of inflammation, for instance by 
providing energy and substrates for production of leukocytes. These changes 
enhance the killing of invading organisms, digestion of cell debris by phagocytosis 
and promote the proliferation of connective tissue cells and repair of the inter­
cellular matrix. Taken together, the changes which occur in the systemic response 
help to protect the host in infection and injury (Sipe 1985b; Stadnyk and Gauldie 
1991; Whicher and Westacott 1992).
The APR is essentially a beneficial reaction of the body to tissue injury. It 
differs from the more delayed immune response by being non-specific and non- 
immune but like the immune response it is a highly complex process. The primary 
aim of the APR is to protect the host by restricting damage at the site of injury 
and restoring homeostasis. Most changes associated with an
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Fig. 1.1 Acute phase response.
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APR occur within hours or at least within days of the tissue damage but these 
alterations can also be present during persistent or chronic diseases (Gordon and 
Koj 1985).
The APR in man has been known since antiquity. The ancient Greeks 
recognised that the red blood cells sedimented faster in peripheral blood from an 
extremely ill person than that from a normal individual. The increase in 
erythrocyte sedimentation rate was later revealed to be due to an elevation of 
fibrinogen and other APP in plasma.
The modem history of the plasma protein acute phase response to tissue 
injury began in the 1930s with the discovery of C-reactive protein (CRP) by 
William S. Tillett and Thomas Francis who identified an active compound while 
working on pneumococcal pneumonia (Tillett and Francis 1930). They found that 
in the serological responses to various pneumococci extracts one particular 
extract, which they named C-polysaccharide reacted with sera of acutely ill 
patients. It was also noted that after the resolution of the clinical crisis the 
capacity of the patient's sera to precipitate C-polysaccharide rapidly disappeared. 
In later studies the C-polysaccharide reactive compound was identified as a serum 
protein and became known as CRP (Pepys 1981). Since the discovery of CRP, 
numerous studies had been conducted to investigate the role of acute phase 
proteins in the inflammatory response in both man and in animals (Koj 1974; 
Pepys 1981; Kushner 1982; Pepys and Baltz 1983; Eckersall and Conner 1988; 
Whicher and Evans 1992).
The term "acute phase response" was first introduced by Abemethy and 
Avery (1941) to describe the properties of sera from patients with febrile 
infectious diseases which contained the C-reactive compound. In 1947, Chanutin 
and Ludewig described a rise in the concentration of fibrinogen in rats following 
intramuscular injection of sterile pus demonstrating that fibrinogen was also an 
APP. However, it was not until the post-war period that
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immunological and electrophoretic methods were used to quantitate changes in the 
concentration of plasma proteins produced during injury or infections (Darcy 
1964). In these studies, Darcy (1970) demonstrated by electrophoresis of serum, 
that following injury, rats produced extra proteins in the alpha-1-globulin region. 
This and further studies in other species showed that the plasma proteins which 
increased during infection or injury vary between species (Kushner and 
Mackiewicz 1987; Fey and Gauldie 1988). Plasma proteins such as CRP in human 
and 0C2  macroglobulin in rats were later defined as "acute-phase reactants" or 
"acute phase proteins" (Koj 1974; Kushner 1982). The use of the term APR has 
now become applicable to include several metabolic changes during the post- 
inflammatory reaction.
In early the 1960, Atkins et al. (1964) studied the mediators of the APR. 
They showed that leukocytes produce protein mediators which they named as 
'endogenous pyrogen' (EP). Kampschmidt and Upchurch (1974), by injecting the 
endogenous pyrogen intramuscularly into rats demonstrated that the animals 
developed an acute phase response characterised by rise in body temperature 
accompanied by a depression of iron and zinc. This was the start of the 
investigations which have led to the conclusion that the acute phase response is 
mediated by cytokines, notably interleukin 1, interleukin 6 and tumour necrosis 
factor (Kampschmidt and Upchurch 1974; Kampschmidt and Pulliam 1978).
This introduction is divided into four sections. The first section deals with 
the acute phase response in general, concentrating on the main features of the 
systemic response as relevant to this thesis. This section is based on investigations 
using laboratory animals and studies in man. The second section deals with the 
APR in domestic animals with particular emphasis on serum amyloid A as a major 
acute phase protein in cattle. In the third section bovine pasteurellosis is briefly 
reviewed as this is an important disease of cattle in which a major acute phase 
response has been observed and was the experimental model used in this study. 
The final section describes the aims of the study.
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1.2 The acute phase response
1.2.1 Local response
The local acute phase response occurs at the site of injury or infection and 
commences immediately after the insult with an increase in the permeability of the 
post-capillary venules. This increase in permeability is due to the action of a wide 
variety of substances such as prostaglandins (PGE2, PGD2 and PGI2) leukotrienes 
and other vasoactive, kinin-like mediators (Emau et al. 1984; Sipe 1985a; Whicher 
and Westacott 1992). The haemodynamic changes that occur as a result of 
vascular leakage include platelet aggregation and the early influx of neutrophils, 
macrophages and other cell types to the site of tissue damage. The vascular 
leakage also leads to tissue oedema and pain. The cells that arrive at the site of 
tissue injury and those that are resident, release proteinases and lysosomal 
enzymes which causes cell necrosis. Many of these changes are mediated by 
cytokines produced by mononuclear phagocytes. Mononuclear phagocytes are 
cells derived from the monocytic linearage and include monocytes, Kupffer's cells 
and peritoneal, pulmonary and other macrophages. Activation of these cells 
(monocytes and macrophages) are one of the earliest cellular responses to tissue 
injury and is associated with the release of a variety of inflammatory mediators 
including arachidonic acid metabolites, complement split products, lysosomal 
enzymes, oxygen free radicals and cytokines.
1.2.2. Systemic response
This section describes the systemic acute phase response which encompasses a 
wide range of pathophysiological alterations such as fever, leukocytosis, trace 
mineral redistribution, increased release of stress hormones and synthesis of 
hepatic APP.
Studies in man and laboratory animals have demonstrated that cytokines 
namely IL-1, IL-6, and TNFa produced by monocytes and macrophages are
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responsible for mounting the systemic acute phase response and have been the 
subject of extensive reviews (Sehgal et al. 1989; Kishimoto 1990; Moldawer 
1992).
1.2.2.1 Fever
Fever is one of the characteristic features of the systemic acute phase response. In 
fever, the thermoregulatory 'set-point' is elevated and as a result heat production is 
increased and concomitantly heat loss is decreased (Snell and Atkins 1967). The 
first link between systemic fever and an inflammatory lesion was discovered when 
it was found that fever could be induced by injecting a protein known as 
'exogenous pyrogen' isolated from sterile pus (Atkins and Bodel 1972). 
According to this study, in the host the exogenous pyrogen induces leukocytes to 
synthesise and release an EP which produced fever. Later studies by Dinarello 
(1984a) demonstrated that the substance originally identified as EP was 
interleukin-1.
Moderate fever plays an important role in improving the host's defence 
against infection as it helps to increase mobility of leukocytes to the site of 
infection and enhances their phagocyte and bactericidal activities. In addition, the 
inflammatory and immune responses are known to function optimally under a 
slightly raised temperature rather than at normal body temperatures (Kluger et al. 
1975).
1.2.2.2 Leukocytosis
Leukocytosis is another component of the APR which commences within a few 
minutes of initiation of the inflammatory process (Sipe 1985a). Under normal 
circumstances, leukocytes in circulation vary from 400 to 11,000 cells per cubic 
millimeter but during the APR this value can increase by 5- to 10-fold. 
Neutrophils predominate in the leukocytosis associated with the APR, except in
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specific allergies or parasitic infections where eosinophil counts tend to increase 
(Sipe 1985b).
At the site of infection several pathological changes take place. These 
include cell necrosis, repair of injured tissues, the removal of waste material and 
debris and the elimination of invading bacteria. Damaged cells release active 
products such as lysosomal enzymes, oxygen radicals, prostaglandins and 
histamine which are toxic to the host (Emau et al.. 1984; 1986; Breider et al. 
1990). The host, in order to protect itself from these toxic compounds, increases 
blood flow to the site of injury by dilation of blood vessels. The changes in the 
blood flow allow large number of leukocytes, particularly neutrophils to be 
brought to the site of injury (Walker et al. 1985; Bowersock et al. 1990). These 
neutrophils, which have an antimicrobial action make their way between 
endothelial cells to arrive at the site of tissue injury where they initiate destruction 
of invading bacteria by the generation of oxygen free radicals and lysosomal 
enzymes (Strieter et al.. 1989; Breider et al. 1991; Whiteley et al. 1992). 
Macrophages follow later as they move much more slowly than the neutrophils, 
but both these cells when activated, phagocytose bacteria and cell debris (Strieter 
etal. 1992).
During the APR, endotoxins, IL-1, neutrophil releasing factor, 
prostaglandins and several other complement factors activate the bone marrow to 
release polymorphonuclear leukocytes and stimulate the maturity of these cells 
resulting in an elevation of both mature and immature neutrophils in circulation 
(Sipe 1985a; Whicher and Westacott 1992; Maheswaran et al. 1993). The 
neutrophils migrate rapidly to the site of tissue damage, as described above, and 
therefore, the rise in circulating neutrophils is transitory since their initial increase 
is followed by a sharp fall as the rate of replacement fails to cope with the rate of 
migration from the circulation.
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I.2.2.3. Trace minerals
Another component of the non-specific host defence response to infection 
involves changes in serum trace mineral concentrations. Specific alterations 
include an elevation of plasma copper and depression of both zinc and iron 
concentrations. Many of these alterations in the storage and binding of trace 
metals have been attributed to the activity of IL-1 (Kampschmidt and Upchurch 
1969; Kampschmidt and Pulliam 1978). The redistribution of trace elements in 
combination with an elevation in body temperature appears to play a major role in 
containing bacterial proliferation (Kluger and Rothenburg 1979).
Iron
Apart from the iron present in the porphyrin ring of haemoglobin the major 
portion of iron in the circulation is bound to transferrin (Bothwell et al. 1979). In 
the APR, the early increase in microvascular permeability allows albumin and 
plasma proteins of similar size, such as transferrin to rapidly leak out of the 
circulation resulting in reduced serum concentrations (Whicher and Westacott 
1992). This reduction of transferrin concentration is believed to contribute 
significantly to the decrease in serum iron concentration during the APR (Fleck 
and Myers, 1985). In man, a significant fall in plasma iron and transferrin 
concentrations were observed 6 hours following elective surgery, and continued to 
be reduced to 80% of the normal level at the end of 12 hours (Kampschmidt and 
Upchurch 1969). However, in a subsequent study by the same group 
(Kampschmidt and Upchurch 1974) it was shown that in elective surgery, the fall 
in serum iron concentration began even before a drop in transferrin commenced 
(Kampschmidt and Pulliam 1978). According to the latter study, this reduction in 
iron concentration is due to an increase in uptake by the liver which may be related 
to IL-1 activity (Kampschmidt 1984; Fleck 1985). According to Bennett and 
Kokocinski (1979) a further reason for the fall in serum iron during injury may be 
due to the action of lactoferrin, an iron binding protein released from neutrophils 
which forms a complex with the iron released from transferrin and is then taken up
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by the liver, van Snick et al. (1974) reported that the transfer of iron from 
transferrin to lactoferrin occurs only in an acidic environment therefore, it is most 
likely that this transfer occurs at the site of injury where an acidic pH prevails. 
Iron is essential for bacterial growth and increases in vitro iron, and zinc 
deprivation has proved to be inhibitory for most pathogenic bacteria (Fleck and 
Myers 1985). The redistribution of the iron in the APR increases competition 
between the host and the microbe for this trace element which could eventually 
limit bacterial proliferation (Kluger and Rothenburgh 1979). In addition, the rapid 
sequestration of iron by the action of lactoferrin at the inflammatory site may also 
serve as an antimicrobial mechanism to curtail multiplication of the bacteria during 
an infection (Bullen 1981).
Zinc
In man, 65% of plasma zinc is bound to albumin while the balance is bound to a  
2 -macroglobulin (Giroux 1975). Following acute trauma, the loss of albumin from 
the vascular compartment is accompanied with reduction (approximately 40%) of 
zinc, particularly during the first 8 hours (Kampschmidt and Pulliam 1978). 
Serum zinc could also be reduced due to the action of IL-6 activation of 
hepatocytes during the APR to synthesise metallothionine, the Zn storage protein 
in liver (Fleck and Myers 1985). Normally, metallothionine synthesis is dependent 
on the intake of dietary zinc but in the APR glucocorticoids, catecholamines, 
glucagon and IL-6 induce metallothionine production there by increasing the 
hepatic uptake of zinc from the circulation (Schroeder and Cousins 1990). In 
man, the rapidity of response of trace metals to infection was demonstrated by 
Pekarek et al. (1972) where it was shown that the serum zinc levels fell even 
before the clinical symptoms of viral infections became apparent. As in the case of 
iron, zinc is an important requirement for the microbial growth thus low plasma 
zinc concentrations benefits the host by limiting microbial proliferation.
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Copper
In contrast to serum zinc and iron, the copper concentration in circulation 
is elevated in the APR due to an increased synthesis of ceruloplasmin, the copper 
binding protein (Pleck and Myres 1985; Auer et al. 1989). The presence of 
elevated copper concentrations in acute and chronic infectious conditions in 
human patients has been known for many decades but the specific role of copper 
in the APR is yet not clear (Reck and Myres 1985).
I.2.2.4. Hormones
Alteration of hormone concentration manifested by an increase of ACTH, 
glucocorticoids, glucogen, catecholamines and a reduction of thyroid hormones is 
another major feature of the APR (Stadnyk and Gauldie 1991; Whicher and 
Westacott 1992; Wong and Hershman 1992). During bacterial infection, 
cytokines stimulated by endotoxin promote interaction between the neurological 
and endocrine pathways through the activation of the hypothalamus. This results 
in the release of corticotrophin releasing factor which in turn activates the anterior 
pituitary to release ACTH.
Extrapituitary pathways are also known to stimulate corticosteroids 
(Whicher and Westacott 1992). Endotoxins can directly stimulate the adrenal 
cortex to release corticosteroids (Whitcomb et al.. 1988). Salas et al. (1990a) 
reported that the cytokines IL-1 and IL-6 are also capable of stimulating the 
release of cortisol directly from the adrenal cortex. In experimental studies, 
Besedovsky (1986) showed that recombinant human IL-lp by itself can increase 
ACTH and cortisol concentration in mice. Furthermore, in vitro studies have 
shown that corticotrophic cells from the pituitary when incubated with IL-1 
release ACTH (Bemton et al. 1987). In the APR the anti-endotoxin and anti- 
shock functions of glucocorticoids assist to overcome the harmful effects of LPS 
(Finley and McKee 1982).
28
The reduction of thyroid hormones in the acute phase response is thought 
to be related to the lethargy associated with the APR. Low thyroxine (T4) levels 
have been reported in man during acute infections although the specific role is yet 
unclear (Chopra et al.. 1979; Kaplan et al. 1982; Semple 1986; Wong and 
Hershman 1992). Recent studies in man have identified the presence of large 
numbers of TNFa receptors in the thyroid gland during the APR indicating that the 
fall in T4 may be associated with the release of TNFa at this time (Wong and 
Hershman 1992).
I.2.2.5. Acute phase proteins
Acute phase proteins are a group of plasma proteins whose concentration
increases by 25% or more in the first 7 days following tissue damage. These are
liver derived glycoproteins (Kushner 1982; ICSH Expert Panel 1988; Evans and
Whicher 1992). As in other systemic responses the cytokines IL-1, IL-6 and TNF 
a  are the prime mediators in stimulation of hepatic acute phase protein synthesis.
It is possible that each cytokine induces a different set of APP (Thomson et al. 
1992). The acute phase proteins of man and laboratory animals have been 
extensively reviewed (Kushner 1982; Koj 1985; Gauldie et al.. 1987; Sipe 1992) 
and some of the more studied APP are shown in Table 1.1. which also gives their 
function, where this is known.
Acute phase proteins serve various roles in inflammation including 
mediators, modulators, inhibitors, scavengers and, immuno-modulators. APP are 
designed to contribute to the repair and restoration of the damaged tissues. In 
certain types of diseases specific APP may be more actively catabolized than 
other types leading to low plasma concentrations. For example in a haemolytic 
crisis haptoglobin binds to haemoglobin forming a haptoglobin-haemoglobin 
complex which is then absorbed by the liver reducing the plasma concentration of 
haptoglobin.
29
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Models of inflammation in laboratory animals have been used extensively 
to study the APR of the rat, rabbit and mouse (Gordon and Koj 1985). Each 
species exhibits a unique pattern of APR in relation to APP synthesis Table 1.2. 
(Kushner and Mackiewicz 1987). In rabbits both CRP and SAA are inducible 
APP while in mice, only SAA increases on stimulation with no significant 
alteration in CRP (Pepys and Baltz 1983; Sipe 1990). Conversely, serum amyloid 
P (SAP), another protein defined by its association with amyloid deposits, is a 
major APP in mice, but not in rabbits or man. The acute phase protein profile of 
the rat differs markedly from other laboratory animals and from that reported in 
man (Kushner and Mackiewicz 1987; Sipe 1992). A major APP in rat serum was 
characterised by Darcy (1964) which was first known as "Darcy Protein", and 
later renamed as "cysteine proteinase inhibitor" based on its function. a 2- 
Macroglobulin, a generalized proteinase inhibitor is another major APP in the rat 
(Fey and Gaulgie 1988) while both SAP and CRP are moderate APP in this 
species (Pepys and Baltz 1983). In the rat the primary structure of SAA protein is 
different from other species of laboratory animals and is uniquely resistant to 
inflammation associated amyloidosis (Baltz et al.. 1987). In some species, plasma 
concentrations of albumin and transferrin have been shown to fall during the acute 
phase response and are known as negative acute phase proteins.
1.2.3. Cytokines
Communication between cells is essential for biological functions. An 
important mode of cell communication, essential for protection from infectious 
agents occurs through a group of soluble mediators known as cytokines. These 
are proteins which are synthesised by a variety of cells including 
monocytes/macrophages, fibroblasts and endothelial cells in response to specific 
stimuli such as cell proliferation, cell differentiation and mediators of the APR. 
Most cytokines function pleiotropically exhibiting a wide range
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of biological effects on cells (Table 1.3) while, on the other hand, a particular cell
can also be influenced by different cytokines. Cytokines have a very short half-
life ensuring that they act only for a limited period in circulation or in extracellular
fluid (Kunkel and Remic 1992). The classification of cytokines is based on their
physiological role; those that activate cell growth are referred to as growth factors
while those that are produced by or act upon cells of the immune system are
known as lymphokines, and cytokines which are implicated in tumour destruction
are termed tumour necrosis factors. Interleukins are a particular group of
cytokines produced and released by activated T lymphocytes that act on other
lymphocytes to produce biological effects (Clemens 1991).
It is possible for each cytokine to induce a different aspect of the systemic 
APR (Evans and Whicher 1992; Thompson et al.. 1992). For example TNFa
activates the early APR. IL-1 plays a major role in inducing fever, whereas IL-6 
has a greater effect on hepatocytes to stimulate APP synthesis. Many biological 
actions are the result of synergistic action of two or more cytokines (Atkins et al.. 
1964; Atkins and Bodel 1972; Le and Vilcek 1989).
Previous studies in man and laboratory animals have demonstrated that 
specific cytokines are invovled in the regulation of the APR and there are several 
recent reviews on this topic (Le and Vilcek 1987; Sipe 1990; Moldawer 1992). 
IL-1, IL-6 and TNFa are the major cytokines which are responsible for mounting
an APR following tissue injury and infection. For example in Gram-negative
sepsis, bacteria invade the host and multiply in the circulation, resulting in a rise in 
the serum endotoxin concentration. This endotoxin induces the synthesis of TNFa
in monocytes which is released into the circulation 1-2 hour later. IL-6 is 
released in a similar manner 30-60 minutes after the TNFa response partly caused
by TNFa and IL-1 stimulation of monocytes and
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endothelial cells. The release of IL-1 in serum probably occurs between those of 
TNFa and IL-6 (Waage et al. 1989; Waage et al. 1992). The interaction of these
cytokines is believed to be important in the stimulation of the systemic APR 
(Hesse et al. 1988; Michie et al. 1988; Shalaby et al. 1989; Rothe et al. 1993).
1.3. Acute phase response in domestic animals
1.3.1. Acute phase protein response
The APP response varies with the species (Table 1.2; Kushnerl982; 
Conner et al. 1988a; 1988b; Eckersall 1992a). In cattle, Hp and SAA are 
recognised as major APP (Eckersall and Conner, 1988; Boosman et al. 1989). 
Although fibrinogen has been widely used in veterinary clinical diagnostic work, it 
only shows a medium response in cattle (Eckersall and Conner 1988; Kent 1992) 
(Table 1.2). The use of acute phase proteins for veterinary diagnosis has been 
recently reviewed by several workers (Eckersall 1992a; Kent 1992; and Gruys 
et al.. 1993). A further potentially important use of APP is in ante-mortem 
examination to identify infected carcases and thereby to improve the quality of 
meat for human consumption (Saini and Webert 1991; Eckersall 1992b).
1.3.1.1. Horse
In the horse, early investigations on the APR were focused on studies 
relating to the APP response. Serum Hp was one of the first acute phase proteins 
to be measured in order to detect a variety of clinical conditions in horses 
(McGuire et al.. 1969). In these studies a reduction in Hp concentration was 
found to be a sensitive marker to detect the presence of intravascular or 
extravascular haemolysis during virus-induced equine infectious anaemia. In 
another study, Willett and Blackmore (1979) attempted to use Hp measurements 
to assess liver function in horses but they failed to demonstrate a definite
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correlation between hepatocellular damage and Hp concentration. The use of 
serum Hp as a clinical test was further studied by Sheldrick et al.. (1982) and Kent 
and Goodall (1991). These workers noted that increased Hp concentrations were 
more sensitive than leukocyte counts in detecting tissue damage, particularly 
when associated with bacterial infections. Hp levels were also found to decrease 
in response to treatment with antibiotic therapy. Sheldrick et al.. (1982) 
concluded that, in the absence of a haemolytic crisis, Hp could be used as a 
positive acute phase indicator to monitor the health status of horses.
In the studies conducted by Pepys et al.. (1989) SAA was recognised as a 
major APP in the horse and it was found to be a more reliable disease marker 
compared to Hp to detect viral and bacterial infections. They also noted that SAA 
concentrations could be used to monitor the general health status of horses in 
training and racing.
Prealbumin protein (Pr) and ceruloplasmin are two other acute phase 
proteins which have been reported to be sensitive disease markers in the horse (Ek 
1980; Barton and Embury 1987). In a clincal study, Ek (1980) measured the Pr 
by an immunodiffsion technique and demonstrated a significant increase of Pr in 
horses with acute infections and malignant tumours. Barton and Embury (1987) 
in an experimental study on the pathogenesis of Rhodococcus equi infection in 
foals showed that the elevation of both serum copper and ceruloplasmin oxidase 
levels to be sensitive markers of infection.
More recent studies on the APR in horses have concentrated on the 
cytokine response to experimentally induced endotoxaemia (Mackay and Lester 
1992; Hawkins et al.. 1993; Carrick et al.. 1993). In these investigations 
injections of LPS or recombinant cytokine preparations have been administered 
directly into the circulation or to target organs such as joints. The consequent 
APR has been evaluated by measuring fever, leukocytosis and analysing the 
cytokine responses. Hawkins et al.. (1993) injected LPS into the synovial cavity 
to measure the APR in the horse. Their studies revealed that IL-6; TNFa and
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prostaglandin E2 were released in response to the subsequent synovitis and that 
the serum TNFa concentration peaked at 2 hours and the IL-6 peaked later at 8
hours post-injection. PGE2 responded immediately and was significantly high for 
66 hours post injection. Typical acute phase reactions such as increased rectal 
temperature, leukocytosis and plasma protein changes were noted. Their study 
reported that TNFa is the key mediator of APR in the horse. In another study
Carrick et al.. (1993) induced endotoxaemia by injecting LPS from E. Coli to 2 
groups while a third group was injected with platelet activating factor (PAF) 
receptor antagonist prior to LPS treatment. They monitored the consequent APR 
activity by measuring the temperature, leukocyte counts, heart rate, packed cell 
volume, capillary refill time, mean arterial pressure and serum lactate 
concentrations. The APR developed in all horses in all 3 groups but the group 
that received PAF receptor antagonist demonstrated a mild APR.
I.3.I.2. Pig
Experimental studies of acute respiratory diseases and atropic rhinitis caused by 
Pasteurella multocida have identified Hp as an acute phase protein in pigs 
(Eurell et al.. 1990; Hall et al.. 1992). In addition Hp concentration has also been 
recognised as an indicator of weight gain in pigs (Eurell et al.. 1992). Eckersall 
(1987) in a preliminary clinical study noted an increase in the Hp, seromucoid and 
CRP concentrations of weaned pigs with pyrexia resulting from a variety of 
clinical conditions. More recently Burger et al. (1992) suggested that CRP is a 
good marker to monitor the general health status of pigs following a clinical study 
involving 120 weaned female piglets in which they observed an increased CRP 
concentration in animals with fever and inflammatory conditions compared to 
normal piglets.
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1.3.1.3. Sheep and Goat
There have been only limited investigations of the APR in sheep. However, Hp, 
fibrinogen and ceruloplasmin have been identified as acute phase proteins in sheep 
following experimental bronchial obstruction (Pfeffer & Rogers 1989) and the 
response profile resembled that of cattle. In a clinical study, the concentration of 
Hp was elevated in dystocia cases where dead lambs were present in utero as 
opposed to ewes which had live lambs delivered (Scott et al.. 1992). It is evident 
that the APR takes place in sheep and that the determination of the APP could 
play a role in detecting inflammatory conditions and monitoring progress after 
medication.
van Mienetal.. (1982; 1983; 1984; 1990; 1992) in a series of experiments
studied the APR in goats following adminstration of a range of inducers which
included E. coli endotoxin, Trypanosoma brucei, various interferons and 
preparations of recombinant bovine and human TNFa . The APR observed varied
with the stimulant but in general, the changes observed include an increased 
heart rate, anorexia, leukocytosis, hypoferraemia, hypozincaemia and 
hypercupraemia. Hypoglycaemia was observed at the onset of APR which was 
followed by hyperglycaemia at a later stage. These studies however, failed to 
examine the hormonal changes or the APP responses which are usually manifested 
in APR.
1.3.1.4. Dog and Cat
Many APP including ceruloplasmin, fibrinogen, haptoglobin are glycoproteins, 
therefore the APR can be monitored by a non-specific assay of serum
glycoproteins. The APR in dogs was identified by an increase in serum
glycoproteins by concanvalin A binding following surgical trauma, endotoxin 
administration and various inflammatory conditions (Eckersall et al. 1985).
Several individual APP such as CRP and Hp have been identified in the dog
(Conner and Eckersall 1988; Solter et al. 1991). Conner et at. (1988a) studied the
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relative and sequential changes of five APP following surgical trauma in the dog. 
These investigations demonstrated a 100-fold increase of CRP which peaked 24 
hours after surgery followed by peak levels of ceruloplasmin, Hp, and seromucoid 
which were detected between the fourth and sixth day after surgery. There was 
little variation in the levels of oq antitrypsin. Measurement of CRP levels as a 
clinical test to detect inflammatory conditions in the dog has been restricted as the 
assay available was based on an immunodiffusion technique which yielded only a 
semiquantivative estimate of the protein. This limitation was overcome with the 
development of an immunoturbidimetric assay which could be performed on most 
modem biochemical analysers (Eckersall et al.. 1991). Measurement of serum Hp 
and ceruloplasmin concentrations have also been found to be useful markers for 
detecting inflammatory conditions in the dog (Solter et al. 1991).
Little is known on the APP response in the cat. Watanabe et al.. (1992) 
isolated CRP from normal cats serum using an affinity chromatography method 
and made a detailed analysis of the biochemical characteristics of the protein. 
They also measured the CRP concentration in cat serum using an immunodiffusion 
method and noted that the CRP value in the normal cat was higher than that 
reported for man (Clause et al. 1975) and the dog (Caspi et al. 1987). However, 
it is not yet known whether CRP is an APP in the cat. (Watanabe et al.. 1992).
L3.1.5. Cattle
Studies on the APR in cattle have concentrated mainly on investigations 
relating to the APP (Conner et al. 1989). Fibrinogen is the most widely known 
APP in cattle and is used to detect inflammatory conditions although it is 
considered to be a moderate APP when compared to other APP such as Hp and 
SAA (Table 1.2). Bremner (1964) was the first to show that Hp which is 
undetectable in normal serum is increased
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markedly in inflammatory conditions and that caution should be taken in the 
interpretation as the serum levels could fall during a haemolytic crisis because of 
an increased hepatic uptake of Hp/haemoglobin complexes by the liver. Spooner 
and Miller (1971) in a subsequent study, investigated the Hp concentration in a 
large population of clinically normal and diseased animals and suggested that an 
assay for Hp can be a useful diagnostic test to detect inflammatory disorders in 
cattle. Makimura and Suzuki (1982) developed a colorimetric assay for bovine 
Hp based on the ability of Hp to prevent the destruction of peroxidase activity of 
haemoglobin in an acid medium. In the studies conducted by Conner et al. 
(1988b) the sequential changes of five APP in cattle were examined following 
inflammatory stimulation by subcutaneous injection of oil of turpentine. These 
studies indicated raised levels of a! antitrypsin, ceruloplasmin, fibrinogen, Hp and 
seromuciod on the second and third day after injection, with a peak occurring 
between the fourth and seventh day. They also noted that the levels of Hp and 
seromucoid varied with the dose whereas no changes were present in 
ceruloplasmin and oq antitrypsin concentrations. In a further experimental study 
conducted by Conner et al. (1989), increased levels of Hp were observed 
following inoculations with both Pasteur el la kaemolytica serotype Al and E.coli 
LPS but there was little Hp response to Ostertagia ostertagi infection. The use of 
Hp as clinical test was examined by Skinner et a l. (1991) who demonstrated 
increased concentrations of Hp in animals with bacterial infections but not in 
healthy animals or those with metabolic diseases such as ketosis and milk fever. 
Recent modifications to the Hp assay procedure have allowed it to be adopted as 
an automated assay in biochemical analysers and this has further improved the 
potential of the Hp assay being used as a routine clinical test to detect 
inflammatory conditions in cattle (Skinner 1992). For many years the Hp 
concentration in bovine serum was expressed as a percentage of Hb binding
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capacity: however the purification of bovine Hp by Eckersall and Conner (1990) 
has now allowed the quantitaion of serum Hp in grams per litre.
Studies conducted by Boosman et al.. (1989) have demonstrated that 
bovine serum amyloid A (b-SAA), a precursior of amyloid protein A (AA), 
increased by a 100-fold in cattle experimentally injected with E. coli LPS. These 
findings (Boosman et al.. 1989) indicate that SAA is a major APP in cattle as it is 
in man (Pepys and Baltz 1983; Eriksen and Benditt 1986) and that it has a 
potential of being used as a disease marker in cattle. The measurement of b-SAA 
was performed using an ELISA system in which a bovine anti-A A (b-AA) 
antibody was used as the primary antibody. In this ELISA system the SAA 
concentration was measured using arbitrary units. This has restricted comparison 
of results with other laboratories. Also anti-AA antibody might not be a suitable 
antibody to measure circulating b-SAA levels. As reported by Niewold et al. 
(1987) there are specific amyloidogenic SAA-isotypes which activate amyloidosis 
and they are different to those that increase during the APR. Thus anti-AA should 
be specific for SAA isotypes which are important to induce amyloidosis and use of 
anti-AA to measure b-SAA in the APR might give false results. The fact that 
SAA concentrations in serum are not affected by haemolysis makes it more 
suitable than Hp as a marker for the APR (Eckersall 1992a; Kent 1992).
The b-SAA concentrations in healthy and diseased cattle were measured by 
both Alsemgeest et al. (1992) and Gruys et al.. (1993). These studies showed 
that the SAA concentration varied with the disease state. In bacterial infections 
and in Gram-negative sepsis SAA concentrations were close to a maximum of 100 
arbitrary units while minor surgical conditions showed only a moderate increase.
Other acute phase proteins studied in cattle include ceruloplasmin (Piercy 
1979; Conner et al.. 1986, 1988b, 1989) oq-Acid Glycoprotein
(Motoi et al. 1992) a x antitrypsin (Conner et al.
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1986, 1988b) seromucoid (Conner et al. 1986, 1988b), and fetuin (Dziegielewska 
etal. 1992).
1.3.2. Trace minerals
Several studies in domestic animals, particularly in ruminants have demonstrated 
alterations in trace mineral concentrations in the APR (Corrigal et al. 1976; 
Verheijden et al. 1983b). Experimental studies conducted by van Miert et al. 
(1982) in goats in which the APR was induced after intravenous injection of 
endotoxin showed an 85 per cent reduction of both plasma zinc and iron 
concentrations. In another study Boosman et al. (1989) reported the development 
of hypozincaemia and hypoferraemia 17 hours after the administration of E.coli 
endotoxin to calves. They also reported that the concentrations of the two trace 
elements rapidly returned to the normal levels and that a second injection of 
endotoxin did not alter the plasma zinc level. Studies reported by Piercy (1979) 
have shown that calves infected with a pathogenic strain of Salmonella dublin had 
developed an acute hypoferraemia 24 to 48 hours after challenge and that it 
coincided with the onset of the bacteraemia and pyrexia.
In ruminants the fall in plasma iron and zinc levels in the APR is associated 
with an increase in copper concentration (Corrigall et al. 1976). Pekarek et al. 
(1972) reported a similar pattern of trace mineral alteration in man with viral 
infections. The inverse relationship between zinc and copper in ruminants was 
demonstrated in a clinical study in cattle and sheep in which it was shown that in 
acute infections in ram lambs the plasma zinc level dropped to its lowest level 
before the copper concentration achieved a peak (Corrigall et al. 1976). 
According to Beisel and Sobocinski (1980) the mechanism by which these effects 
are produced is attributed to the production of a heat labile factor (later identified 
as IL-1) by phagocytosing cells which when injected into normal animals enhances 
liver mRNA synthesis resulting in the production of a
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variety of glycoproteins, one of which is ceruloplasmin. This sequence of events 
results in a rise in ceruloplasmin and hence copper.
Although the potential of using the altered concentration of trace mineral 
concentrations in the APR as disease marker in ruminants was emphasised by 
Corrigall et al. (1976), few studies have been carried out to fully explore this 
possibility. In the clinical study conducted by Corrigall et al. (1976) cattle with 
acute infections showed raised plasma copper concentrations and low zinc levels 
while animals with chronic conditions in which there was little or no systemic 
illness exhibited only a slight change in the copper and zinc values.
1.3.3 Hormones
Species vary greatly in their response to glucocorticoids, with some 
species (rat, mouse, rabbit) being more sensitive to glucocorticoids than others 
(human, monkey, guinea pig). Cattle respond as a corticosteroid-resistant species 
(Roth 1985). Parturition (Hudson et al. 1975), endotoxin-induced mastitis (Paape 
et al.. 1974) and neonatal diarrhoea (Roth 1985) are among the stressful 
conditions associated with increased plasma cortisol concentrations in cattle.
Alterations in metabolic hormones such as cortisol in the APR in cattle 
have been the subject of few studies (Elsasser 1992). However, studies of bovine 
pneumonic pasteurellosis (the subject of the next Section) have shown that 
increased cortisol is associated with this condition in field cases (Roth 1985). 
Indeed bovine pneumonic pasteurellosis (BPP) is one of the best examples of 
stress-associated infectious disease in calves due to its association with high 
cortisol levels (Roth 1985). Various infectious agents have been associated with 
this disease, also known as shipping fever pneumonia, but for a long time no 
single agent was consistently found or able to reproduce the syndrome. A factor 
generally present is stress and a working hypothesis for the pathogenesis of 
shipping fever, which was first advanced by Hoerlein and Marsh (1957), proposes 
that stressors encountered by the animal reduced its resistance mechanisms 
sufficiently to allow viral and secondary bacterial infections to occur. Many of
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the stresses associated with a predisposition to shipping-fever pneumonia are 
known to cause increased plasma cortisol concentrations. Some of these 
conditions are weaning, handling, acute pain and transport. The high plasma 
cortisol associated with BPP could lead to immunosuppression. However, 
increased plasma cortisol is probably not the only mechanism for stress-associated 
immunosuppression in shipping fever, but it is undoubtedly an important 
contributory factor.
1.3.4. Bovine Cytokines
The concentration of tumour necrosis factor in calves after separate challenges of 
S. typhimurium and E coli LPS has been demonstrated by Peel et al. (1990). In 
this study TNFa levels began to rise as early as 30 minutes after administration of
the LPS, reached peak levels between 1-2 hours post-treatment and returned to 
baseline 4 hours later. In another in vivo study Kenison et al. (1991) 
demonstrated similar TNFa responses following the administration of E-coli LPS.
However, the calves infected with S. typhimurium failed to show a TNFa response 
in spite of proven septicaemia on blood cultures. Recently, two groups of
workers reported conflicting results from experiments designed to study the 
systemic TNFa response in calves infected with P. haemolytica. Pace et al.
(1993), using a bioassay, demonstrated an increase in circulating TNFa following
intra-tracheal inoculation of P. haemolytica. The rise in the TNFa concentration
was observed within 2 hours of challenge and lasted for 48-72 hours. In contrast
to these observations Espinasse et al. (1993), using a radioimmunoassay, were 
unable to detect any increases of serum TNFa concentrations in calves inoculated
with P. haemolytica by intra-nasal/intra-tracheal route as described by Gibbs et 
al. (1984). In the latter study TNFa levels were measured in serum collected at 6
hourly intervals over a period of 3 days after treatment.
There have been few reports on the IL-1 and IL-6 in cattle (Collins et al. 
1989; Shuster et al. 1993; Nakajima et al. 1993). Collins et al. (1989) reported
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IL-1 like activity after using intra-mammary devices. IL-1 like activity has also 
been reported in milk after experimental udder infection by intra-mammary 
administration of LPS (Shuster et al. 1993). Nakajima (1993) was able to detect 
an APR in cattle following repeated infusion of human recombinant IL-6.
1.4 Bovine Pasteurellosis
1.4.1. Introduction
Pasteurellae are important bacterial pathogens of domestic animals, in which they 
cause a variety of diseases including pneumonia, septicaemia and mastitis (Carter 
1967). Within the genus Pasteurellae the most important respiratory pathogen of cattle 
is P. haemolytica which is responsible for bovine pneumonic pasteurellosis (BPP), an 
economically inport ant disease to the farming industry in Western Europe and North 
America (Dagleish 1989; Frank 1989; Whiteley et al. 1992). Currently, BPP costs 
over one billion dollars per annum to the beef cattle industry in the USA (Whiteley et 
al. 1992) and in the UK, the annual estimated losses due to BPP and other infectious 
respiratory diseases in cattle is almost £30 million (Dalgleish 1989).
P. haemolytica is a Gram-negative, non-motile facultatively anaerobic 
bacterium which displays characteristically weak haemolysis on blood agar. The 
species can be separated into two biotypes, A and T, on the basis of several in vitro 
criteria including carbohydrate fermentation reactions (Smith 1961), nucleic acid 
homology (Biberstein and Francis 1968) and antibiotic sensitivity (Biberstein and 
Kirkham 1979). Clinically, the A biotypes are associated with pneumonic 
pasteurellosis in ruminants and the T biotypes with systemic disease in 
weaned lambs (Smith 1961). Sixteen serotypes are differentiated by an 
indirect haemagglutination (IHA) test which depends on the capsular 
antigens of the bacteria (Biberstein 1978; Fodor et al. 1987). The 
serotype Al is the most frequently isolated serotype in BPP 
(Whiteley et al. 1992)
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Bovine pneumonic pasteurellosis which is also referred to as transit fever, 
stockyard fever or shipping fever was first described in the United States in 1915 
by Kinsley (1915). The causative agent of BPP was then referred to as Bacillus 
bovisepticus and it was suggested that the organism was universally distributed 
but rarely produced the disease unless the animal's resistance was diminished. 
Kinsley (1915) also stated that young cattle developed this disease following 
movement and mixing with different populations. The first description of BPP in 
the UK was made by Hepburn (1925) when he noticed the disease in cattle 7-10 
days after they had arrived in Aberdeen following a journey by ship from Ireland 
via the Orkney islands. On post-mortem examination, Hepburn observed the 
presence of fibrinous pneumonic lesions in the apical lobes and recovered the 
bipolar organism which had been described previously by Kinsley (1915). Many 
years later the bacterium isolated from animals with transit fever was renamed as 
Pasteurella haemolytica by Carter (1956).
In Britain, BPP is primarily a disease of recently weaned, newly housed, 
single-suckled beef cattle (Selman 1986; Dalgleish 1989). Several factors are 
known to predispose calves to the disease and these include extremes of 
temperature, housing in poorly ventilated buildings, sudden changes of feed, 
primary respiratory virus infections (Parainfluenza 3, Infectious bovine 
rhinotracheitis) and stress induced by transport and mixing of different cattle 
populations. In Britain, the peak incidence of BPP occurs between September and 
December when the bulk of the calf sales take place. A seasonality of the disease 
has also been observed in the United States where a high incidence of BPP has 
been reported during the fall and spring seasons (Frank 1989).
For many years a controversy existed on the role of P. haemolytica in the 
aetio-pathogenesis of BPP. Several workers in North America considered a 
multifactorial aetiolgy for BPP where many predisposing factors such as primary virus 
infections, transport-induced stress were thought to be essential for 
P. haemolytica to produce the disease (Rehmtulla and Thomson, 1981). These
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postulations were refuted following the experimental studies reported by Gibbs et al. 
(1984) in which a disease resembling the field cases was reproduced by intra­
tracheal inoculation of the organism alone. Subsequent studies performed by 
Panciera et al. (1984) and Ames et al. (1985) in the United States of America 
were also able to reproduce the disease experimentally in calves following intra- 
thoracic or intra-tracheal administration of P. haemolytica alone.
1.4.2. Virulence Factors of P. haemolytica
The virulence of P. haemolytica is associated primarily with four virulence factors 
namely fimbriae, the polysaccharide capsule, leukotoxin and lipopolysaccharide 
(LPS, endotoxin). The interaction of these virulence factors with components of 
the pulmonary alveolus is believed to initiate a complex inflammatory reaction 
resulting in an array of pathophysiological alterations which are manifested as the 
clinical and pathological changes of bovine pasteurellosis. Apart from the 
interaction of the virulence factors, each factor on its own plays a specific role in 
the pathogenesis of the disease. The polysaccharide capsule inhibits both 
complement-mediated as well as intracellular killing by phagoctes and enhances 
neutrophil directed migration and adhesion of P. haemolytica to the alveolar 
epithelium (Czuprynski et al. 1991). Leukotoxin on the other hand allows the 
survival of the organism by destroying bovine phagocytic cells and platelets 
(Clinkenbeart et al. 1989a; 1989b; 1989c). The specific role of P. haemolytica 
fimbrae in the pathogenesis of BPP has not been studied but Confer et al. (1990) 
suggested that the fimbrae may enhance colonisation of the upper respiratory 
tract, the first major step in the production of BPP.
1.4.3. Lipopolysaccharide (LPS)
LPS is a major virulence factor which has wide ranging effects on the host (Confer 
et al. 1990; Fenwick 1990; Whiteley et al. 1992). It alters bovine leukocyte 
function by dose dependent inhibition or augmentation (Confer and Simon 1986) 
and is toxic to bovine pulmonary endothelium (Paulsen et al. 1989;
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1990; Breider et al.. 1990). Additionally, P. haemolytica LPS modifies 
cardiopulmonary haemodynamics (Keiss et al. 1964) and elevates circulatory 
prostonoids, serotonin, cAMP,and cGMP (Binkhorst et al. 1990; Emau et al.. 
1984; 1986).
Recent studies by Davies et al.. (1992) have demonstrated variations in the 
LPS of virulent and a non-virulent isolates of P. haemolytica under different 
growth conditions in vitro. The influence of such differences in the LPS on the 
virulence of the organism in vivo is as yet unknown. Pasteurella haemolytica 
LPS is similar to LPS from other Gram-negative bacteria in which it is an integral 
component of the outer membrane of bacterial cell wall (Confer et al. 1990). 
Studies conducted by Keiss et al. (1964) and Rimsay et al. (1981) estimated that 
the quantity of LPS in dried Pasteurella haemolytica cell walls ranges from 12 to 
25 per cent and that the majority of the LPS is of the smooth type. The chemical 
structure of LPS consists of a long chain of sugars (i.e. polysaccharide) and a fat, 
called lipid A (Riestschel and Brade 1992; ; Lacroix et al. 1993). The 
polysaccharide component of the molecule varies from one bacterial species to 
another and is made up of the O-specific chain and a two part core referred to as 
inner and outer core. The O-specific chain is the most variable segment of the 
molecule and consists of 20 to 40 repeating units that include up to eight sugars. 
The structure of the inner core (the part linked to the lipid) consists of two 
unusual sugars one of which is a heptose made up of seven carbon atoms instead 
of the more typical six carbon atoms. The other is Kdo (3-deoxy-D-manno-2- 
octulosonic acid) which is found in all LPS molecules and links the polysacchride 
to the lipid. The structure of the lipid A component of LPS is highly conserved 
between species of bacteria (Riestschel and Brade 1992) and consists of two 
glucosamine sugars modified by phosphate and a variable number of fatty acids. 
Lipid A is the active inflammatory moiety of LPS giving rise to most of the 
deletrious effects of LPS (Bone 1991).
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1.5 Aims of the study
• To develop a sensitive and specific assay which allows accurate quantitation of 
b-SAA and can be widely used to detect inflammatory conditions in cattle.
• To develop a suitable method to purify b-SAA to provide standard material for 
the quantification of SAA concentration during APR.
• To identify and characterise the systemic APR in cattle during experimental 
infection of calves with P. haemolytica.
• To compare the systemic APR to different field isolates of P. haemolytica.
• To determine whether the APR to purified LPS extracted from field isolates of 
P. haemolytica is capable of inducing an APR similar to that induced by the whole 
bacterium.
• To identify the cytokines which are responsible for stimulating the acute phase 
response in bovine pasteurellosis.
CHAPTER H
PURIFICATION OF BOVINE SERUM AMYLOID A
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2.1. Introduction
Serum amyloid A (SAA) derives its name from its close biochemical and 
immunochemical relationship to amyloid A (AA), the fibril protein deposited in 
tissues in secondary amyloidosis. SAA was discovered approximately 18 years 
ago when antibodies raised against AA protein were shown to cross-react with a 
serum component, which was subsequently isolated and identified as consisting 
of a series of isoforms which are now known as the SAA family (Husby and 
Natvig 1974; Anders et al. 1977; Linke et al. 1984). It was found by sequencing 
that the first 76 amino acids in the N-terminal region of SAA represented the 
fragment which is deposited as the AA protein in tissues (Linke et al. 1975; 
Benson et al. 1985). Several laboratories have been successful in raising 
antibodies against purified SAA and have used it as a tool to study the site of 
SAA synthesis (Anders et al. 1975; Linke et al. 1975V In its native state in 
serum, more than 90 per cent of SAA in the form known as apo-SAA, is 
associated with high density lipoprotein3 (HDL/SAA) (d = 1.12-1.21g ml-1) which 
has a combined molecular weight of 180 kD. In the presence of proteolytic 
enzymes or on denaturation with acids, alkalis or detergents HDL/SAA releases 
SAA, a polypeptide of 104 amino acid residues with a molecular weight of 12-14 
kD (Benditt et al. 1988; Pepys and Baltz 1983; Husebekk et al. 1987). In man, a 
small proportion of apo-SAA is associated with low density lipoprotein (LDL), 
intermediate density lipoprotein (IDL) and very low density lipoprotein (VLDL) 
fractions (Feussner and Zeigler 1991).
Serum amyloid A is not a single protein. Heterogeneity of SAA has been 
reported in several species including man (Eriksen and Benditt 1986; Parmelee 
et al. 1982; Sletten et al. 1983; Dwulet et al. 1988), rabbit (Tobias et al. 1982; 
Liepnieks et al. 1991), mouse (Benditt et al. 1979), hamster (Niewold and Tooten
1990), horse (Husebekk et al. 1986; Pepys et al. 1989; Nunokawa 1992) and 
monkey (Parks and Rudel 1985). In man, there are 6 isoforms of SAA
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(Strachan et al. 1989; Raynes and McAdam 1991) while in mice SAA is encoded 
by at least three genes designated SAA^ (Benditt and Meek 1989). Niewold and 
Tooten (1991) demonstrated four isoforms of hamster SAA. In the bovine, only 
one isoform has been identified up to the present time (Rossevatn et al. 1992).
The hepatocyte is believed to be the major site of SAA synthesis and does 
so upon stimulation by cytokines, particularly EL-1, IL-6 and TNFa (Selinger et
al. 1980; Husebekk et al. 1985; Sipe 1992). SAA synthesis has been detected in 
extra-hepatic tissues such as gastrointestinal tract, spleen and kidney by 
identification of SAA-specific mRNA (Sipe 1990).
Although SAA is present in serum primarily during the APR, indicating 
that it has a role in the host non-specific defence system, its biological function is 
not yet clear. One proposed function is that HDL/SAA is involved in reverse 
cholesterol transport by guiding HDL from sites of inflammation to the liver 
(Glomset 1968). Serum amyloid A can preferentially direct HDL to macrophages 
(Kisilevsky 1991) and at the site of injury macrophages absorb cholesterol and 
lipid debris so that the HDL/SAA may aid the transfer of cholesterol from these 
macrophages to tissues, such as liver, where it can be further metabolised 
(Kisilevsky 1991; Kisilevsky and Subrahmanyan 1992). A second possible role of 
SAA in cholesterol metabolism may be as a modulator of lecithin:cholesterol acyl 
transferase (LCAT) activity on HDL (Kisilevsky 1991). A third possible function 
of SAA is that it may aid in the removal of bacterial endotoxin, which is known to 
bind to HDL so that the rapid clearance rate of HDL/SAA may accelerate the 
elimination of complexes of such toxins or other unwanted tissue debris which can 
associate with HDL (Tobias et al. 1982). Another suggestion is that SAA has an 
immunoregulatory role as it may induce fibroblast collagenase synthesis 
(Brinckerhoff et al. 1989) while more recent work suggests that SAA may play a 
role in regulating tissue collagenase gene expression or oxidative burst in 
neutrophils (Linke et al. 1991).
ii
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Serum amyloid A has been purified from serum of humans (Benditt et al. 
1979; Raynes and McAdams 1988; Smith and McDonald 1991), hamsters 
(Niewold and Tooten 1991), mice (Sipe et al. 1989), rabbits (Liepnieks et al.
1991) and recently from bovine serum (Rossevatn et al. 1992). The purified apo- 
SAA has been used for amino-acid sequencing (Husebekk et al. 1988; Rossevatn 
et al. 1992), to characterise the protein (Benditt et al. 1979; Marhaug et al. 1988; 
Niewold and Tooten 1991) and to raise antibodies (Raynes and McAdams 1988) 
for immunoassay development. Although some laboratories have been successful 
in raising antibodies against SAA, the human protein is a relatively poor 
immunogen in rabbits, goats and sheep (MeAdam et al. 1982; Marhaug et al. 
1988; Pepys and Baltz 1983).
Different forms of bovine amyloidosis have been reported (Gruys and 
Timmermans 1979; Hoi and Gruys 1984) and AA protein has been purified from 
these tissue deposits by water extraction and repeated gel filtration in the presence 
of guanidine-HCl (Hoi and Gruys 1984). Furthermore, bovine AA amino-acid 
residues showed a high homology (87%) to the AA proteins of other species. 
Human AA, present in secondary amyloidosis cross-reacted strongly with 
antibodies raised against bovine AA (Gruys and Hoi 1984). Indeed, these 
antibodies have been used by Boosman et al. (1989) to develop an ELISA for 
estimating b-SAA. Rossevatn et al. (1992) performed a complete amino-acid 
sequence of b-SAA following isolation of the protein by sequential 
ultracentrifugation (Havel et al. 1955). According to Rossevatn et al. (1992) 
b-SAA consists of 112 amino acid residues compared to 104 residues present in 
other species which have been studied. This difference is attributed to the 
insertion of 9 amino acids between position 69 and 70 of b-SAA. Despite the 
increased number of amino acid residues there are several common characteristics 
between b-SAA and the SAA of other species such as human, horse and mink. 
The C-terminal region and the middle region (residues
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33-63) of b-SAA are similar to other species whereas from residues 1 to 32 and 
from residue 64 to 73 vary from species to species.
As more than 90 per cent of SAA in circulation exists as an apolipoprotein 
of HDL, methods used for HDL apolipoprotein isolation can be applied to the 
initial stage of SAA purification. The traditional method for HDL isolation is 
sequential density gradient ultracentrifugation in which various lipoprotein 
fractions are separated one step at a time (Havel et al. 1955). However, obtaining 
a significant quantity of SAA by this process is laborious and time consuming. In 
contrast, hydrophobic interaction chromatography (HIC) used in the purification 
of human SAA (Raynes and McAdam 1988) and affinity chromatography (AFC) 
used in the preparation of hamster SAA (Niewold and Tooten 1991) offer 
convenient alternatives for the initial stage in the isolation of b-SAA.
In the present study, hydrophobic interaction chromatography, affinity 
chromatography and a single-step method of preparative ultracentrifugation 
(Liepniek et al. 1991) have been used in the initial purification of b-SAA followed 
by repeated gel filtration for further purification of the protein. These three 
methods have been evaluated and the purified b-SAA was subsequently used to 
quantify a pool of APbS to use as assay standards in the development of an 
ELISA for bovine serum (Chapter III).
2.2. Materials and Methods
Phenyl-Sepharose 4B, molecular weight standards, guanidine-HCl, 3-amino-9- 
ethyl carbazole (AEC), cholesteryl hemisuccinate agarose, dimethyl formamide, 
dithioerythritol, Tween-20, bovine serum albumin (BSA), bicinchoninic acid 
(BCA) protein assay kit (B-9643), cellulose membrane dialysing tubing (12 kD 
cut-off) and other general laboratory chemicals were obtained from
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Sigma Chemical Company (Poole, Dorset, UK). Sephacryl S-200 and Superose- 
12 beads, for preparation of gel filtration columns, and the fast protein liquid 
chromatography (FPLC) system were from Pharmacia AB, Pharmacia Ltd., 
(Milton Keynes, Bucks, UK). Nitrocellulose paper was purchased from Bio-Rad 
Laboratories Ltd. (Bio-Rad House, Hertfordshire, UK). Horseradish peroxidase- 
conjugated anti-rabbit IgG was obtained from the Scottish Antibody Production 
Unit, (Law Hospital, Lanarkshire, UK). Rabbit antiserum to human SAA was 
obtained from Calbiochem, (Novabiochem, Nottingham, UK Cat. No. 566702). 
The Chloride Analyser 925 was manufactured by Ciba-Coming Diagnostics Ltd, 
(Essex, UK). The densitometer was a Chromoscan-3 supplied by Joyce-Loebl 
Ltd., (Gateshead, Tyne & Wear, NE, UK). Beckman L7 ultracentrifuge and 
Beckman Ti50.4 rotor was from Beckman Instruments UK Ltd., (Milton Keynes, 
Bucks, UK).
2.2.1. Purification of b-SAA
The APbS used in this study was harvested from the blood collected at 
slaughter from a cow with an ulcerating tumour. The serum was separated and 
stored at -20°C until it was used.
2.2J.1. Hydrophobic interaction chromatography (HIC): A phenyl-Sepharose 
4B column (3x20 cm) was prepared and equilibrated (flow rate 0.2 ml mur1) with 
5 column volumes of 10 mM phosphate buffer, pH 7.4 containing 4 M NaCl 
(PBS). The serum was dialysed overnight against 10 mM phosphate buffer (PB), 
pH 7.4, and applied to the column in 100 ml aliquots. The column was washed 
with 500 ml of PBS and then eluted with a reducing chloride gradient going from 
4 M NaCl in 10 mM PB to 10 mM PB alone, at a flow rate of 0.5 ml min-1 over a 
total volume of 180 ml. This was followed by an increasing gradient, starting 
from 10 mM PB and rising to 6 M guanidine-HCl in 10 mM Tris-HCl buffer (pH 
7.0) over a total volume of 150 ml at a flow rate of 1.65 ml min-1 to elute the 
bound material. The gradients were formed and controlled with a FPLC
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and 1 ml fractions were collected. The eluant was monitored at 280 nm and the 
chloride concentration of the fractions was determined using a chloride analyser. 
Ten microlitre aliquots of the fractions were analysed on immuno-dot-blot assay 
(Section 2.2.6) using rabbit antiserum to human SAA which demonstrated a 
specific cross reaction with b-SAA. The specificity of the antiserum was 
investigated as part of the validation of the b-SAA ELISA which used the same 
antiserum and is described in chapter 3 and is illustrated by the Western blot 
shown in Figure 3.5. Fractions containing b-SAA were pooled. Five millilitre 
aliquots of the pooled fractions were dialysed in cellulose membrane tubing 
(12 kD cut-off) against three changes of 10% acetic acid and subsequently with 
six changes of distilled water and finally concentrated by dialysis against 
polyethylene glycol (PEG, 20,000 Mr) or by ultrafiltration using an Amicon YM3 
filter, prior to sodium dodecyle sulphate polyacrylamide gel filtration (SDS- 
PAGE) (Section 2.2.4). The bulk of the pooled SAA rich fraction was 
concentrated to 10 ml by dialysis against PEG prior to gel filtration (Section 
2.2.1.4) with an aliquot prepared for SDS-PAGE as described in Section 2.2.1.4.
2.2.I.2. Affinity chromatography: Ten millilitre aliquots of APbS were applied 
to a cholesteryl hemisuccinate agarose column (3 x 30 cm) equilibrated with 
0.15 M NaCl. The flow rate was 0.4 ml min-1 , the eluant was monitored at 280 
nm and recovered in 1 ml fractions. The unbound protein, eluting in the break 
through peak, was pooled as fraction I. Subsequently the column was eluted with 
1 M NaCl to remove non-specifically bound material (fraction II) followed by 
elution with 6 M guanidine-HCl in 50 mM Tris-HCl (pH 7.4) which released the 
affinity bound material (fraction III). Between runs the column was reconstituted 
by washing with 1% (v/v) Triton X-100 in distilled water. Fraction III was 
concentrated as described in section 2.2.1.1 and subjected to gel filtration as 
described in section 2.2.1.4.
2.2.1.3 Preparative Ultracentrifugation (UC): Acute phase bovine serum was 
mixed at a ratio of 3.56 g potassium bromide to 10 ml of APbS to raise the non­
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protein density of the serum to 1.21 g m l1. A 6.5 ml aliquot of the serum-KBr 
mixture was placed in a thermoplastic ultracentrifuge tube (Ultraclear, 13 x 64 
mM; Beckman Instruments Inc.). The tubes were capped and centrifuged at 
164,000g, 4°C for 48 hours in a fixed angle rotor which had a maximum capacity 
of 44 tubes (type 50.4 Ti, Optima L-70 preparative ultracentrifuge; Beckman 
Instruments Inc.). The top layer (1 ml) which contained the SAA rich HDL3 
fraction was aspirated; dialysed against distilled water and lyophilised. The 
lyophilised products were delipidated at 0°C by mixing with 1 ml of a 3:2 (v/v) 
mixture of ethanol:ether, washing with anhydrous ether followed by centrifugation 
and drying in air. The residue was dissolved in 1 ml of 4 M guanidine-HCl 
containing 0.01 mg of solid dithioerythritol prior to fractionation on a gel filtration 
column (Section 2.2.1.4.).
2.2.1.4. Gel filtration: Gel filtration was used as a final step in all purification 
procedures and was performed on the FPLC system. A Sephacryl S-200 column 
(0.8 xlOO cm) was equilibrated with 4 M guanidine-HCl in 50 mM Tris-HCl 
(pH 7.0) and the SAA enriched fractions from HIC, AFC or UC were applied in 
1 ml aliquots and eluted in the same buffer at a flow rate of 0.4 ml min-1. The 
eluant was monitored at 280 nm and the SAA content of the fractions (1 ml) was 
estimated by immuno-dot-blotting (Section 2.2.6). Fractions with a high SAA 
content were rechromatographed on a Superose 12 column (1 x 25 cm) with the 
same buffer at a flow rate of 0.13 ml min-1. Fractions with SAA were pooled and 
dialysed, and the purity assessed by SDS-PAGE (Section 2.2.4). Purified SAA, 
following gel filtration, was also examined by Western blotting as described in 
Section 2.2.5.
2.2.2. Bicinchoninic Acid (BCA) Protein Assay 
Reagents
The reagents for the BCA protein assay were obtained from Sigma Chemicals 
Company (Poole, Dorset, UK).
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Reagent A: 1 g solution bicinchoninate (BCA), 2 g Na^Og, 16 g sodium tartrate, 
0.4 g NaOH, and 0.95 g NaHC03 were brought to 100 ml with distilled H20  and 
the pH adjusted to pH 11.25 with 10 M NaOH.
Reagent B: 0.4 g CuS04.5H20  in 10 ml distilled H20. Solutios A and B are 
stable. Working solution: The working solution was prepared by mixing 100 
volumes of reagent A with 2 volumes of reagent B. The reagent is stable for 1 
week and should be green in colour.
Protein standard: Bovine serum albumin (BSA) was prepared at concentrations of 
2, 1, 0.5 and 0.25 mg ml-1 from a stock solution which was quantified by 
absorbance at 280 nm based on the known extinction coefficient (e) for a 1% 
(w/v) solution of BSA in a 1 cm light path (Bradford 1976).
Extinction coefficient of BSA at 280 nm
=  6.6
Assay Procedure
The BCA assay was performed in microtitre plates using volumes of 1/10 of those 
described by the manufacturer. Ten microlitres of standard or sample in duplicate 
was added to microtiter plate wells and mixed with 200 jul of the working 
solution. After incubation at 37°C for 30 minutes the absorbance was read at 562 
nm using an ELISA plate reader and the protein concentration determined by 
comparison to the standard curve.
2.2.3. Molar Extinction Coefficient of bovine SAA
The molar extinction coefficient £2801M of bovine SAA was determined on a (Pye- 
Unicam 8P8-500 UV/vis spectrophotometer). Purified b-SAA was diluted in 
duplicate to approximately 0.1% (w/v) in 0.1M NaHC03 (pH 9.6) and the 
absorbance at 280 nm (A280) was measured (Eriksen and Benditt, 1986). Protein
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concentration was determined by the BCA assay and the Mr was determined by 
comparison to Mr standards on SDS-PAGE. The molar extinction coefficient was 
calculated as follows where A280 represents the absorbance at 280 nm in a 1 cm 
light path.
/  \
1 M  A o o n  
e280 = Molarity
A
280_______
protein conc./Mr
A 280 x 
protein conc. ( gl"1)
V_________________________ )
The extinction coefficient of a 1% (w/v) solution of b-SAA was calculated using 
the formula mentioned below.
protein conc. (g 1 )
2.2.4. Sodium Sulphate - Polyacrylamide Gel Electrophoresis
Sodium dodecyl sulphate - polyacrylamide gel electrophoresis (SDS- 
PAGE) was performed in a Mighty Small electrophoresis tank (Hoeffer Scientific 
Ltd.) with 12.5 % (w/v) polyacrylamide slab gels (7.3 x 10.2 x 0.75 cm) as 
described by Laemmli (1970). Detailed description of all the buffers used in this 
procedure is given in Appendix 2.1. Aliquots of dialysed 
fractions were mixed in a ratio of 1:1 with treatment buffer
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giving a final concentration of in 5% (w/v) 2,3-dihydroxybutane- 1,4-dithiol 
(dithiothrietol) and heated to 100°C in a water bath for 5 min to reduce disulphide 
bonds. Serum samples were diluted 1:20 in diluted stacking gel buffer (pH 6.8) 
and then reduced with treatment buffer as described above. Gels were loaded 
with 10 jllI of treated sample and electrophoresis was performed with tank buffer 
(25 mM Tris; 192 mM glycine; 0.1% (w/v) sodium dodecyl sulphate; pH 8.3) at a 
constant current of 20 mA per gel until the bromophenol blue dye front reached 
the bottom of the gel (approximately 1 hour). The gels were then stained for 30 
minutes with 0.1% (w/v) Coomassie Brilliant Blue R-250 in 50% (v/v) methanol 
and 10% (v/v) acetic acid in distilled water and subsequently destained in the same 
solvent mix. Mr standards, which were bovine albumin, 66 kD; egg albumin, 45 
kD; pepsin, 34.7 kD; trypsinogen, 24.1 kD; p lactoglobulin 18.4 kD and lysozyme,
14.3 kD (Sigma MW-SDS-70KIT) were included at a concentration of 
0.5 mg m l1.
2.2.5. Immunoblotting
Immunoblotting after SDS-PAGE (Section 2.2.4) was performed according to 
Towbin et al. (1979). Prior to protein transfer, gels, nitrocellulose sheets, filter 
papers and pads were equilibrated in transfer buffer (25 mM Tris; 192 mM 
glycine; 20% (v/v) methanol, pH 8.3) with gentle agitation for 10 minutes. The 
polyacrylamide gel after SDS-PAGE was placed on a nitrocellulose membrane, 
sandwiched between filter paper and Scotbrite pads. Protein transfer was carried 
out using a Bio-Rad transfer apparatus at 12 mA for 1 hour with the cellulose 
nitrate membrane on the anodal side of the gel. The nitrocellulose sheets were 
then blocked overnight by incubating in 5% (w/v) dried skimmed milk powder in 
50 mM Tris-HCl-buffered saline pH 7.4 (TBS). The first anti-serum was rabbit 
anti-human SAA and was prepared at a dilution of 1:5000 in TBS containing 1% 
(w/v) dried skimmed milk powder and 0.05% (v/v) Tween-20 (TBS-Tween-milk). 
After incubation for 1 hour at room temperature in the diluted first antiserum the 
membrane was washed three times for 10 minutes in TBS-Tween-milk and then
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incubated for 1 hour in donkey anti-rabbit IgG conjugated to horseradish 
peroxidase at a dilution of 1:1000 in the same buffer. After three further 10 
minute washes in the TBS-Tween-milk buffer, the chromogen solution containing 
3 amino-9-ethyl carbazole (AEC) was added after being freshly prepared by 
dissolving 20 mg of AEC in 2.5 ml of dimethyl formamide, mixing with 47.5 ml of 
50 mM acetate buffer (pH 5.5) followed by filtration through Whatman No.l 
paper and addition of 25 |il of hydrogen peroxide 30% (v/v). The reaction was 
terminated by washing in distilled water. The membrane was then dried in air.
2.2.6. Immiino-Dot-Blotting
During purification a semi quantitative immuno-dot-blotting method (Hawkes et 
al. 1982) was used to identify SAA in the chromatographic fractions. A strip of 
nitrocellulose membrane (Bio-Rad) was washed for 10 minutes by gentle agitation 
with distilled water and dried at room temperature. Ten microliter aliquots of the 
fractions of HIC, AFC and UC, were applied in duplicate and dried at room 
temperature. The paper was then blocked with 5% (w/v) dried skimmed milk 
powder in TBS for 2 hours and treated as the immunoblotts described in Section
2.2.5. Finally the immuno-dots were semi-quantified by densitometric scanning 
reflection mode at 530 nm.
2.2.7. SAA Concentration:
The SAA concentration in fractions during purification was measured 
retrospectively by analysing stored aliquots of pooled fractions with the ELISA 
described in Chapter 3.
2.3. RESULTS
In the purification of b-SAA, either HIC or AFC or UC was used as an initial step 
followed by gel filtration for further purification of protein. The purification of b- 
SAA was performed approximately 15 times by HIC and the results are presented 
by describing typical examples for the three alternative initial stages and then a 
typical gel filtration stage. During the comparison of the isolation procedures,
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a common starting material was used which was pooled APbS with a SAA 
concentration of approximately 200 pg'l.
2.3.1. Hydrophobic Interaction Chromatography
The elution profile of 100 ml of APbS from the HIC column is shown in Figure
2.1 giving the absorbance at 280 nm and an estimation of the SAA concentration 
in the fractions given by the immuno dot blot for SAA. After APbS was applied 
to the column of phenyl Superose a peak of non-bound protein was collected. 
After the descending gradient of chloride ions was applied, a further peak of 
weakly bound proteins was eluted. As elution with a rising gradient of guanidine- 
HCl proceeded, a series of protein peaks eluted and when the chloride ion 
concentration reached 2 M a peak was eluted where the SAA-rich HDL fraction 
was identified. The presence of SAA in this fraction (shaded peaks in Fig. 2.1) 
was identified by immuno-dot-blotting (Fig. 2.2). In SDS-PAGE (Fig. 2.3), the 
protein of this peak (the lane D) showed major proteins with molecular weights of 
>66 kD, 23 to 27 kD and with minor proteins of 17 kD and 12.5 kD. The SAA- 
rich fraction (shaded peak in Fig. 2.1) was then subjected to gel filtration (Section 
2.3.4). Typical performance results from HIC were for a yield of 50% and a 
purification factor of 18 which are given in Table 2.1 to allow comparison to AFC 
and preparative UC.
2.3.2. Affinity chromatography
When 10 ml of APbS was applied to the cholesteryl hemisuccinate column, non­
bound material was eluted in the break through peak by maintaining the eluant as 
0.15 M NaCl till the base line absorbance was approched. Additional non- 
specifically bound protein was eluted with 1M NaCl, but SAA remained bound to 
the column. Desorption of SAA was achieved by eluting with 6 M guanidine-HCl 
(Fig. 2.4.) and the high SAA content of this fraction was identified by its strong 
reaction with anti-SAA antibodies on immuno-dot-blots. The SDS-PAGE gel
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Figure 2.2 Immuno-dot-blots from different fractions from the HIC run 
shown in Fig. 2.1 and using rabbit antiserum to human SAA as the first 
antibody. The numbers correspond to the fraction numbers in Fig. 2.1.
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66 kD —
45 kD —  
24 kD —
12.5 kD —
[A] [B] [C] [D] [E] [F] [G]
I
« b-SAA
Figure 2.3 SDS-polyacrylamide gel (15%) electrophoresis of (A) Normal 
bovine serum 1:20 dilution (B) acute phase bovine serum 1:20 dilution 
(C) fraction C of affinity chromatography (D) b-SAA rich fraction in 
hydrophobic interaction chromatography (E) b-SAA rich fraction after 
Sephacryl-200 (F) b-SAA after Superose-12 (G) concentrated purified 
b-SAA.
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(Figure 2.3 [C]) of the SAA rich affinity bound fraction only revealed a faint 
protein band at Mr of 12.5 kD (i.e. at Mr of SAA) as the fraction was not 
concentrated sufficiently prior to electrophoresis. Using AFC, the yield of SAA 
was 45% and the purification factor was 18, which were similar to HIC (Table 
2.1).
2.3.3. Ultracentrifugation
After ultracentrifugation of APbS a distinct yellow band was visible on the surface 
of centrifugation tube contents and this was the total LP fraction HDL which was 
confirmed as containing SAA by dot blotting. Ultracentrifugation of 6.5 ml of 
APbS gave 1 ml of HDL rich lipoprotein with a yield of 85% and a purification 
factor of 87 (Table 2.1). After extensive dialysis against distilled water this 
fraction was subjected to SDS-PAGE and two distinct protein bands (Fig. 2.5.) 
were visible with Mr of 23 kD and 12.5 kD. The band with a Mr of 23 kD was 
likely to be apo-AI.
2.3.4. Gel filtration
Sephacryl S-200 gel filtration of SAA-rich fractions from HIC and AFC gave very 
similar elution profiles with three main peaks and an example is shown in Fig. 2.6. 
From ultracentrifugation there were minor differences in the relative sizes of the 
peaks. The presence of a protein of Mr 12,500 in the third peak was identified by 
SDS-PAGE (Fig.2.3 [E]) and this peak was positive in the immuno-dot-blott for 
SAA. Further fractionation of this third peak on an analytical scale FPLC 
Superose 12 column produced one major peak (Fig. 2.7) which gave a positive 
reaction in immuno-dot-blot and gave a single band of Mr 12.5 kD on SDS-PAGE 
(Fig.2.3 [F] and [G] after concentration). Western blotting showed that the rabbit 
antiserum to human SAA reacted strongly with this protein of Mr 12.5 kD (Fig. 
2.8).
As HIC became the method of choice for the initial purification of SAA, 
the overall performance of the isolation procedure was determined based on a
I
iIi
i
TABLE 2.1: Comparison of three isolation methods of b-SAA.
Isolation Method Yield % Purification Factor
HIC 50% 18
AFC 45% 18
UC 85% 87
UC, Hydrophobic Interaction Chromatography; AFC, Affinity
Chromatography; UC, ultracentrifugation
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Figure 2.4 The elution profile of acute phase bovine serum obtained by 
Cholesteryl-hemisuccinate affinity chromatography, sample was applied 
and eluted at a flow rate of 0.4 ml m in1. Affinity bound proteins were 
eluted with 6M guanidine-HCl; 0.5M Tris NaCl pH 7.4. Elution was 
monitored at 280 nm. One millilitre fractions were collected and analysed 
for b-SAA by dot-blot. Peak A is the unabsorbed proteins; Peak B is non- 
specifically bound proteins and Peak C is the HDL rich bovine SAA 
fraction. Arrows show when the buffer was changed to (x) 1 M NaCl and 
to (y) 6M guanidine hydrochloride. Shaded area shows SAA rich 
fractions.
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66.0 kD
45.0 kD 
34.7 kD
24.1 kD
18.4 kD
12.5 kD
Figure 2.5 SDS-polyacrylamide gel (15%) 
electrophoresis of the dialysed HDL fraction 
from the ultracentrifugation and gel 
filtration on a Sephacryl S-200 column.
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Figure 2.6 Elution profile of Sephacryl S-200 gel filtration 
chromatography (flow rate 0.2 m in1) with the SAA rich fraction 
from hydrophobic interaction chromatography. Shaded area 
represents fractions with SAA.
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starting volume of 100 ml of APbS being loaded on to the phenyl Sepharose 
column. In relation to this starting material the yield of b-SAA after gel filtration 
on Sephacryl S-200 was 33 % and the purification factor was 80 while after the 
final Superose-12 column the yield of b-SAA was 25% and the purification factor 
was 400x (Table 2.2).
2.3.5. Extinction Coefficient of b-SAA
The £2 8o1M of b-SAA was 22 x 103, assuming the Mr of b-SAA to be 12.5 kD as 
identified by SDS-PAGE, with the absorbance of a solution of 0.34 g I 1 being 
0.62 OD units. The extinction coefficient of a 1% (w/v) solution of SAA was 
calculated as 18.
A
280 = 0.62
0 34Molarity of b-SAA sample = ^ 5
r iM  _ 0.62 x 12.5 
280 0 .3 4
= 2 2  x 1 0 3
v J
a
p l%
z80
0.62 x 1 0  
"  0.34
= 18
j
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Figure 2.7 Elution profile of Superose-12 gel filtration chromatography 
on SAA rich fraction from the Sephacryl S-200. Single peak of b-SAA 
(flow rate 0.2 ml min 1 and fraction size 1 ml). The major peak at 
fraction 11-12 gave a positive reaction for SAA in the immuno-dot-blot.
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Figure 2.8 Immuno-blott after SDS-PAGE of b-SAA rich 
fraction from hydrophobic interaction chromatography and 
gel filtration using rabbit antiserum to human SAA as the 
first antiserum.
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DISCUSSION
The purification of any protein from a complex biological fluid, such as serum, 
requires a specific assay system to identify fractions containing the protein. In 
order to isolate SAA from APbS a suitable detection system was required for the 
protein. Fortuitously it was found, in the present study, that b-SAA could be 
detected in column fractions by an immuno-dot-blot method using a commercially 
available rabbit anti-human SAA, shown to cross react with b-SAA (see chapter 3 
Section 3.3.2.1). The use of this antiserum in a Western blot of the 12.5 kD 
protein isolate by HIC and gel filtration confirmed that b-SAA had been purified 
by the methods developed during this study.
In the purification based on HIC the isolation of SAA from serum was 
facilitated by its strong association with HDL which binds avidly to phenyl- 
Sepharose, providing a convenient first step in the process (Raynes and McAdam
1988). Elution of HDL/SAA was achieved using the denaturing agent guanidine- 
HC1. The presence of guanidine-HCl at this stage was advantageous as it ensured 
solubility of SAA and, as the buffer for the final stage of purification by gel 
filtration also contained guanidine-HCl, it allowed the SAA containing fractions to 
be applied to the appropriate columns without dialysis. However, small fractions 
were dialysed against 10% (v/v) acetic acid and distilled water in order to prepare 
for SDS-PAGE which is readily distorted by high salt concentrations. The SDS- 
PAGE (Fig.2.3 lane [D]) showed that several other proteins were present. The 
protein with a Mr of 27 kD, was likely to be apo-AI and the protein with a Mr of 
17 kD was likely to be apo-AII as these are the major apo lipoproteins of HDL 
and have the relevant Mr. Reports of HIC in the isolation of human SAA (Raynes 
and Mac Adams 1988) showed that on a phenyl-Sepharose column apo-AI eluted 
before SAA while with an octyl-Sepharose column SAA eluted before Apo-AI. 
Indeed a matrix of octyl-Sepharose gave a better separation between peaks than a 
phenyl-Sepharose column (Raynes and McAdams 1988) possibly due to the 
varying hydrophobic interaction of SAA
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with different matrices. Better purification might have been achieved with APbS 
on octyl-Sepharose but there was not sufficient opportunity to compare this 
matrix with phenyl-Sepharose.
Using HIC a 50% yield of b-SAA was achieved which was slightly lower 
than the yield of 55% achieved with phenyl-Sepharose in the isolation of human 
SAA (Raynes and McAdam 1988).
The b-SAA yield obtained with affinity chromatography was similar to that 
achieved by HIC. This may be due to binding of similar amphipathic regions of 
SAA in both matrices. In the affinity chromatography method described by 
Niewold and Tooten (1991), the recovery of HDL3 in the hamster was 70% while 
in the same study the density gradient ultracentrifugation method had a recovery 
of HDL3 of 80%. However they did not report the recovery of SAA which may 
not be the same as that of the whole HDL fraction.
Alternative desorbents to guanidine-HCl have been used for elution of 
bound HDL/SAA from HIC or AFC. However, it has been reported (Anders et 
al. 1975) that murine and human SAA, isolated from acute phase serum by HIC 
with formic acid dissociating the bound protein for the column followed by gel 
filtration chromatography in formic acid, may bear little resemblance to apo SAA 
in its native state in lipoprotein particles. Furthermore, SAA prepared using 
formic acid is known to be contaminated with other proteins, such as albumin, 
prealbumin and p2-macroglobulin (Marhaug and Husby 1981; Pepys and Baltze 
1983). In another study Smith and McDonald (1991) purified human SAA by 
HIC using ethanol and 10% formic acid as denaturing agent instead of 6M 
guanidine. According to these workers the advantages of using ethanol over 
guanidine was that there was less need for exhaustive dialysis which is required to 
remove guanidine, before the recovered material can be placed in biological 
systems. In their method the final recovery after the complete process of purified 
SAA was 56% which was greater that achieved here or that achieved by Raynes 
and McAdam (1988).
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Wickman (1979), reported the selective binding of HDL to cholesteryl 
hemisuccinate. The binding of HDL to affinity gel was so strong that, elution was 
only possible using denaturing agents or detergents, which have to be removed 
prior to the next stage of purification by extensive dialysis. Niewold and Tooten 
(1991) purified hamster SAA using the same technique as Wickman (1979), but 
instead of detergent to denature the bound HDL they used guanidine-HCl. In this 
study guanidine was found to be a effective dissociating agent in purification of b- 
SAA by AFC.
Comparison of the performance of the 3 methods demonstrates that HIC 
and AFC were equivalent to each other but that the single-step UC had a better 
yield and a higher purification factor. The lower recovery of SAA using HIC and 
AFC in comparison to UC might result from the fundamental procedures of 
column chromatography, which present more opportunity to loose material during 
the process whereas UC took place in one step. Despite this HIC was used for 
subsequent purification. HIC on phenyl-Sepharose had a major advantage over 
the traditional method of sequential step UC for lipoprotein in that which used a 
number of steps, isolating VLDL, LDL and HDL in turn. SAA purification on 
HIC was more convenient in dealing with large volumes of serum. SAA is present 
only in mg quantities per litre of serum and large volumes of acute phase serum 
had to be processed in order to obtain sufficient quantities of b-SAA for future 
investigation. Preparative UC is time-consuming and laborious and was not 
appropriate for this purpose. Unfortunately the single-step procedure, described 
by Liepnieks et al. (1991) to isolate SAA-rich HDL from acute serum in rabbits 
was only available towards the end of this study. In future investigations this is 
likely to become the method of choice for the initial purification of b-SAA.
Despite the lower yield with the HIC method it is convenient, highly 
reproducible and is particularly useful for processing of large quantities of serum 
for apo-SAA purification. The column matrix for HIC is considerably less
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expensive than that used in the AFC columns. In the present study therefore, HIC 
was selected as the method for initial isolation of SAA as it was found to be the 
more economical of the two column procedures. This study identified the optimal 
method to isolate b-SAA and it was repeated on several occasions and therefore 
enabled the development of the quantitate ELISA for b-SAA described in the 
following Chapter.
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CHAPTER HI
DEVELOPMENT OF AN ENZYME LINKED IMMUNOSORBENT ASSAY 
FOR THE QUANTIFICATION OF BOVINE SERUM AMYLOID A
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3.1. Introduction
The concentration of serum amyloid A (SAA) in plasma is of clinical significance 
in man (Pepys and Baltz 1983; Sipe 1992) and in cattle (Hoi and Gruys 1984; 
Boosman et al. 1989; Gruys et al. 1993). There is minimal SAA synthesis during 
homeostasis, but within a few hours of injury or infection SAA can be detected in 
the high density lipoprotein (HDL) fraction of plasma (Benditt and Eriksen 1977; 
Bausserman et al. 1980). Among the various biochemical and haematological 
parameters of the APR in man, SAA exhibits the most striking changes and it is 
therefore a sensitive marker for monitoring the intensity of APR (Mozes et al. 
1989). The amount and duration of SAA production during the APR to tissue 
injury and cell necrosis depends upon the type of injury and its magnitude 
(McAdam et al. 1978; Pepys et al. 1989; Nakayama et al. 1993). Circulating 
SAA concentrations may remain elevated for considerable period of time 
depending on the inflammatory conditions. In viral infections, however, SAA 
tends to disappear rapidly from the circulation (McAdam et al. 1975; Nakayama et 
al. 1993).
Among domesticated species, SAA has been identified as the major acute 
phase protein in the horse and has shown to be a reliable marker for assessment of 
tissue damage during training and racing (van Andel et al. 1988; Pepys et al.
1989). Increased concentrations of SAA are also known to be associated with 
amyloidosis in the hamster (Niewold et al. 1991), rabbit (van Andel et al. 1988), 
dog (Westermark et al. 1985), cat (Dibartola and Tarr 1986) and cattle (Gruys 
1977; Hoi and Gruys 1984). In more recent studies, SAA has been identified as an 
acute phase reactant in cattle (Boosman et al. 1989; Alsemgeest et al. 1992; Gruys 
et al. 1993). The plasma concentration of SAA increased a 100-fold in response 
to endotoxin administered intradermally and intravenously (Boosman et al. 1989) 
and SAA was also raised in the peripartum period (Alsemgeest et al. 1992). 
These investigations suggested that monitoring bovine serum amyloid A (b-SAA)
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concentration may serve as a specific and reliable marker for clinical inflammation 
and tissue injury (Gruys et al. 1993).
The technical difficulties surrounding accurate and reproducible 
quantification of SAA concentrations in human plasma and other biological fluids 
have been widely discussed (Marhaug 1983; Pepys and Baltz 1983; Godenir et al. 
1985; Benditt et al. 1988). It has been reported that optimal immunochemical 
measurement requires complete dissociation of SAA from the HDL3 fraction of 
lipoproteins. Studies have shown that denaturation by heat, acid or alkali increases 
the immunoreactivity and reproducibility of SAA measurements (Sipe et al. 1976; 
Eriksen and Benditt 1986). In contrast, other investigators report that the use of 
denaturing treatments results in less satisfactory quantification (Benson and Cohen 
1979; Marhaug 1983). The basis for these differing observations is thought to lie 
in the epitope specificity of the antibodies used and the particular type of 
immunoassay employed, that is whether radial immunodiffusion, 
radioimmunoassay or enzyme linked immunosorbent assay (ELISA) were used in 
a particular study (Sipe et al. 1989; McDonald et al. 1991).
Immunoassays have been described for the quantitation of SAA in various 
species. In addition to differences in analytical methods e.g. radioimmunoassay 
(Rosenthal and Franklin 1975), ELISA (Sipe et al. 1989; Pepys et al. 1989) or 
latex agglutination (Yamada et al. 1993), these assays have used a variety of 
sources for their standards with either AA protein, SAA, or acute phase HDL 
being employed. The antisera used has been either anti-AA (Boosman et al. 1989) 
or anti-SAA and prepared as either monoclonal (Wood et al. 1982) or polyclonal 
antibodies (Godenir et al. 1985; Pepys et al. 1989; Sipe et al. 1989). Recent 
publications demonstrated the use of latex coated anti-SAA (Yamada et al. 1993) 
and sequence-specific rabbit antibodies in assays for human SAA 
(Casl and Grubb 1993).
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In the studies reported by Boosman et al. (1989) the relative concentration 
of SAA in cattle was estimated by ELISA using a rabbit antisemm to b-AA which 
required absorption by affinity chromatography to remove non-specific cross 
reactions. The results were expressed as arbitrarily assigned units based on the 
percentage of positivity between a negative and positive sample which were foetal 
bovine serum and a bovine acute phase serum sample, respectively. During 
attempts to reproduce this assay in our laboratory, it was found that commercially 
available antisera to human SAA cross reacts specifically with b-SAA. The use of 
this readily available rabbit polyclonal antibody to human SAA for an ELISA for 
b-SAA would greatly increase the transferability of b-SAA assays between 
laboratories (Bangham 1993). A further improvement in the assay for b-SAA 
would involve quantification with standards of known SAA concentration (in S.I. 
units such as jug m l1) rather than by comparison to arbitrary units.
Aims of study
The aims of this study were to develop an ELISA to measure b-SAA using 
a commercially available rabbit antiserum to human SAA and to quantify the 
b-SAA in bovine serum by comparison to standards of b-SAA purified as 
described in Chapter II of this thesis.
3.2. Materials and Methods
3.2.1. Enzyme linked immunosorbent assay
Reagent and Equipment
Reagents were obtained from Sigma Chemical Company Ltd. (Poole, Dorset, 
UK.) unless otherwise stated. Microtitre plates used were from (Nunc Co., as 
supplied by Gibco, Paisley, Scotland Cat. No. 439454 ). An Electric shaker 
(Luckham Recipro-shake, Luckham Ltd., Sussex, UK.) and an ELISA reader 
(Titertek Multiskan® Plus, Flow Laboratories, Helsinki, Finland.) connected to a
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personal computer (IBM PC) running the ELISA reader programme Immuno Soft 
(Flow Laboratories) were used in the ELISA assay. The densitometer 
(Chromoscan 3) was supplied from Joyce Loebl Ltd., (Gateshead, Tyne & Wear, 
UK.).
Primary antibody
Rabbit antiserum to human SAA was obtained from Calbiochem, Novabiochem, 
catalogue No. 566702 (Nottingham, UK).
Secondary antiserum
Horseradish peroxidase-conjugated donkey anti-rabbit IgG was obtained from 
Scottish Antibody Production Unit, Law Hospital, (Lanarkshire, UK).
Coating buffer
10 mM sodium bicarbonate (NaHC03) and 10 mM sodium carbonate buffer 
(Na2C03) at pH 9.6.
Assay buffer (PBST)
20 mM mono sodium dihydrogen phosphate NaH2P04, 20 mM di sodium mono 
hydrogen phosphate Na2HP04, 154 mM sodium chloride NaCl and 0.05% (v/v) 
Tween-20 (Sigma) buffer at pH 7.4.
Blocking buffer
10 % (w/v), instant dried skimmed milk powder (’Marvel') in assay buffer without 
Tween-20 (PBS, pH 7.4). The milk powder contained 36.4% (w/w) of protein 
and 1.5% (w/w) of fat.
Substrate buffer
10 mM sodium acetate (CH3COONa) buffer with the pH adjusted to pH 5.5, 
with citric acid.
Peroxidase substrate
25 ml substrate buffer plus 100 p.1 of 1% (v/v) H20 2 plus 400 }il of a stock 
solution of 0.6% (w/v) 3,3',5,5'-tetramethylbenzidine (TMB) in dimethyl- 
sulfoxide.
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3.2.2 Preparation of bovine SAA standards
To overcome known problems of standardisation of SAA which are caused 
by its association with HDL3, working standards were prepared according to the 
method described for human SAA by Godenir et al. (1985) and used subsequently 
by Sipe et al. (1989), McDonald et al. (1991) and Yamada et al. (1993). The 
working standards were prepared from a pool of acute phase bovine serum 
(APbS) in which the b-SAA was quantified by comparison to purified b-SAA in 
foetal bovine serum (FBS) using SDS-PAGE and densitometry.
Serum amyloid A was isolated by HIC and gel filtration as described in 
Section 2.2.1.1. After protein determination by the Bicinchoninic assay method 
(Section 2.2.2), a primary standard of purified b-SAA (1 mg ml1) was diluted in 
1% (v/v) foetal bovine serum (1 ml FBS in 99 ml PBST) at protein concentrations 
ranging from 3 jig to 200 |ig m l1 These primary standards were subjected to 
SDS-PAGE (Section 2.2.3) along with aliquots of the working standard of APbS 
at 1:20 dilution. Gels were stained with Coomassie Blue dye and the SAA 
content in the APbS working standard was determined by comparison to the 
primary standards by transmission densitometry at 590 nm. The working 
standard was then diluted in 1% (v/v) FBS in PBST to provide standards over the 
range of 3-200 }ig mF of SAA which were stored in aliquots at -20°C. All 
assays included duplicate wells containing 1% (v/v) FBS in PBST as a blank.
3.2.3 Assay procedure
The ELISA for b-SAA was modified from the assay described by Boosman et al. 
(1989) and the following optimal assay procedure was established after extensive 
investigation described in Section 3.2.4.
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Coating
Standards, controls and test samples were diluted 1:100 in coating buffer and then 
100 |il per well was dispensed in duplicate into the wells of a 96 well flat bottom 
microtitre plate and incubated at room temperature (20-22°C) for 18 hours under 
constant gentle shaking.
Blocking
After coating the excess sample was removed and the unoccupied binding sites 
were blocked by the placing 300 |il of 10% (w/v) dried milk in PBS (blocking 
buffer) in each well and incubating the plate for 1 hour at room temperature (20- 
22°C) with constant gentle shaking.
Washing
The ELISA plate was decanted and rinsed three times with 300 jllI per well of 
PBST.
First antibody
Rabbit antiserum to human SAA (1:10,000 in PBST) was freshly prepared and 
100 \i\ per well was added after which the plate was incubated for 90 min. at room 
temperature (22°C) with constant gentle shaking.
Second antibody
After decanting, the plate was washed as above and 100 |il of second antibody, 
which was horse radish peroxidase conjugated donkey antibody to rabbit IgG 
(1:2500 in PBST) was dispensed to the wells and incubated as above for a further 
90 minutes. Following incubation, excess conjugate was removed by washing as 
above for four times.
Substrate
The peroxidase absorbed to the wells was detected by addition of 150 fil of freshly 
prepared peroxidase substrate to each well. The plate was covered with an 
aluminium foil to prevent photoreactivity and incubated at 37°C for 15 min.
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Termination
The peroxidase enzyme reaction was terminated by addition of 50 jil of 2 M 
H2S04 to each well.
Absorbance
The absorbance was measured at 450 nm using a ELISA plate reader and the 
results were analysed using the Immuno Soft programme which employed a linear- 
logarithmic (Lin-Log) transformation in the calculation of the ELISA results.
High, medium and low control samples were included in all assays. The 
non-specific binding (NSB) was measured in every plate where high control 
samples with a high concentration of SAA were processed without the first 
antibody.
3.2.4 Assay optimisation
Assay validation was carried out as described by Sipe et al. (1989) in several 
steps. Each step was carried out minimum of three times, and the mean values are 
presented in the results (section 3.3).
3.2.4.1 Titration o f the first and the second antibodies 
Initially, the approximate dilution of the first and the second antisera was 
determined by coating an ELISA plate with a APbS which was diluted 1:100 in 
the coating buffer, 100 |il was dispensed to each well and the plate was incubated 
over night (18 hr.) at 22°C. After decanting, the wells were blocked with 10% 
(w/v) dried skimmed milk in PBS and washed 3 times with PBST. Serial dilutions 
of the first antibody (1:1250; 1:2500; 1:5000; 1:10,000; 1:20,000; 1:40,000) and 
the second antibody (1:1000; 1:2000; 1:4000; 1:8000) were prepared in PBST. 
The various dilutions of the first and the second antibody were dispensed at the 
appropriate times in a matrix allowing for every combination of first and second 
antibody in duplicate. Following this initial screen, the optimal dilutions of 
antisera were determined by demonstration of the effect of varying antibody
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dilutions on ELISA plates on to which the b-SAA standards had been absorbed. 
A series of assay standards were coated on to six microtitre plates. Three plates 
were reacted with a constant first antibody concentration (1:10,000) with variation 
in the second antibody concentration the other three plates had a constant second 
antibody (1:2500) while the first antibody was varied. The objective was to 
identify the combination of first and second antibody dilutions which gave a 
maximum optical density of 1.0-1.5 OD Units for the highest standard and also 
gave a steep standard curve.
3.2.4.2. Optimisation of the standard and sample dilution
Standard curves prepared by diluting the working standard in foetal bovine serum, 
for the b-SAA ELISA were obtained by using 3 different dilutions of the standards 
in the coating buffer. The standards were diluted to 1:200, 1:100 and 1:50 and 
100 p.1 was applied in duplicate to the ELISA plates.
3.2.4.3 Incubation temperatures
The influence of different incubation temperatures on the assay was determined in 
order to optimise the incubation temperature. Four microtitre plates were coated 
with two sets of standards and two plates were incubated at 4°C with the two 
remaining plates at room temperature (22°C). All plates were left overnight with 
constant agitation and the remaining steps were carried out as described above 
(Section 3.2.3).
3.2.4.4 Incubation times
The influence of different incubation times with first antibody on the ELISA was 
determined. Six microtitre plates were coated with standards as described above 
(Section 3.2.2) and incubated at room temperature overnight. After blocking with 
dried milk and washing, first antibody (1:10,000 dilution) was added to all the 
plates which were incubated for different periods. Duplicate plates were incubated
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for 30 minutes, for 90 minutes and for 2 hours. All the other steps were carried 
out as above (Section 3.2.3).
3.2.4.5 Optimisation o f assay pH
The standards were coated on to three microtitre plates. Assay buffer (PBST) was 
prepared with pH values of 8.0, 7.4, 7.2 and 6.8 and used in the. procedure 
described above (section 3.2.3).
32.4.6 Assessment o f blocking agents
The ELISA was carried out using 10% (v/v) FBS; 5% (w/v) dried milk; 10% 
(w/v) dried milk and bovine serum albumin (BSA) 0.1% (w/v) and 0.5% (w/v) as 
blocking agent in PBS.
3.2.5. Assay Validation
Assay validation was carried out, using methods described by Fraser (1986), Sipe 
et al. (1989), and Price and Newman (1992), on the b-SAA ELISA assay which 
was performed according to the method described in Section 3.2.3.
32.5.1. Assay Specificity
Assay specificity relied on the antibody specificity which was demonstrated by 
Western blotting (Section 2.2.5). To confirm the specificity of the anti-SAA 
antiserum, four serum samples (diluted 1:20) which were known to be from 
animals during the acute phase as they all had a high haptoglobin (Hp) 
concentration were concentrated by boiling for 5 minutes in treatment buffer and 
electrophoresed on 15% SDS-PAGE (7.3 x 10.2 cm, 0.75 mM thick) with 30 Jig 
protein per lane (Section 2.2.4.) and duplicate gels were run. After 
electrophoresis the gels were either stained with Coomassie Blue or Western 
blotting was performed with the rabbit anti-human SAA antiserum at 1: 500 
dilution as first antiserum. The specificity of the rabbit anti-b-AA antiserum 
(Boosman et al. 1989) was also determined in an identical procedure except that 
the antiserum was used at a dilution of 1:200.
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3.2.5.2 Precision
The reproducibility of ELISA was demonstrated by intra-assay and interassay 
coefficients of variation (CV%). Intra-assay precision was determined by 
calculating the coefficient of variation (CV) of 25 duplicate samples within one 
assay using the formula (Fraser 1986).
Interassay precision was estimated by deriving the CV of low, medium and 
high quality controls (14 jig m l1, 6 6  pg m l1 and 178 |ig m l1) in 25 assays and was 
calculated by taking the standard deviation as a percentage of the mean of the 
results from the different assays. The repeatability of the standard curves was 
analysed by determination of the mean ± SD and CV of the absorbance obtained 
by the standards over 15 assays.
3.2.5.3 Accuracy
The accuracy of the assay was determined by adding known amounts of purified 
b-SAA to FBS and then measuring the recovery by ELISA. These samples were 
mixed by vortexing and allowed to stand for 2  hr at room temperature, vortexed 
again and then the concentration of SAA determined by ELISA. The recovery 
was estimated as the observed concentration as a percentage of the expected 
value.
3.2.5.4 The limit of detection
The limit of detection was determined as the lowest amount of SAA that could be 
distinguished from the zero standard (Fuentes-Arderiu 1992). This was 
determined as the SAA concentrations at 2 SD away from the mean (mean ± 
2xSD) of the zero standard (1% v/v FBS in PBST).
3.2.5.5 Comparison to other methods
To further confirm the accuracy of the assay, the SAA concentration of six bovine 
serum samples determined by ELISA was compared to results for the same 
samples assayed in triplicate by SDS-PAGE followed by densitometry, which is
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used in human clinical biochemistry as the reference method for SAA 
determination (Godenir et al. 1985; Yamada et al. 1993).
32.5,6 Reference range and in vivo validation
Serum samples from 36 clinically healthy calves (12 males, 24 females) present in 
Glasgow University Veterinary School (GUVS) as experimental animals but 
sampled prior to any experimental procedure, and from 15 cows at an abattoir 
were obtained in order to give an indication of the b-SAA concentration in healthy 
animals. Twenty-five serum samples from cows referred to the GUVS large 
animal clinic and suffering from a variety of clinical conditions were used to 
demonstrate the range of concentrations in diseased animals and were compared 
to the Hp concentration in the same samples in order to compare assay results for 
these acute phase proteins (McDonald et al. 1991; Taktak and Lee 1991).
The ability of this SAA ELISA to demonstrate the acute phase response in 
calves was determined by analysis of the SAA concentration in sera from calves 
experimentally infected with P. haemolytica. However, this was a part of a wider 
investigation of the acute phase response to P.haemolytica in calves which is the 
major topic described in the next chapter and experimental details are given in 
Section 4.2.10 and results in Section 4.3.
3.3 Results
3.3.1. Assay optimisation 
3.3.1J Antibody titration
From the results of the initial screen of antibody dilutions, final optimisation 
covered a range of 1:5,000 to 1:20,000 of the first antibody (Fig. 3.1a) and a 
range of dilutions of the second antibody of 1:2500 to 1:4000 (Fig. 3.1b). These 
studies showed that a combination of 1:10,000 of first antibody and 1:4000 of
90
1.2
0.9
a
-  0 . 6
0.3
0.0
F i g . 3 . l a
1:5,000
1:10,000
1:2 0 , 0 0 0
1000100101
1. 2
0.9
0.6
0.3
0.0
F i g . 3 . l b
1:2 , 0 0 0
1:2,500
1:4,000
1000100101
SAA c o n c e n t r a t i o n  ug / ml
Figure 3.1 Optimisation of the ELISA for bovine serum amyloid A: The effect of the 
first antibody (rabbit anti-human SAA) dilutions at 1:5000, 1:10,000 and 1:20,000 
(Fig 3.1a), and the second antibody (horseradish peroxidase conjugated rabbit IgG) 
dilutions at 1:2000, 1:2500 and 1:4000 (Fig 3.1b) on the b-SAA standard curve.
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second antibody gave the best results with the maximum standard giving an 
optical density of 1.0-1.5 OD Units.
3.3.1.2 Sample dilution
Figure 3.2a shows the influence of the sample dilution. A dilution of 1:100 gave 
the best results as with a 1:200 dilution the OD was too low while at a dilution of 
1:50 the optical density was too high.
3.3.1.3 Influence of different incubation temperatures on the assay 
Incubation temperatures of 4°C and 22°C resulted in similar binding in the assay, 
and subsequent incubations were performed at 22°C (Fig. 3.2b).
3.3.1.4 Influence of the incubation time on the assay
Figure 3.3a shows the influence of incubation time on b-SAA serum 
concentration. Thirty minutes of incubation or less was not sufficient to complete 
the binding as the slope was flat while increasing the incubation time improved 
binding and increased the slope of the curve. Anti b-SAA binding to the coated 
well was maximal with an incubation of 1.5-1.8 hours but with 1.8 hours the 
binding at the low concentrations of SAA increased, reducing the overall gradient 
of the cu^ve so that an assay incubation time of 1.5 hours was selected.
3.3.1.5 Influence of pH
Figure 3.3b shows the influence of the pH of assay buffer on the b-SAA ELISA. 
The best results were obtained with pH 7.4 buffer as this gave the steepest 
standard curve with the OD in the maximum standard being close to 1.0 to 1.5 OD 
Units. There was little difference with buffers of pH 7.4 and 7.2, and pH 7.4 was 
selected as the assay pH. At pH 6 .8  and 8.0, the standards were flat and giving 
low binding with the highest standard malting other buffers unsuitable.
92
1:50
1:100
2
1:200
1
0
1 10 100 1000
2.0
F i g . 3 . 2b
4-C
22-C
5
0
0.5
0.0
1 10 100  1 0 0 0  
SAA o o n o v R t r a t l o R  « | / r i I
Figure 3.2 Optimisation of the ELISA for bovine serum amyloid A: The 
effect of sample dilutions at 1:50, 1:100 and 1:200 (Fig. 3.2a) and the 
incubation temperature at 4°C and 22°C (Fig. 3.2b) on the b-SAA 
standard curve.
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Figure 3.3a Optimisation of the ELISA for bovine serum amyloid A: The effect 
of the first antibody incubation time at 1 hr, 1.5 hrs and 1.8 hrs on the b-SAA 
standard curve.
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Figure 3.3b Optimisation of the ELISA for bovine serum amyloid A: The effect 
of the assay buffer pH at 6 .8 , 7.2, 7.4 , and 8.0 on the b-SAA standard curve.
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3.3.1.6 Influence o f the blocking agents
Figure 3.4 shows the results of the OD of the zero standard with different blocking 
agents. The (0.5% w/v) bovine serum albumin (optical density <0.160), foetal 
bovine serum (optical density <0.050) and 10% milk (optical density <0.060) were 
all suitable as blocking agents. However, due to the convenience in preparation 
and lower cost, dried milk of 1 0 % (w/v) was used as the blocking agent in the 
assay.
3.3.2. Assay validation
3.3.2.1. Specificity o f antiserum to b-SAA
The rabbit-antiserum to human SAA stained a doublet band in Western blots of 
APbS (Fig.3.5) which was not evident in Western blots, of normal bovine serum. 
A similar band stained with antisera to b-AA (Fig. 3.5) but the antiserum was not 
specific as it reacted with other high Mr proteins. The band seen in Western blots 
of APbS, which stained with anti human SAA, corresponded to a faint protein 
band of Mr 12 kD serum in SDS-PAGE gels of APbS stained with Coomassie blue 
and this band was not present in normal bovine serum (Fig. 3.6).
3.3.2.2. Intra-and interassay precision and the assay repeatability
The intra-assay coefficient of variation was 4.0% for 25 duplicate samples from 
one assay (Fraser 1986).
The interassay coefficients of variation were 8 .8 %, 5.5% and 7.2% at 
b-SAA concentrations of 14 |ig m l1, 6 6  }xg mH and 178 |ig m l1 respectively for 
25 assays. The repeatability of b-SAA ELISA standard curve was demonstrated 
by the CV's of the absorbance at 450 nm of the standards in 15 assays being 5.8 to 
11.3% (Table 3.1) and the mean ± SD are shown in Fig 3.7.
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Figure 3.4 Effect of the blocking agents on the b-SAA standard curve. FBS Fetal 
bovine serum; BSA Bovine serum albumin.
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Figure 3.5 Western blots of acute phase bovine serum 
using rabbit anti-human SAA (A) and rabbit anti-bovine 
amyloid A (B) as the first antibody.
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Figure 3.6 SDS polyacrylamide gel (15%) electrophoresis 
of serum from a healthy calf (A) and an animal with acute 
pneumonic pasteurellosis (APbS) (B). Note the SAA band 
with a Mr of approximately 12.5 kDa in the APbS.
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Table 3.1. The repeatability of the b-SAA standard curve assessed at the coefficient of 
variation (CV) of the absorbance at 450 nm of standards in 15 b-SAA ELISA assays.
b-SAA jig ml*1 Absorbance Mean ± SD cv%
0 0.06 ±0.1 11.3
3 0.11 ±0.2 9.6
12.5 0.24 ±0.2 9.2
25 0.30 ±0.2 8.7
50 0.44 ±0.1 6.5
100 0.73 ±0.1 6.1
200 1.11 ±0.1 5.8
100
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Figure 3.7 Standard curve for quantitation of b-SAA (mean ± SEM).
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3.3.2.3. Accuracy
The recovery of b-SAA added to zero serum varied within acceptable ranges of 8 6  
to 112 per cent with a mean of 92 per cent (Table 3.2) The correlation coefficient 
and linear regression between observed and expected concentrations of b-SAA 
were calculated. The correlation coefficient (r) was 0.94 (P<0.05), and the 
regression equation was y = 1.39 + 0.94 x where y was the observed and x was 
the expected concentration of b-SAA.
3.3.2.4. The lower limit o f detection
The minimum detection limit significantly different from the zero standard 
(P<0.05) was 0.03 |ig of b-SAA in the assay well, representing a b-SAA serum 
concentration of 3 |ig m l1.
33.2.5. Comparison to the reference method
The SAA concentrations of the bovine serum samples measured by both ELISA 
and SDS-PAGE gave equivalent values (Table 3.3) and the correlation was 
between results from both methods was r = 0.94 P<0.05 and the regression 
equation was y = -0.55 + 1.05 x where y was the b-SAA concentration by ELISA 
and x was the b-SAA concentration by SDS-PAGE.
3.32.6. Clinical validation
The ELISA was used to measure b-SAA concentration in serum samples from 
animals with different disease conditions and the results are presented in Figure 
3.8. The b-SAA in serum samples from cattle with confirmed disease or following 
surgery ranged from 15 |ig mI1 to 130 p.g m l1. Comparison of the b-SAA 
concentration to Hp concentrations in 25 samples showed that they were 
significantly correlated r = 0.58; P<0.05; and with a regression equation of y= 23.7 
+ 9.1 lx where y was the SAA concentration and x was the Hp concentration 
(Fig. 3.9). The b-SAA concentration measured by the ELISA in sequential
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Table 3.2 Recoveries of purified b-SAA when added to foetal bovine serum, 
allowed to stand at room temperature for 2 hours and the SAA concentrations 
were measured by ELISA. Mean (± SD) was calculated from three separate 
analyses.
Added SAA |ig m l1 Recovered fig m l1 Recovery %
170 186 (16.4) 109 ± 8 .8 %
105 96 (12.2) 92 ± 12.7%
65 56 (6.3) 8 6  ±11.3%
25 28 (5.2) 1 1 2  ±18.6%
1 0 9.3 (3.4) 93 ±37.0%
5 5.2 (2.0) 104 ±45.0%
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Table 3.3 Comparison of b-SAA concentrations in six bovine serum samples by ELISA 
and SDS-PAGE analysis results. The table gives the mean ± SD of duplicate estimates.
Sample
number
ELISA 
mean (±SD) pg m l1
SDS-PAGE 
mean (±SD) pg m l1
1 4.8 (0.2) 5.2 (0.3)
2 18.6 (0.9) 2 0 .6 (1 .2 )
3 88.0 (3.9) 93.2 (4.7)
4 130.0 (5.2) 122.0 (5.3)
5 152.0 (9.1) 166.0 (9.9)
6 178.0 (9.6) 190.0 (9.9)
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Figure 3.8 Bovine serum amyloid A concentrations in serum from animals with 
different disease conditions: 1. Unknown field conditons 2. Acute pneumonic 
pasteurellosis 3. Secondary amyloidosis 4. Liver abscesses 5. Abomasal 
displacement.
SAA u g /m l
Figure 3.9 Correlation between the 25 parallel measurements of b-SAA and Hp 
concentrations in cattle (r =0.58; y=23.7 + 9.1 lx; y =SAA and x =Hp).
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samples during the P. haemolytica type A1 infection showed a rapid rise to reach 
a peak within 24 hours and then falling close to baseline levels within 5 days 
(Fig. 4.6b). This is fully described in the next chapter (section 4.3.8).
3.4. Discussion
The method described in this chapter is the first ELISA reported to measure 
b-SAA using a readily available antibody and able to quantitate the concentration 
of b-SAA in S.I. units. The use of a readily available antibody allows this assay to 
be more transferable so that it may be performed in laboratories world wide 
(Bangham 1993). Rabbit anti-human SAA used in the assay was specific to 
b-SAA and did not cross react with any other proteins when used to stain Western 
blots acute phase bovine serum. The rabbit anti-bovine AA used by Boosman et 
al. (1989) cross reacted with several other large molecular weight proteins present 
in serum and an additional absorption step which was reported by Boosman et al. 
(1989) would be required to remove such non-specific binding before use to assay 
SAA in bovine serum. As the Western blots showed that the antibody to human 
SAA did not need absorption prior to use, the b-SAA ELISA was developed using 
it as the first antibody.
The assay of b-SAA in serum does present a problem in that the bulk 
(90%) of SAA in serum exists in HDL3  particles with lipid and phospholipid 
surrounding the hydrophobic portions of the protein (De Beer et al. 1982; 
McAdam et al. 1982). Therefore fewer antigenic determinants .of SAA are 
exposed in the native state than when purified SAA is used as standards (Godenir 
et al. 1985; Sipe et al. 1989). Serum amyloid-A is also an amphipathic protein, 
causing problems in solubility and aggregation. The problems of the matrix effect 
may be minimised by using acute phase serum as the working standard (De Beer et 
al. 1982). In early work on human SAA quantification, results were expressed as 
arbitrarily assigned units by comparison to positivity of an acute phase serum 
standard (De Beer et al. 1982). However, in subsequent studies (Godenir et al.
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1985; Sipe et al. 1989) purified SAA has been used to calibrate working standards 
in mass units by densitometry. This technique facilitates the comparison of results 
between laboratories especially if suitable reference material is available for 
standardisation.
Boosman et al. (1989) in their SAA ELISA for cattle serum used a pool of 
acute phase HDL to standardised the ELISA and Pepys et al. (1989) in horses 
used a single pool of acute phase horse semm. These were the only assays 
available to measure SAA in domestic animals so that before the method described 
here no fully quantitative assay was available to measure SAA in these species. In 
this study the availability of purified b-SAA allowed the establishment of an 
ELISA to quantitatively measure b-SAA. Purified SAA, acute phase-HDL and 
acute phase serum could be used as assay standards. Purified SAA is difficult to 
solubilise and is unstable in physiological solutions, possibly due to its 
hydrophobic characteristics, and thus would be unsuitable for use as standard for 
this ELISA. An APbS sample with SAA concentration determined by comparison 
to purified SAA on SDS-PAGE was chosen as the most suitable standard material 
as it shared the same matrix as the samples to be assayed. The same approach has 
been taken in quantification of non-competitive radioimmunoassay, non­
competitive enzyme immunoassay and latex agglutination nephelometric 
immunoassay for human SAA (Godenir et al. 1985; Yamada et al. 1989; Yamada 
etal. 1993).
During development of the final assay protocol, described in section 3.2.3, 
several stages of the assay had to be optimised. Investigations relating to the 
optimisation of first antibody revealed that the methodology described in this 
study uses a significantly less volume of rabbit anti-human SAA than does the
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procedure of Boosman et al. (1989) who used a dilution of 1:1000 of rabbit anti- 
bovine AA antiserum. The incubation temperature at 4°C and 22°C produced 
standard curves of a similar shapes therefore in subsequent assays, room 
temperature was selected as it was more convenient. In the assay described in this 
study reproducible coating of b-SAA to microtitre wells was achieved with a 
coating buffer pH of 9.6 as has been described for many ELISA systems (Dubois 
and Malmendier 1988; Boosman et al. 1989; McDonald et al. 1991; Taktak and 
Lee 1991).
Assay validation revealed that the performance of the assay was within 
acceptable limits for ELISA with an intra-assay CV% of 4% and interassay of less 
than 9% (Fuentes-Arderiu 1992; Price 1992). These results could not be 
compared with the previous assay reported by Boosman et al. (1989) as they did 
not present assay validation data. In an ELISA developed to measure human SAA 
using a commercially available polyclonal antisera the mean intra-assay and inter­
assay CV%'s were 7.9% and 7.3% respectively (Taktak and Lee 1991). In 
another human SAA ELISA developed by McDonald et al. (1991) using a rat 
monoclonal antibody, an average intra-assay CV of 4.9% and inter-assay CV of 
7.8% was obtained for four serum samples with SAA concentrations in the range 
of 74-1030 p.g m l1.
The ability of the assay to monitor the APR was confirmed by examination 
of serum from calves before and during experimental infection of P. haemolytica 
and by analysis of normal calf serum and serum from animals suffering from 
various clinical conditions. Recently Gruys et al. (1993) have also observed 
increases in b-SAA in animals with a variety of conditions including endocarditis, 
mastitis, pyelonephritis, peritonitis and inflammatory conditions of the 
gastrointestinal system. In man, SAA concentrations are widely used to detect 
and monitor the progress of several acute disorders such as myocardial infactions,
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renal allocraft rejections and in malignancies (Yamada et al. 1993). It is likely that 
the assay for b-SAA described here, will have an important role to play in 
detecting the presence of such disease states.
To monitor the time course of the SAA rise during infection, six calves 
were experimentally infected with P. haemolytica type Al. This was part of the 
experiment described in chapter 4 and full results discussed in that chapter, but the 
obvious increase of b-SAA concentration following infection as monitored by 
ELISA (Fig. 4.6b) provides clinical validation of the assay (Fraser 1986). In other 
words, the ELISA for b-SAA as a marker for the APR in cattle, was able to 
demonstrate a significant increase in the serum concentration of b-SAA following 
an experimentally induced APR. The ELISA was shown to offer a simple and 
sensitive assay to measure b-SAA. The highest concentrations of SAA have been 
obtained in clinical samples taken in the field, indicating that the response in the 
experimental animals was not maximal and supporting the potential clinical use of 
an assay for b-SAA.
The effect of anti inflammatory therapy can be monitored by the 
measurement of APP (Kushner 1982; Eckersall and Conner 1988; Pepys et al.
1989). In cattle, up to the present time Hp has been the most reliable and widely 
used marker for this purpose (Conner et al. 1989; Skinner et al. 1991; Kent. 1992) 
but SAA, due to its greater incremental range could be a more sensitive indicator 
of inflammation (Boosman et al. 1989; Rossevatn et al. 1992) and would not be 
affected by haemolysis which can reduce haptoglobin levels. It has been suggested 
that SAA and Hp concentrations are regulated independently (Gruys et al. 1993), 
with disease specific pathways involved in their production suggesting a role for b- 
SAA as a complementary assay for haptoglobin.
In man and certain domestic species SAA is the one other acute phase 
protein which shares with CRP or Hp the following clinically useful characteristics
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of a very low normal plasma level and an extremely rapid change of concentration 
in response to injury and infection. This extended dynamic range is an important 
feature of SAA to use as a disease marker. Consequently, in man, CRP and SAA 
concentrations are used in routine clinical monitoring of inflammation and acute 
disorders (Kushner and MacKiewicz 1987; Yamada et al. 1993). In most human 
inflammatory diseases, SAA is a more sensitive indicator of inflammatory stimuli 
than Hp but studies in cattle have been limited due to non availability of a b-SAA 
assay. The concentration of circulating b-SAA also appeared to correlate with the 
nature of the disease, whether acute, sub acute or chronic. The quantitative 
measurements of b-SAA in cattle may therefore be a useful aid in monitoring the 
course of various diseases.
The main limitation of the b-SAA assay is the assay time and when large 
numbers of samples are to be analysed a more rapid system would be necessary. 
In man, a rapid method to measure SAA has been developed recently using a latex 
agglutination nephelometric immunoassay (Yamada et al. 1993). In this system 
purified anti-human SAA antibody was coated on to latex particles and allowed to 
react with the SAA standards with the light scattering being read every 15 
seconds. After a suitable calibration curve was obtained, 10-100 fold diluted 
serum samples were processed in the assay. Casl and Grubb (1993) developed 
another rapid analysis system to measure human SAA with an ELISA using 
sequence-specific antibodies. The assay time was only 3.5 hours and the working 
range was 0.1-2500 |ig m l1.
If time and resources are available, the b-SAA ELISA could be improved. 
For instance purified b-SAA could be coupled to biotin to develop a system where 
the second antibody is coated to the plate and stored at -20°C prior to use, so that 
the assay time could be reduced to a couple of hours (Meyer et al. 1990). 
Alternatively the purified analyte could be used to develop a monoclonal
I l l
antibodies which could be used in the sandwich format of ELISA; to decrease the 
limit of detection or reduce the time of the assay.
In summary this assay offers distinct advantages over existing method in 
that it is accurate, simple, reproducible, sparing of antibodies and can quantitate 
b-SAA in jig m l1. Therefore, estimation of b-SAA in serum or plasma will permit 
more widespread determination of this analyte as a marker of inflammation in both 
research and clinical situations.
CHAPTER IV
THE ACUTE PHASE RESPONSE IN 
BOVINE PNEUMONIC PASTEURELLOSIS
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4.1. Introduction
Bovine pneumonic pasteurellosis (BPP) is an economically important disease 
which is manifested usually as a severe acute respiratory disease in calves. Under 
field conditions several factors such as mixing of herds, environmental changes, 
transport and stressful management practices precipitate the disease in susceptible 
animals. Microbiological investigations of the aetiology of BPP have 
demonstrated the presence of a wide variety of organisms in the respiratory system 
of affected animals (Yates 1982; Frank 1989). However, in the experimental 
model developed by Gibbs et a l (1984) Pasteurella haemolytica biotype A 
serotype 1 when inoculated intra-tracheally reproduced the clinical, pathological 
and microbiological features of the disease, which are indistinguishable from the 
field disease.
The survival of a host challenged by infection or injuiy depends on many 
factors. Some are specific, such as antimicrobial T and B cell responses, while 
others are non-specific. The non-specific host response or the acute phase 
response (APR) complements the specific responses, commences within hours of 
the inflammatory stimuli and results in changes in a broad array of cellular, 
metabolic, endocrine and physiologic functions (Gordon and Koj 1985; Whicher 
and Evans 1992) and was discussed in detail in Chapter I. The APR may be 
divided into two phases; a local response which involves coagulation, kinin 
generation, phospholipid metabolism, vasodilatation and cellular infiltration and a 
systemic response that encompasses fever, leukocytosis, trace mineral 
redistribution, hepatic-acute phase protein synthesis, increased stress hormone 
levels (corticosteroids, glucagon), anorexia and redistribution of body protein and 
energy substrates (Beisel 1977; Kampschmidt 1984; Dinarello 1984a; Fong et al.
1990). The systemic APR helps to inhibit bacterial overgrowth and reduces the 
degree of tissue damage. Any one component of the APR is insufficient to 
eliminate a bacterial infection and integration of the systemic response with the
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local response may improve the host's condition and ensure survival until a specific 
immune response to infection occurs.
Despite intensive research on BPP, a clear understanding of the host's non­
specific defences against P. haemolytica Al is still lacking (Whiteley et al. 1992). 
Indeed there are few reports of studies on the non-specific response of catde to 
bacterial infection but most of these have used E. coli endotoxin as a model 
(Deldar et al. 1984; Elsasser 1992). Previous investigations on the host response 
to pasteurellosis have focused on the local cellular response to P. haemolytica Al 
(Slocombe et al. 1985; 1990; Dalgleish et al. 1986; Dalgleish 1989). These 
investigations have demonstrated an increase in the number of alveolar 
macrophages and rising neutrophil count in lung lavage collected during the initial 
phase of clinical disease. Conner et al. (1989) examined the changes in the acute 
phase protein response (APP) during BPP by measuring the concentration of 
haptoglobin (Hp), ceruloplasmin, seromucoid fraction, a x proteinase inhibitor and 
(Xj macroglobulin. The changes in the APP in this study indicated a rise in serum 
concentrations of Hp, a 2 proteinase inhibitor and the seromucoid fraction. 
Haptoglobin which was undetectable prior to the infection, increased within 24 
hours and peaked on day 3 and did not return to normal concentrations until day 
8 . The seromucoid fraction and the ctj proteinase inhibitor showed a moderate 
response.
Although some aspects of the APR in BPP namely the cellular response in 
the lung and the APP changes have been studied, other systemic responses that 
include endocrine, metabolic, mineral and haematological changes vital for the 
survival of the host, have not been investigated (Binkhorst et al. 1990; Conlon et 
al. 1991). Because BPP is an acute disease the APR is likely to play an important 
role in protecting the animal, particularly during the initial stages of the infection. 
Furthermore, an understanding of this complex and multicomponent response may 
have important implications in the treatment of diverse inflammatory disorders 
associated with this and other infections. In cattle there has been no thorough and
iii!
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co-ordinated examination of the many facets of the response therefore findings 
from this study are likely to be relevant to many other situations where the APR is 
induced in cattle.
Lipopolysaccharide (LPS) or endotoxin, a component of the outer-cell 
wall of Gram negative bacteria, has been identified as one of the important 
components that mediate the virulence of these organisms. The LPS present in 
the cell wall of P. haemolytica Al, is also believed to play a key role in mediating 
the virulence of this bacterium (Confer et al. 1990; Paulsen et al. 1989). Recent 
in vitro studies of Pasteurella haemolytica Al recovered from field outbreaks of 
BPP have demonstrated distinct differences between isolates with regard to their 
LPS profiles and outer membrane proteins (Davies et al. 1992, Ali et al. 1992). 
Although such biochemical variations in field isolates have been recognised, the 
response of hosts to different isolates of P. haemolytica Al has not been studied 
prior to this investigation. Indeed it may be that the differences in the structural 
composition of the bacterial cell wall influence the pathogenicity of the organism 
in vivo. In order to investigate the pathogenicity of different field isolates the 
pathological lesions in the lung have to be quantified at post-mortem examination. 
It is possible that monitoring the APR to different field isolates might be an 
alternative to post-mortem examination, or at least might provide a useful 
additional means of determination of the pathogenicity of a particular isolate, 
without euthanasia and post-mortem.
Aim of study
The aim of this study, was to determine the APR to P. haemolytica Al in calves. 
Thus clinical, haematological and endocrinological changes and variations in the 
acute phase proteins, trace minerals and clinicochemical analytes in response to P. 
haemolytica Al infection have been investigated. In addition, systemic APR in 
calves to two field isolates of P.haemolytica Al were compared in order to 
determine whether the level of response could be affected by the nature and 
pathogenicity of the bacterial challenge.
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4.2. Materials and Methods
4.2.1. Animals and inoculation procedure
The animals used in these experiments were healthy, weaned, Hereford X 
Holstein/Freisian calves 2 to 3 months of age with a mean weight of 104 ± 12 kg 
(range 83-148 kg) and were obtained from a dealer. Calves were selected on the 
basis of good physical condition, the absence of Pasteurella species in the upper 
respiratory tract as determined from nasopharyngeal swabs obtained 14 and 7 days 
prior to their arrival at the Glasgow University Veterinary School (GUVS). In 
addition the animals selected also had a reciprocal serum indirect 
haemagglutination antibody titre of 8  or less which was considered to be negative 
for presence of serum antibodies to the organism (Pirie and Allen, 1975). All 
calves were housed in loose boxes, bedded on straw and fed on hay and 
concentrates (190 calf pencils, BOCM-Silcock). Group daily food intake was 
recorded rather than that of individual animals. Water was available 
ad libitum throughout the experiment.
Seventeen calves (12 females and 5 males) were allocated to three groups. 
Group I and II comprised six calves each and were inoculated intra-tracheally 
with P. haemolytica Al as described by Dalgleish (1989). In this method a 30 
cm stomach tube was introduced through the nose to reach the upper third of the 
trachea via the larynx. A urinary catheter (Arnold Veterinary Products Ltd.) cut 
approximately to 30 cm, was then passed along the stomach tube and the 
inoculum was delivered from a syringe which was connected to the catheter.
Animals were inoculated with two field isolates of P. haemolytica Al, 
namely SB 82/1 and SC 82/1. The freezed dried isolates were grown on 
Trypticase Soy Broth (BBL; Becton Dickson, USA.) at 37°C and a log phase 
culture was inoculated into calves. All calves were inoculated with 20 ml of a 
three hour log phase culture of the organism at 1 1 .0 0  hours followed by 1 0  ml of 
a three hour log phase culture at 16.00 hours on day zero. The approximate 
bacterial counts of these inocula were 1.3 x 1012 and 5 x 1012 colony forming units
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(cfu) m l1, respectively. The inoculates were kindly provided by Dr. H.A. Gibbs, 
Department of Veterinary Medicine or Dr. R. L. Davies, Department of 
Microbiology, University of Glasgow . The inoculations were performed by Dr. 
H.A. Gibbs.
Group III (control group) comprised of five calves. To avoid cross­
infection of the control calves, this group was brought to the GUVS at a separate 
time from the experimental groups. These calves were inoculated with 20 ml and 
10 ml of sterile 0.01 M phosphate-buffered saline pH 7.4; 37°C (PBS) intra- 
tracheally using an identical inoculation procedure to the experimental groups. A 
summary of the analysis is given in Table 4.1.
4.2.2. Clinical examination
A thorough clinical examination was performed once daily for 3 days prior to 
infection at 1 0 .0 0  hours and twice daily thereafter at 1 0 .0 0  hours and 16.00 hours. 
On each instance, the following parameters were assessed; demeanour by 
recording dullness scores (Appedix 4.0), rectal temperature, respiratory rate and 
character, the presence of cough, nasal and ocular discharges.
4.2.3. Blood samples
Jugular blood samples were collected at 10.00 hours and 16.00 hours using 
vacutainer tubes containing lithium heparin ( 1 0  ml) for acute phase protein 
determination and 7 ml plain vacutainer tubes fitted with a zinc-free stopper for 
mineral analysis. Serum was transferred into polyvinyl storage tubes with a plastic 
pipette. Plasma and serum harvested from blood was stored at - 20°C until 
assayed. Blood for haematological studies was collected into glass vacutainers (7 
ml) containing ethylenediamine tetra-acetic acid (EDTA). All vacutainer tubes 
were obtained from Becton Dickinson Ltd., (Oxford, UK.).
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Table 4.1 Summary of the parameters analysed
Group I Group II Control
Isolates SB/82/1 SC/82/1 0.01M PBS
No. of calves 6 6 5
Clinical examination + + +
Food intake + + -
Body weight + + -
Haematology - + +
Trace minerals + - +
Cortisol + + ■ +
Thyroxine + + +
Haptoglobin + + +
Serum amyloid A + + +
Ceruloplasmin + + -
Fibrinogen - + +
Clinical chemistry + - +
Post-mortem lesions + + +
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4.2.4. Haematological examination
Haematological analysis was carried out at the haematology laboratory, 
Department of Veterinary Pathology, GUVS. Red cell count (RBC), white cell 
count (WBC), haemoglobin (Hb) haematocrit (Hct) were assayed in an automated 
haematology analyser (Roche ABX Minos Vet, Roche Products Ltd, (Welwyn 
Garden City, Hertfordshire, UK.). The RBC indices mean corpuscular 
haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC) and 
the mean corpuscular volume (MCV) were calculated using the Hct, total RBC 
and Hb content (Dacie and Lewis 1984). Differential cell counts were obtained by 
examining 200 white blood cells on blood smears stained with May-Grunwald 
Giemsa-stain.
4.2.5. Analysis of copper, zinc and iron
Serum copper, zinc and iron were measured at the Department of Animal 
Husbandry of the GUVS by using an atomic absorption spectrophotometer with a 
Perkin-Elmer analyser (Perkin-Elmer Ltd., Beaconsfield, Buckinghamshire, UK.). 
Control serum samples were Precinorm-U from Boehring Mannheim (Lewis, 
Surrey, UK.). For each mineral a single element bulb with a hollow cathode was 
used.
42.5.1 Copper
Copper was estimated in diluted serum (1:10 in 10 mM Nitric acid) according to 
the method described by Parker et al. (1967) with minor modifications. The 
atomic absorption spectrophotometer was calibrated for absorbance at a 
wavelength of 324.8 nm with two copper standards at 1.0 pg m l1 (equivalent to
15.7 pmol l 1) and at 3.0 pg mH (equivalent to 47.2 pmol H). All samples, 
including the control (a serum sample of Precinorm-U containing copper at 4.0 pg 
m l1), were assayed in duplicate and the results were calculated using a HGA-400 
Programmer (2380 AAS, Perkin Elmer Ltd.).
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4.2.5.2 Zinc
Serum zinc concentrations were assayed using a method described by Butrimovitz 
and Purdy (1977). The analysis was performed against zinc standards containing 
1 pg m l1 (equivalent to 15.30 pmol I 1) and 3 pg mb1 (equivalent to 45.90 pmol 1* 
*) prepared in glycerol to approximate the viscosity of diluted samples at a wave 
length of 213.9 nm. The control and the test samples were run in duplicate in the 
atomic absorption spectrophotometer, and the average values were calculated 
using a HGA-400 Programmer (2380 AAS, Perkin Elmer Ltd.).
4.2.53 Iron
Samples for iron determination were diluted 1 :2  with 20% trichloroacetic acid 
(TCA) solution and heated in a water bath at 90°C for 15 minutes. This 
procedure precipitated plasma proteins and released iron present in transferrin. 
The tubes were then centrifuged and the supernatant was directly analysed using 
the atomic absorption spectrophotometer at a wavelength of 248.3 nm calibrated 
with a standard of iron at a 5.0 pg m l1 (equivalent to 89.53 pmol l 1)- 
Haemolysed samples were excluded from the analysis.
4.2.6. Cortisol Radioimmunoassay
42.6.1 Assay Design
A solid phase, competitive radioimmunoassay, developed for measuring cortisol in 
human serum (McConway and Chapman 1986), was modified for use with bovine 
plasma. In this assay, cortisol in the standards, controls and test samples 
competed with 125I-labelled cortisol for binding to a suspension of antibody linked 
to a solid phase. At equilibrium, the solid phase was separated by centrifugation, 
washed and counted in a gamma scintillation counter (Packard auto-gamma-5230, 
Pangboume, Berks, UK). Unknowns were determined by reference to the inverse 
relationship between plasma cortisol concentration and radioactivity counts.
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Reagents
Cortisol radiolabelled with iodine [125I] (cortisol-3-(o-carboxymethyl) oximino-2- 
[125I] iodohistamine) was prepared according to the method described by 
McConway and Chapman (1986) and was either supplied by Dr. C. Gray, Institute 
of Biochemistry, Royal Infirmary, Glasgow or purchased from Amersham 
International pic, (Amersham, Bucks, UK.). Cortisol for the preparation of 
standards was obtained from BDH (Poole, UK). Sheep anti-cortisol antiserum 
(S004-201) was provided by the Scottish Antibody Production Unit (SAPU) 
(Carluke, Lanarkshire, UK.). 8 -Anihno-l-naphthalene sulphonic acid (ANS), an 
inhibitor of cortisol-binding globulin, gelatine, micro particulate cellulose 
(Sigmacell Type 20), caprylic acid (99% w/v) and carbonyl di-imidazole were 
purchased from Sigma Chemicals (Poole, Dorset, UK.). Assay buffer was 0.1M 
phosphate buffer, 0.1% (w/v) gelatine, pH 7.4 and included ANS at 
1 % (w/v) when necessary (see Appendix 4.a).
Standards
To improve the limit of detection of the assay an extra standard was included at 
the lowest end to give 3.91 nmol l 1 as the lowest standard in the bovine cortisol 
assay and the standards ranged from 3.91 to 500 nmol I 1. The eight cortisol 
standards (3.91, 7.81, 15.63, 31.25, 62.5, 125, 250 and 500 nmol l 1) were 
prepared in a normal bovine serum pool from which cortisol had been removed by 
stripping with agarose-coated charcoal as described by McConway and Chapman 
(1986). Briefly the appropriate amount of stock cortisol (320 mmol I 1) solution 
(11.832 mg of cortisol dissolved in 100 ml of ethanol) was dried in glass test tubes 
and mixed with the stripped serum for an hour. The stripped serum was included 
in the assay as a zero cortisol serum standard. All standards were stored in 
aliquots at -20°C.
Preparation o f anti -cortisol IgG
IgG was separated from sheep anti-cortisol antiserum for the preparation of the 
solid phase reagent, using a method described by Steinbuch and Audran (1969).
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Specificity of this antibody has been described by Naylor et al. (1990). Briefly, 
the pH of the serum (20 ml) was adjusted to pH 5.0 with 0.1 M acetic acid and 
1.76 ml of caprylic acid added dropwise. In this process all the proteins except 
IgG were precipitated. After centrifuging at 1500g for 20 min, the IgG 
supernatant was separated, collected and then dialysed against three changes of 
154 mM NaCl and finally concentrated by dialysis against polyethylene glycol 
(PEG 20,000 Mr). The protein concentration of the IgG sample was measured by 
the BCA (Bicinchoninic acid) protein assay (Section. 2.2.2.).
Activation o f microcrystalline cellulose
Activation of cellulose and the covalent linkage of IgG was performed as 
described by McConway and Chapman (1986). In a 50 ml conical flask 5 g of 
microparticulate cellulose, 0.6lg of carbonyl di-imidazole and 25 ml acetone were 
mixed. This mixture was stirred for 60 min at room temperature to activate the 
cellulose. The activated cellulose was recovered by filtering under reduced 
pressure. It was then washed 3 times with 100 ml aliquots of acetone and air- 
dried on filter papers.
Coupling o f IgG to activated cellulose
Coupling was carried out by rotating 1 g of activated cellulose in 4 ml of 0.05M 
barbitone buffer (pH 8 ) for 18 hours at room temperature with 500 pi of IgG with 
a protein concentration of 10.25 mg m l1. The solid phase antibody was washed 3 
times with the assay buffer and stored at 4°C. It was diluted for use in assay 
buffer to give 30% binding in the zero cortisol serum standard (B0).
4.2.6.2 Assay procedure
Fifty microlitre aliquots of standards, quality controls and test samples were 
aliquoted in duplicate in to 12 x 55 mm tubes (Ciba Coming Diagnostics Ltd., 
Halstead, Essex, UK.). 100 pi of radiolabelled cortisol, diluted in assay buffer to 
give 30,000 to 40,000 counts per minute per tube and containing 1% (w/v) ANS 
and 200 pi of antibody, was added to all the tubes. The tubes were vortexed and 
incubated at room temperature for 1 hour. The "bound" and "unbound" cortisol
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were separated by washing 3 times with 2.5 ml of 154 mM sodium chloride 
solution and after each wash centrifuging at 1500 g for 5 minutes. Finally the 
bound fraction was counted using a gamma-scintillation counter (Packard Auto- 
Gamma-3255, Pangboume, Berks, UK). The results were subsequently analysed 
using the “SAS” system computer programme 632014 written by Dr. P. Edwards 
Department of Molecular Endocrinology, UCMSM, London, UK.
4.2.6.3 Cortisol assay validation for bovine samples
Accuracy, precision and the limit of detection for cortisol measurement in bovine 
sera were determined by the methods of Bangham (1993). Accuracy was 
measured from the recovery of known amounts of exogenous cortisol added 
(18.8, 32.5 and 95.7 nmol l 1) to bovine serum. The mean ± SD % of recovery for 
cortisol was 108.6 ±8.1 per cent (n = 18). The precision was determined as the 
coefficient of variation (CV) calculated for both intra- and interassay CVs in 
samples containing high, medium and low cortisol levels included in all assays. 
Intra-assay CV was < 9.9% (n = 12) for samples containing 16.2, 62.5 and 125.8 
nmol-1 and inter-assay CV was <18% (n = 18) for samples containing 12.5; 26.6 
and 87.3 nmol1. The limit of detection of the assay was improved to permit 
accurate cortisol measurement and at 2 SD of maximum binding (B0) the detection 
limit was 3.0 nmol H.
4.2.7. Thyroxine (T4 )
The serum concentration of total T4 was measured using a radioimmunoassay kit 
(Magic T4) from Ciba Coming Diagnostic Limited (Halstead, Essex, UK). This is 
a competitive assay in which T4 in standards, controls and samples compete with 
[125I] labelled T4 for a limited amount of T4 antibody, which is covalently coupled 
to magnetic particles. Bound and unbound T4 were separated by magnetic 
attraction followed by decantation of supernatant.
4.2.7.1 Thyroxine assay validation for bovine samples
The T4 kit was designed for human plasma and needed validating for the bovine 
plasma prior to analysis. Validation was carried out by measuring the accuracy,
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precision and the limit of detection as described for the cortisol assay (Section 
4.2.6.3). In brief, T4 was added as 30 pi volume to 1.0 ml volumes of serum 
(which covered the range of 32 - 98 nmol l 1) and the recovery was 103.2 % ± 6.2 
over 15 samples. The intra-assay coefficient of variation was < 6.7 % (n = 30) for 
samples containing 40.5, 64.2 and 75.4 nmol l 1 T4 concentrations. The interassay 
CV's for 40.4, 64.8 and 92.3 nmol F  T4 concentrations were at 7.8 %, 5.6 % and
8.7 % respectively over 5 assays. The limit of detection of the assay was 5 nmol b 
1 being the T4 concentration at 2 SD from the mean of the concentration with a 
zero serum sample from which T4 had been removed by stripping with agarose 
coated charcoal.
4.2.8 Acute phase proteins
4.2.8.1 Haptoglobin
The haptoglobin (Hp) content in serum was measured by a modification of the 
method described by Conner et al (1988b) and based on previous report by 
Makimura and Suzuki (1982).
Reagents
Tetramethyl benzidine (TMB, Sigma Chemical Company) was used as the 
chromogen instead of the carcinogenic reagent o-dianisidine and the pH of the 
chromogen buffer (0.5g sodium EDTA; 15.6g Na H P0 4 .2H20  in 1 1 distilled 
water) was adjusted to pH 3.8. A stock solution of TMB at 6  mg ml" 1 was 
prepared in dimethyl sulphoxide and, for use in the assay, was diluted 1 0 0  x in 
chromogen buffer. A working haemoglobin (Hb) solution was freshly prepared 
by diluting a stock concentrated Hb solution to 0.3 mg mb1 with saline for each 
assay. The Hb was quantified in the stock solution by a haematocrit analyser 
Roche ABX Minos Vet. (Roche products Ltd, Diagnostic Division, P.O. Box 8 , 
Welwyn Garden City, Hertfordshire) The stock Hb solution was prepared 
according to Makimura and Suzuki (1982). Flat-bottomed Microtitre plates were 
obtained from Nunc, Gibco Ltd., (Paisley, UK.).
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Standards
Serial dilutions (0 to 2.0 g l 1) of acute phase bovine serum with a known amount 
of haptoglobin, quantified by comparison to purified Hp (Eckersall and Conner 
1990), were used as standards. The dilutions were made in normal bovine serum 
and had a range from 0.03 to 2  g l1 with the normal serum as zero standard.
Assay procedure
A 20 pi aliquot of acute phase semm was mixed with 100 pi of working Hb 
solution in a glass test tube (3 x 100 mm) and incubated for 10 minutes at room 
temperature. The reaction mixture was then diluted with 5 ml of saline, mixed and 
duplicate 2 0  pi aliquots delivered into the wells of a microtitre plate followed by 
200 pi of chromogen buffer to each well and incubated for 1 hour at 37°C. At the 
end of the incubation period 50 pi of H20 2 substrate (12 pi of 30% H20 2 in 10 ml 
dH20) was added and incubated at 37°C until a strong blue colour developed in 
the maximum standard. Subsequently, 50 pi of 2M H2S04 were added to all the 
wells to inhibit any further peroxidase activity. The plate was read using an 
ELISA plate reader at 450 nm and the haptoglobin concentration of the test sera 
calculated by comparison with the standards, using an immunoassay analysis 
computer programme (Titersoft, Flow Laboratories, UK). The standards were 
2.0, 1.0, 0.5,0.25, 0.13, 0.06, 0.03 g l 1. The limit of sensitivity was 0.02 g I 1 and 
was calculated as 2 x SD of the zero standard. The intra-assay coefficients of 
variance were 6.0% and 5.0% respectively for thirty samples containing 0.5 and
1.0 Hp g H concentrations. The interassay precision was determined by 
calculating the coefficients of variation obtained with samples containing 0.5 and
1.0 g I 1 of Hp and were 6 .6 % and 4.3%, respectively, over fifteen assays.
In previous reports results of this assay Hp concentrations have been 
expressed as mg haemoglobin binding capacity per decilitre (HbBC 100ml1) 
which is based on the haemoglobin binding capacity of Hp. In this assay the Hp 
concentration was quantified with standards which had been standardised against
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purified bovine Hp. To allow comparison with previous results a conversion 
factor of 29 should be used (Dr. P.D. Eckersall personal communication), thus 1 g 
F  = 29 mg HbBC 100ml1.
4.2.82 Serum Amyloid A
Serum amyloid A concentrations were determined by ELISA as described 
previously in Chapter 3. Plasma concentrations of SAA are expressed in |ig m l1. 
42.8.3 Ceruloplasmin
Ceruloplasmin (Cp) activity in the serum was estimated using the method of 
Sunderman and Nomoto (1970) using p-phenylenediamine dihydrochloride (PPD) 
from Sigma Chemical Company Ltd. (Poole, Dorset, UK.; P-1519) as substrate. 
The principle in this assay is that at pH 5.9 Cp catalyses the oxidation of PPD to 
yield a coloured compound which absorbs at a wavelength of 530 nm. The rate of 
formation of the coloured compound is proportional to the concentration of serum 
Cp. Correction was made for non-enzymatic oxidation of PPD by carrying out a 
blank assay in the presence of sodium azide which inhibits the oxidase activity of 
Cp. The difference between the two assays is proportional to the serum Cp 
concentration.
The pH optimum for the reaction of bovine ceruloplasmin was confirmed 
as pH 5.9 by testing 0.1M acetate buffers from pH 5 to 7.5. The activity of 
ceruloplasmin was expressed in oxidase units, where one oxidase unit is the 
amount of ceruloplasmin which alters the optical density at a rate of 0 .0 1  unit per 
minute at 530 nm in a 1 cm light path under the conditions described (Conner et 
al. 1988b).
Reagents
p-phenylenediamine dihydrochloride and sodium azide (NaN3) were from Sigma 
Chemicals (Poole, Dorset, UK). The assay was performed in 10 ml glass test 
tubes and a water bath at 37°C. Absorbance was measured on a 
spectrophotometer (Cecil, CE 373, Cambridge, UK).
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Assay Buffer and Chromogen reagent
The assay buffer consisted of 430 ml of 0.2 M sodium acetate mixed with 70 ml of 
0.2M acetic acid diluted to a litre with dH20. The chromogen reagent consisted 
of 27.8 mM PPD (0.5g PPD to 100 ml) in assay buffer which was adjusted to pH 
5.9 with 1 M NaOH. This was prepared fresh as PPD is stable in solution for only
3 hours.
Assay Procedure
Aliquots of serum (100 |il) were added in quadruplicate to 3x100 mm glass tubes. 
Acetate buffer (2 ml) and 1 ml of buffered PPD was added to all tubes and 50 fil 
of 1.5M NaN3 added immediately to 2 tubes to serve as sample blanks. All tubes 
were incubated for 30 minutes at 37°C, after which 50 fil of 1.5M NaN3 were 
added to the untreated sample tubes. Absorbance were measured at 530 nm.
4.2.8.4 Fibrinogen
The concentration of plasma fibrinogen was determined by the Haematology 
laboratory of Department of Veterinary Pathology GUVS using a Diagen 
Fibrinogen Kit (Diagnostic Reagents Limited, Thames, Oxon). The assay 
principle was originally described by Clauss et al. (1957) and was based on the 
inverse relationship between the fibrinogen content of blood and the clotting time. 
However, blood samples were collected into EDTA which chelated calcium ions 
and the test had to be modified in consultation with the manufacturers, by adding
4 ml of 1M calcium chloride to 1 ml of thrombin reagent before the fibrinogen 
content was assayed.
4.2.9. Clinical Chemistry Profile
A biochemical profile focused on plasma protein and liver enzymes and 
metabolites was performed on plasma samples from Group I and control group 
using an automated biochemical analyser (Mira Roche Diagnostica, Welwyn 
Garden City, Herts, UK) with commercial assay kits (Roche Products Ltd., Herts, 
UK). The analytes included in the assessment of the responses in calves to
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P. haemolytica infection were albumin, globulin, total protein, bilirubin, aspartate 
transaminase (AST), alanine transaminase (ALT), alkaline phosphatase, gamma 
glutamyl transferase (7 GT) and glutamate dehydrogenase (GLDH). However, 
only bilirubin and GLDH results are reported in the results section as these were 
the only two analytes to show a significant change following infection.
4.2.10 Post-mortem
Detailed post-mortem examination was restricted to the respiratory system and 
was performed by Dr. H.A. Gibbs of the Department of Veterinary Medicine. 
Lung lesions were examined grossly and pulmonary consolidation scores were 
mapped and finally photographed. Apart from one calf (Calf 9 in Group I) which 
died on the first night of the experiment, the calves were sacrificed by stunning 
with a captive bolt pistol followed by exsanguination. One calf (calf 3 in Group I) 
was slaughtered for humane reasons on day 1 .
4.2.11 Statistical methods
Results are presented as group means + SEM. Data obtained from infected and 
control calves comparing rectal temperature, respiratory rates, acute phase 
protein concentrations, hormone assays, haematology and the clinical chemistry 
profile were subjected to analysis of variance with repeated measures design using 
a computer statistical package ANIMAL DESIGNS 1, V 1.21 5/6 (Data 
International Service, Glasgow). Paired't' tests were used to identify the time 
points at which particular group differences were significant. Iron, zinc and 
copper were analysed on the basis of their respective pre-infection concentrations. 
In experiments involving more than two treatment groups (Group I, Group II and 
control) comparisons were analysed by one way analysis of variance followed by 
a between group comparison test, the Newman-Keuls Multiple Range Test. 
Comparisons were considered significantly different at P<0.05.
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4.3. RESULTS
Bovine pneumonic pasteurellosis was successfully established in both infected 
groups using the infection regime described above. All the infected calves showed 
signs of typical bovine pneumonic pasteurellosis by the afternoon of day 0  or by 
the morning of day 1 at the latest.
4.3.1. Clinical Signs
4.3.1.1 Demeanour
All calves remained bright and healthy during the acclimatisation period. Infected 
calves in Group I became dull, anorexic and pyrexic within six hours of 
inoculation (Appendix 4.0). Two calves died within two days of inoculation. 
Surviving animals remained dull and listless until they were sacrificed on day 6  
post-inoculation. Group II calves were dull and anorexic during the early stages 
of infection but became brighter after day 3. Calves in the control group, 
inoculated with sterile PBS, remained bright and healthy throughout the 
experiment.
4.3.1.2 Rectal temperature
Individual rectal temperatures were recorded throughout the experimental period 
and are shown in Appendix 4.1. Mean (± SEM) daily rectal temperatures are 
presented graphically in Figure 4.1a.
Calves were afebrile during the acclimatisation period (rectal 
temperatures < 40°C). After the inoculation on day 0 there was a moderate rise in 
the mean rectal temperatures of both experimental groups. On the following day 
Group I calves showed other severe signs of BPP such as dullness and respiratory 
signs but showed no further rise in mean rectal temperature. The most likely 
reason for this was that one calf was sacrificed on humane grounds and the calf 
which died on day 1 of the experiment: these calves were moribund with falling 
rectal temperatures at the time of clinical examination (Appendix 4.1). From day 
2  onwards the mean rectal temperature rose further and remained high for the rest 
of the experimental period. After day 0 the mean rectal temperature of Group II
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calves was indistinguishable from the control calves and was similar to the pre- 
infection values.
4.3.1.3 Respiratory rate
Individual respiratory rates were recorded throughout experimental period and are 
presented in Appendix 4.2. Mean values for each of the groups between day -1 
and day 5 are presented graphically in Figure 4.1b. No calves were noted to be 
tachypnoeic (which for this experiment was considered to be a respiratory rate 
equal to or greater than 60 min1) during the pre-infection period. There was a 
dramatic rise in group mean respiratory rates following infection on day 0  in all 
calves in Group I and II from means of between 20 and 30 min-1 to means in the 
region of 70 min-1 within 12 hours of infection. The respiratory rate of calves in 
the control group was raised slightly, (16 to 22 ± 3 min-1) on day 1 and then 
decreased over the next 1 2  hours to the normal level of 18 min-1 for the remainder 
of the experiment.
4.3.1.4 Food intake
The group daily food intakes of the calves in Group I and II are shown in Figure 
4.2a and in Appendix 4.3.1. The food intake of the calves infected with 
P.haemolytica A1 in Group I fell markedly from 1.3 kg per 50 kg live-weight 
during pre-infection period to zero on day 0  and remained severely depressed for 
the duration of the experiment. However, in Group II, food intake dropped by a 
third, from 1.5 to 1 kg per 50 mg body weight on day 0 but increased on day 3 
with a slight reduction thereafter.
Individual live weights at various points over the experimental period are 
recorded in Appendix 4.3.2. Following infection on day 0 weight loss was seen in 
all infected calves but was most dramatic in the Group I calves which, as a group 
suffered a 9.9% drop in total body weight over the period day 0 to day 6  
(Fig.4.2b). The total body weight of the calves in Group II remained unchanged 
(810 kg) throughout the experimental period.
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Figure 4.1 The mean (± SEM) rectal temperatures (Fig. 4.1a) and mean 
(± SEM) respiratory rates (Fig. 4.1b) of calves intra-tracheally inoculated with 
P.haemolytica Al. Calves in Group I (n=6 ) were inoculated with isolate SB/82/1 
and the calves in Group II (n=6 ) were inoculated with isolate SC/82/1. The 
control group (n=5) received phosphate buffered saline intra-tracheally. Animals 
were examined daily at 10.00 hrs and 16.00 hrs. Two calves in Group I died of 
severe pasteurellosis on day 1 .
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Figure 4.2 The daily total group food intake of calves in Group I (n=6 ) and 
Group II (n=6 ) (Fig. 4.2a). The individual live weights of calves in Group I (n=4) 
and Group II (n=6 ) 6  days before infection, on the day of infection and
6  days after the infection (Fig. 4.2b). Two calves in Group I died of severe 
pasteurellosis on day 1 .
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4.3.2. Haematology
Though several haematological parameters were measured (4.2.4.) only the 
parameters that were affected by P. haemolytica infection are presented. The 
daily mean ± SEM for total leukocyte count, neutrophils, monocytes and 
lymphocytes (Group II) are presented graphically in Figure 4.3a. The individual 
WBC counts and the neutrophil count are presented in Appendix 4.4.
In the control calves no change was observed in total leukocyte count, 
neutrophils, monocytes or lymphocytes, after the PBS inoculation. In the calves 
of Group II, a significant increase (P< 0.05) was found in mean total leukocyte 
counts by 4 hours post-inoculation. This increase was reflected by a significant 
rise (P< 0.05) in neutrophil counts which included numerous band neutrophils 
(Fig. 4.3a). The total leukocyte and neutrophil counts reached a peak on day 1 
and then gradually dropped over days 2 to 3. By day 4 the count was equivalent 
to pre-infection levels. Differences between Group II and control calves in 
lymphocyte or monocyte counts were not statistically significant, although at 4 
hours post-inoculation the lymphocyte values did drop slightly below pre-infection 
level. The Group II mean (± SEM) for RBC counts and haematocrit are given in 
Figures 4.3b and 4.3c respectively. Both RBC and haematocrit showed a 
significant (P<0.05) drop from the time of infection to day 5 post-inoculation.
4.3.3. Trace Minerals
The individual daily serum Fe, Zn and Cu concentrations of the infected Group I 
are given in Appendix 4.5 and the daily group mean (± SEM) for Fe, Zn and Cu 
concentrations of infected and the control group are presented graphically in 
Figures 4.4a and 4.4b, respectively. The pre-infection concentrations of the trace 
minerals were significantly high in the infected group compared to the control 
group which was purchased from a different farm. The
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Figure 4.4 Mean (± SEM) serum iron, zinc and copper concentrations of 
calves (n=6 ) infected intra-tracheally with P. haemolytica (Fig 4.4a). The 
control calves (n=5) received phosphate buffered saline intra-tracheally(4.4b). 
Two calves in the infected group died on day 1 with severe pasteurellosis.
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values in the control group were found to be at the lower end of the reference 
range (Fe: 10.2 - 29.0 pmol F, Zn: 6.0 - 16.0 pmol F  and Cu: 8.0 - 11 pmol F; 
Reference values, Department of Animal Husbandry, GUVS; Kaneko 1989) for 
healthy calves of this age group. Therefore, statistical analysis was carried out by 
comparing the post-infection results not only with the control group (ANOVA) 
but also with the pre-infection values of the infected group (paired t-test). A 
dramatic and significant (P<0.001) fall occurred in serum Fe concentration from 
25.97 ±1.15 pmol F  to 7.24 ± 0.33 |imol F  on day 1 post-infection. Although 
the Fe concentration gradually increased from day 2 the concentration did not 
reach the pre-infection values within the trial period.
Similarly the mean serum zinc concentration which, before infection, was 
14.13 ± 1.5 pmol F  dropped significantly (P<0.05) on day 1 post-inoculation to 
6.12 ±1.3 |imol F . Concentrations increased gradually thereafter but remained 
below the base-line value even after day 5. The mean serum copper 
concentrations remained unchanged (12.39 ± 0.4 pmol F ) until day 4 and showed 
a 50% rise (18.7 ± 3.87 |imol F) on day 5 but this was not significantly different 
from the controls. The control group showed a slight rise in mean serum copper 
on day 1, returning to pre-infection concentrations by day 3.
4.3.4. Cortisol
The daily mean (± SEM) serum cortisol concentrations are shown in Figure 4.5a. 
and individual results are present in Appendix 4.6. The control and both the 
infected groups had similar group mean plasma cortisol concentrations during the 
pre-infection period in a range of 3 - 30 nmol F . Following inoculation the group 
mean cortisol concentrations increased significantly (P < 0.001) in both infected 
groups. In Group I the mean cortisol concentration continued to rise throughout 
the experimental period, whereas in Group II the mean cortisol concentration rose 
from the pre-infection level of 16 ± 1.6 nmol F  to reach 43 ± 2.7 nmol I 1 on day 1 
then showed a gradually decline after day 3.
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4.3.5. Thyroxine
Daily variation in mean (± SEM) serum T4 concentration in the control and the 
infected groups are shown in Figure 4.5b and the individual results are presented 
in Appendix 4.7. On day 1 post-infection, T4 concentrations were significantly 
reduced in both infected groups. In Group I the mean T4 concentration decreased 
from 65 (± 7.5) to 17.9 (± 12.1) nmol l 1 while in Group II the drop was from 60 
(± 4) nmol I 1 to 36 (± 7) nmol l 1. The two calves that died in Group I had low 
concentrations of T4 on day 1 of <5 nmol l' 1 which was the detection limit of the 
assay. The serum T4 concentration of the control group ranged between 53.6-
43.4 nmol l 1. There was no change in the T4 serum concentration after PBS 
administration to the control group.
4.3.6. Acute phase proteins
The individual daily values for Hp, serum amyloid A, fibrinogen (Fb) and 
ceruloplasmin concentrations are shown in Appendices 4. 8  to 4.11. Hp and SAA 
were undetectable in pre-infection samples while the mean Fb for the group II was 
normal (250 mg m l1)* Within 24 hours of infection, serum levels of Hp, SAA and 
Fb significantly increased, while ceruloplasmin remained unchanged until day 4 
post-infection. The main increases occurred in Hp, SAA and Fb concentrations 
during day 1 and 2. After the peak of the serum concentration on day 2 the 
concentration of SAA and Hp declined rapidly but during the trial period 
concentrations did not declined to the pre-infection levels. The plasma Fb was 
maintained at a raised concentration for 4 days till the end of the experiment in 
Group II.
4.3.6.1 Haptoglobin
Haptoglobin concentrations were, 0.6 g I 1 in all groups during the pre-infection 
period but increased significantly (P <0.001) on day 1 and reached a peak value of
2.0 to 2.5 g I 1 by day 2 (Fig. 4.6a.). Thereafter, values declined gradually. The 
concentration of haptoglobin was significantly higher in both infected groups
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Figure 4.5 Mean (± SEM) plasma cortisol (Fig. 4.5a) and thyroxine 
concentrations (Fig. 4.5b) of calves infected intra-tracheally with
P haemolytica A1 in Group I (isolate SB/82/1) and Group II (isolate 
SC/82/1). The control group received phosphate buffered saline intra- 
tracheally. Two calves in Group I died on day 1 with severe pasteurellosis.
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when compared to the controls (P < 0.001) and there was no significant difference 
between the two infected groups in Hp concentration.
4.3.6.2 Serum amyloid A
The SAA concentration in both Group I and Group II was close to the detection 
limit on day 0 (<3 |ig m l1) but was slightly higher in the control group. On day 1 
the SAA concentration increased in both infected groups while the control calves 
remained unchanged (Fig. 4.6b). In Group I the concentration of SAA was 
significantly higher than Group II (P <0.05) and controls (P< 0.001). Peak 
concentration occurred on day 2 with a mean (± SEM) 133.5 ± 12 |ig mb1 SAA in 
Group I and 73.0 ± 6  p,g m l1 SAA in Group II. The SAA concentration declined 
rapidly from day 3 but during the experimental period the levels remained higher 
than the controls.
4.3.63 Fibrinogen
Fibrinogen concentration was measured only in the Group II calves and the 
controls, and the daily group means (± SEM) are shown in Fig. 4.7a. The mean 
pre-infection plasma concentration for Fb was 200 ± 5 mg d l1 and the 
concentration rose 4 hours after infection, reaching a peak of 800 mg d l1. On day 
2 the Fb concentration was 1200 ± 6  mg d l1 and this increase was found to be 
highly significant (P <0.001). Concentration fell between day 2 and day 3 to 800 
mg d l1 but then remained at this level till the end of the experiment
4.3.6.4 Ceruloplasmin
The daily group mean (± SEM) of serum ceruloplasmin in Group I and Group II 
are shown in Fig. 4.7b. From a mean pre-infection concentration of 0.1 (± 0.04) 
oxidase units, ceruloplasmin showed little variation in either group, although a 
slight rise to 0.22 (± 0.04) oxidase units was observed on the day 5 in group I. 
However, this increase was not significant (P>0.05).
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Figure 4.6 Mean (± SEM) haptoglobin (Fig. 4.6a) and serum amyloid 
A (Fig. 4.6b) concentrations of calves infected intra-tracheally with 
P. haemolytica A1 in Group I (isolate SB/82/1) and Group II (isolate 
SC/82/1). The control group received phosphate buffered saline intra- 
tracheally. Two calves in Group I died on day 1 with severe 
pasteurellosis.
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Figure 4.7 Mean (± SEM) fibrinogen (Fig. 4.8a) and ceruloplasmin 
(Fig. 4.8b) concentrations of calves infected intra-tracheally with 
P. haemolytica A1 in Group I (isolate SB/82/1) and Group II (isolate 
SC/82/1). The control group received phosphate buffered saline intra- 
tracheally. Two calves in Group I died on day 1 with severe pasteurellosis.
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4.3.7. Clinical Chemistry Profile
Most analytes estimated by routine clinical chemistry were not affected by 
P. haemolytica infection.
4.3.7.1 Glutamate dehydrogenase activity
The Group I daily mean (± SEM) plasma GLDH activity are given in Figure 4.8a. 
In Group I there was a significant reduction (P <0.05) in the GLDH activity, 
reducing from 43.38 U l 1 on day 0 to 13.12 U l 1 on day 4. Thereafter, levels 
increased gradually but within the trial period the pre-infection levels were not 
reached. The GLDH activity was unaltered in the control group.
4.3.7.2 Bilirubin
The pre-infection mean (± SEM) plasma concentration of bilirubin in Group I 
calves was 2 . 0  mg mF and increased to a maximal value of 1 0 .6  (± 0 .2 ) mg m l1 
by day 2  post-infection and, despite the subsequent reduction, remained 
significantly (P<0.05) greater in infected calves than in the controls calves during 
the experimental period (Fig. 4.8b).
4.3.8. Post-mortem report 
Group I
The pulmonary consolidation scores for the calves that were killed on humane 
grounds or died on first and the second day of the experiment was 52.7% and for 
the calves which were killed on the day 6  of the experiment was 61.8%. The 
group mean pulmonary score was 58.7% with a range of 40.3% to 87.8%. 
(Appendix 4.12). Pulmonary consolidation maps of individual calves are 
presented in Figures 4.9a to 4.9d. Lesions characteristic of an acute exudative 
fibrinous pneumonia and considered typical of those associated with bovine 
pneumonic pasteurellosis due to infection with P. haemolytica A1 infection were 
found in the calves of Group I. These lesions varied from widespread areas with a 
severe exudative fibrinous pneumonia with consolidation and pleurisy (Figures 
4.10a. and 4.10b) to mild acute pneumonic lung lesions is present (Figure 4.10c).
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Figure 4.8. The mean (± SEM) glutamate dehydrogenase activities 
(Fig. 4.8a) and bilirubin concentrations (Fig 4.8b) of calves infected intra- 
tracheally with P. haemolytica A1 in Group I (isolate SB/82/1) and the 
control group. The control group received phosphate buffered saline 
intra-tracheally. Two calves in Group I died on day 1 with severe 
pasteurellosis.
£alfNQt 8 
(Slaughtered, day 6 )
Figure 4.9a Pulmonary score charts of calf 2, 3 and 8 infected intra-tracheally
with P. haemolytica A1 isolate SB/82/1 in Group I.
m
Calf No. 14 
(Slaughtered, day 6 )
Calf No. 21 
(Slaughtered, day 6 )
Figure 4.9b Pulmonary score charts of calf 9, 14 and 21 infected intra-tracheally
with P. haemolytica A1 isolate SB/82/1 in Group I.
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.Calf No, 2 
(Slaughtered, day 6 )
Calf No, 4 
(Slaughtered, day 6 )
Calf NO, g
(Slaughtered, day 6 )
Figure 4.9c Pulmonary score charts of calf 2, 4 and 5 infected intra-tracheally 
with P. haemolytica A1 isolate SC/82/1 in Group II.
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Calf No. 7 
(Slaughtered, day 6)
Calf No. 21 
(Slaughtered, day 6)
Calf No. 24 
(Slaughtered, day 6)
Figure 4.9d Pulmonary score charts of calf 7, 21 and 24 infected intra-tracheally
with P. haemolytica A1 isolate SC/82/1 in Group II.
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Figure 4.10a Dorsal view of the lungs of calf 2 (Group 1) 
showing severe acute fibrinous pneumonia with pleurisy. The 
animal was infected with P. haemolytica A1 isolate SB/82/1.
Figure 4.10b Dorsal view of lungs of calf 8 (Group I) 
showing severe acute fibrinous pneumonia. The animal was 
infected with P. haemolytica A1 isolate SC/82/1.
149
Figure 4.10c Dorsal view of lungs of calf 5 (Group II) 
showing mildly acute pneumonic lung lesions. The animal was 
inoculated with P. haemolytica A1 isolate SC/82/1.
Figure 4.10d A part of a lung from an infected animal (calf 
14; Group I) showing a typical nodule (arrow) 
produced by P haemolytica A 1.
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Some animals had resolving nodular lesions where small foci of fibrinous 
pneumonia became encapsulated (4. lOd).
Group II
The group mean pulmonary consolidation scores was 10.3% with a range from 
1.15% to 19.54% (Appendix 4.12). All calves of Group II had areas of acute 
exudative fibrinous pneumonia with fibrinous pleurisy overlying the anterior lung 
lobes (Figure 4.10a) but these lesions were smaller and more discrete than those 
seen in Group I. A few calves in Group II had very low-grade lesions of cuffing 
pneumonia.
Control
At necropsy, none of the calves in the control group had pulmonary lesions that 
represent BPP.
4.4. Discussion
The two objectives of these studies described in this chapter were to extend our 
knowledge of the acute phase reaction in cattle to infection with P.haemolytica 
A 1 and to determined whether the response varied when induced by different field 
isolates of this Gram-negative bacterium. The results pertaining to the former 
objectives are derived largely from the experimental infection with isolate SB/82/1 
(Group I) apart from the assessment of the haematological aspects of the systemic 
host response which were investigated with isolate SC/82/1 (Group II). This 
discussion will first cover all these new finding on the APR in bovine 
pasteurellosis and will subsequently compare those acute phase reactants which 
were monitored in Group 1 and Group II to consider whether different field 
isolates have a similar or differing effects on the APR.
The post-mortem reports, the results for rectal temperature, respiratory 
rate, demeanour and post-mortem findings confirmed that calves inoculated with 
isolate SB/82/1 (Group I) developed a severe infection typical of BPP. In contrast
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calves inoculated with isolate SC/82/1 (Group II) had a less severe infection 
indicated by rectal temperature and post-mortem findings. Fever and a rise in 
respiratory rate are well established signs of BPP in the field (Hepburn 1925) and 
in experimental models of the disease (Gibbs et a l 1984; Dalgleish 1989). These 
clinical signs of the disease are likely to be caused by cytokine release (Whiteley 
1992; Pace et a l  1993).
Gram-negative bacteria release several toxins such as endotoxins, 
leukotoxins and fimbrial antigens which trigger macrophages and monocytes to 
stimulate the release of cytokines such as EL-1 IL- 6  and TNFa (Dinarello et a l
1989; Atkins 1989). Several studies in laboratory animals have shown that the 
development of fever is a result of LPS or its mediators IL-1, IL- 6  and TNFa, the 
pyrogenic cytokines, which in turn induce the anterior hypothalamus to release 
prostaglandin Ej and bring about pyrogenesis (Dinarello 1984a) by increasing the 
thermo-regulatory set point (Kluger 1989).
Fever is one of the characteristic features of the systemic APR. Moderate 
fever may improve the host's defence in several ways, such as increasing migration 
of leukocytes to the site of infection and by enhancing their phagocytic and 
bactericidal activities. These aspects of inflammation and the immune response 
do not function optimally at normal body temperature (Kluger 1975; van Merit 
e ta l  1992).
In previous studies of the APR in cattle infected with P.haemolytica Al, 
the distinctive rapid increase in APP such as Hp, a 2 acid glycoprotein and 
aj antitrypsin has been described (Conner et al. 1989). This investigation has 
extended our knowledge by demonstrating that SAA is a major bovine APP and 
for the first time, by revealing simultaneous alterations in the other classes of acute 
phase reactants, notably the trace elements, hormones and neutrophil count in 
calves with BPP.
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The control group was brought to the GUVS at a different time to 
minimise the risk of cross-infection during handling and sampling and were not 
purchased from the same farm as the infected groups with the result that the 
control and infected group of calves had different basal iron, zinc and copper 
values, due to the difference in the nutrition and the management practices of the 
two farms. In order to avoid this discrepancy the mineral changes observed in the 
infected group were compared with the pre-infection values as well as those 
ootained with the control groups.
The immediate drop, following infection, in circulating concentrations of 
the trace elements Fe and Zn found in calves has been shown to occur in acute 
infection in species such as sheep where trauma, digestive disorders and stress can 
reduce the circulating zinc and copper (Corrigal et al. 1976; Pfeffer and Rogers 
1989). In goats, E coli endotoxin administration caused a reduction in serum iron 
and zinc concentrations (van Merit et al. 1984). Hypoferraemia during bacterial 
infection has also been studied extensively in laboratory animals after treatment 
with bacterial components, particularly LPS (Kampschmidt and Upchurch 1969; 
Butler et al. 1973; Turchik and Bomstein 1980). Interestingly an injection of iron 
or zinc reduced the survival rate of experimentally infected animals (Kluger and 
Rothenburgh 1979). From these and other studies the postulate has arisen that the 
benefit to the host of a reduction in trace elements is to limit the available supply 
of iron and zinc which are essential for bacterial growth. It is known that the 
combination of fever and low plasma zinc and iron concentrations helps the host 
to survive during acute infections (Bullen 1981). Iron is essential for bacterial 
growth and bacteria compete with host tissue for bound and free iron. Therefore, 
decreasing the availability of iron, could curtail the multiplication of the organism. 
A further benefit to the host of a reduction in circulating iron may be to reduce 
leukocyte-derived toxic oxygen metabolites which are a major contributing factor 
to the lung lesions found in BPP (Slocombe 1985). Iron plays a major role in the 
generation of these toxic oxygen radicals and therefore a reduction in iron
153
availability during the APR may reduce neutrophil dependent tissue injury 
(Slocombe et al. 1990).
Hypoferraemia is thought to be due to redistribution of plasma iron during 
inflammation with an increase in liver uptake and storage by incorporation into 
ferritin (Kushner 1982; Koj 1985). This iron is not available for haematopoiesis 
(Feldman et al. 1981a) and may therefore lead to anaemia in chronic infections. A 
hypoferraemic state during chronic infections has been described in humanS 
(Cartwright 1966), goats (van Merit et al. 1992) and dogs (Feldman et al. 1981a).
Injury and infection are often accompanied by haemolysis which may lead 
to further loss of iron. Haptoglobin (Hp), a major acute phase protein in cattle is 
also involved in recovery of iron as it binds haemoglobin stochiometrically and 
irreversibly. This complex (Hp-Hb) retains peroxidase activity and is cleared 
rapidly from the plasma by the liver. This action of Hp as an effective and specific 
scavenger is important in bacterial diseases as Hb-iron is known to support 
bacterial growth (Koj 1985).
Davies et al. (1992) reported that iron limitation by the host is influenced 
by the outer membrane proteins (OMPs) of P. haemolytica bacteria and different 
P. haemolytica isolates can have different OMPs (Ali et al. 1992). As OMPs are 
immunogenic, a clear understanding of the relationship between the OMP 
composition and the host defence could be useful for the production of new 
vaccines.
In the present study, serum zinc concentrations fell significantly 24 hours 
post-inoculation. Similar results have been documented in other domestic and 
laboratory animals (Corrigall et al. 1976;. Boosman et al. 1989; Kampschmidt and 
Pulliam 1978). An APR in the horse caused a sharp fall in serum zinc 
concentration one day after adjuvant administration (Auer et al. 1989) and foals 
experimentally infected with Rhodococcus equi became hypozincaemic in 
comparison with healthy controls (Barton and Embury 1987). A reduction in 
plasma zinc concentration has been reported in mice following endotoxin injection
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and in rabbits after an intra-cranial injection of LL-1 (Fleck and Myers 1985; 
Turchik and Bomstein 1980). In contrast, serum zinc concentration in dogs 
increased by 1 0 0  per cent after inflammation induced by adjuvant, but this was 
measured 10 days after treatment (Feldman et al. 1981b) and may have followed 
an immediate drop in serum zinc.
The hypozincaemia observed during the APR occurs when zinc is taken up 
from the plasma and deposited as metallothionein-bound zinc in the liver (Pekarek 
et al. 1972). Metallothionein is a liver protein, the synthesis of which can be 
induced by stress, glucocorticoids and administration of metals such as zinc, 
copper and cadmium (Koj 1985). However, liver uptake of zinc may be 
dependent on several other factors because in the early stages of the APR the 
immediate fall in circulating zinc precedes the synthesis by the liver of 
metallothionein (Koj 1985; Schroeder and Cousin 1990). As these changes occur 
rapidly, it is also possible that the central nervous system is involved in the 
increased uptake of zinc by the liver or that cytokines may be involved in the 
redistribution of zinc in the early stages of the APR (Kampschmidt and Pulliam 
1978).
Circulating copper did not change in the infected group until day 5. The 
increase in copper in the control group on day 1 may have been caused by the 
contamination of food or water with copper. The increase in copper in the 
infected group was probably related to the increase in ceruloplasmin which is the 
major form of copper in the circulation and which has been observed previously in 
BPP (Conner et al. 1989). The mean serum ceruloplasmin in Group I was one of 
the last acute phase proteins to increase and comparison of Fig. 4.7b with Fig 4.4a 
indicates that the rise in serum Cu reflects the rise in the acute phase protein 
ceruloplasmin. In dogs with an adjuvant-induced abscess (Feldman et al. 1981b; 
Fisher 1977), the plasma copper concentration increased on day 10 when the 
abscesses were opened and drained. Similarly adjuvant stimulated horses showed 
an increase in copper concentrations from the day 9 to 36 and in these horses
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ceruloplasmin levels started rising from day 5 onwards (Auer et al. 1989). 
Furthermore, increased serum copper concentrations have been reported in 
human rheumatoid arthritis patients (Lunec et al. 1981). In the present study a 
continuing rise in copper (and ceruloplasmin) was not observed because of the 
short duration of the experimental period.
The rise in serum cortisol and fall in T4 during BPP has not been described 
before and indeed, there have been few studies in cattle of the endocrine 
involvement with infection (Elsasser 1992). However, a rise in cortisol 
concentration following bacterial infection has been described in other species 
such as human (Finlay and McKee 1982), mice (Besadovsky et al. 1986) and 
lactating cows (Shuster et al. 1993). The mechanism for these hormonal changes 
during the APR is a subject of much debate. Infection, injury or inflammation can 
induce the hypophyseal-adrenocortical system to release corticotrophin releasing 
factor (CRF) to which the pituitary responds with the release of ACTH which, in 
turn, activates the adrenal cortex to increase glucocorticoid release. In addition 
cytokines too play a role by stimulating the adrenal cortex directly to release 
cortisol. Both direct and indirect stimulation of the adrenal cortex will lead to a 
rise in cortisol concentration (Whicher and Westacott 1992). Besedovsky et al. 
(1986) showed that recombinant human-IL-lp increased ACTH and cortisol 
concentration in mice. Further studies of corticotropic cells from pituitary 
incubated with IL-1 confirm that it is a potent inducer for ACTH. In vivo 
increases in ACTH and corticosterone in response to IL-1 were blocked by 
antibodies to CRF (Sapolsky et al. 1987). It has also been reported that IL-1 is 
able to induce corticosterone release direcdy from adrenal gland cells in the rat 
(Salas et al. 1990a; 1990b). More recently it has been shown that rh-IL- 6  is more 
potent in this respect and it synergizes with low concentrations of ACTH (Salas et 
al. 1990b; Smith etal. 1986).
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In this study in Group I the circulating cortisol concentration rose within 
hours after induction of the acute response and gradually increased till the end of 
the experiment. The hypophyseal-adrenocortical response was similar for both 
Groups over the first day of the infection. However, after the second day calves in 
the Group II began to recover and their cortisol concentrations decreased.
In contrast, to the generally accepted function of cortisol during the APR 
in its role as a stress hormone, there is still considerable doubts about the cause 
and function of the fall in thyroxine during the APR. Thyroxine concentrations 
showed a dramatic fall on day 2  following infection and gradually rose thereafter. 
In acutely ill human patients with non-thyroidal diseases, low serum 
concentrations of total T4, T3 and thyroid binding globulin (TBG) concentrations 
are found (Kaplan et al. 1982; Wong and Hershman 1992). The main mechanism 
responsible for the low concentration of T3 in non-thyroidal illness is a decrease 
in the peripheral conversion of T4 to T3 (Wong and Hershman 1992), whereas the 
cause of the decrease in T4 concentration remains speculative. One possibility is 
that it may be due to low TBG, or the presence of a circulating inhibitor that 
inhibits T4 from binding to its carrier proteins (Kaptein et al. 1987). Another 
possible cause of low total T4 is that decreased biological activity of TSH during 
acute infections may reduce the secretion of T4, but as the half-life for T4 in cattle 
is 8  days, the sharp drop found in this investigation within 24 hours of infection 
can not be solely due to reduced production.
Depletion of tissue nutrients during the catabolism of illness can also be the 
basis of low T4, T3 and TBG (Chopra et al. 1979). Recent evidence has indicated 
that acute phase cytokines like TNFa can inhibit thyroid function directly and may 
be responsible for the changes in the pituitary-thyroid axis as large amounts of 
TNFa receptors are located in the thyroid gland (Wong and Hershman. 1992). 
However, to date, no mechanism has been accepted as fully explaining the low T4 
state during APR.
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Although previous studies on the local response to BPP have 
demonstrated increased presence of leukocytes in the lung (Dalgleish 1989) this is 
the first report of systemic leukocytosis in this condition. The cause of 
leukocytosis was clearly due to a rapid increase in neutrophil counts on day 1 
which fell back to normal levels by day 3. This phenomenon is further discussed 
in Chapter V in relation to the similar response observed following LPS injection.
In this study the pattern of APP to infection showed results in agreement 
with the previous work reported by Conner et al. (1989). Using the ELISA 
method described in Chapter in bovine SAA was shown to be a major acute phase 
protein in BPP supporting the previous study (Boosman et al. 1989) where SAA 
was shown to respond to E coli LPS. These findings are similar to those reported 
in man (Sipe 1992), hamster (Niewold and Tooten 1991) and horse (Pepys et al.
1989). Bovine SAA was revealed as being equivalent to Hp as an APR, reaching 
a peak of concentration on the second day after infection. In species, such as man, 
where Hp is a moderate rather than major APP, SAA demonstrates a more rapid 
response to stimulation. It would require more frequent blood sampling to 
establish whether SAA is more sensitive to stimulation than Hp in bovine species.
Fibrinogen is commonly assayed by its coagulating activity in plasma and 
was determined in these studies only for isolate SC/82/1. It was not surprising 
that Fb was identified for the first time as an APP in BPP. Although Fb is widely 
used in veterinary clinical diagnostic work, it only shows a moderate response in 
cattle (Kent 1992). However Fb in animals with BPP, showed a clear acute 
response. Unfortunately this protein was not analysed in animals infected with the 
more virulent isolate (SB/82/1) and it remains unknown whether Fb response may 
help differentiate between the 2  isolates.
Glutamate dehydrogenase activity was reduced significantly after the 
P. haemolytica infection. Generally plasma GLDH activity indicates that the
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liver is damaged and hepatocyte destruction leads to an increase of this enzyme in 
serum. The reasons for the observed reduction is not known but could relate to 
the increase in protein synthesis in the liver for the production of the APP. 
Increased bilirubin levels can indicate biliary obstruction or increased destruction 
of RBC and the latter would relate to the fall in RBC count found in Group II.
Despite the weight loss that follows an inflammatory insult, the overall 
host non-specific response to infection and injury is beneficial and is aimed at 
reducing tissue damage and to avoid secondary bacterial invasion. The similarity 
of the host response to dissimilar exogenous stimuli have led to the conclusion 
that it is the local and systemic release of cytokines by monocytes and 
macrophages that is responsible for the initiation and regulation of inflammation 
patho-physiological response to BPP infection. However, additional studies are 
required to characterised the cytokine involvement with BPP and the response of 
the host to this infection (see Chapter V).
Both of the isolates of P. haemolytica used in the investigation (SB/82/1 
and SC/82/1) contain similar types of LPS and are both known to be highly 
virulent (personal communication Dr. R.L. Davies). In this study the APR 
produced by the two isolates of P. haemolytica (SB/82/1 and SC/82/1) was 
measured independently in order to compare the pathogenicity of the two isolates. 
The elevation of body temperature is a classical feature of the APR but was clearly 
demonstrated only by the SB/82/1. Furthermore calves given the SB/82/1 isolate 
exhibited a marked anorexia, apathy and dramatic drop in the live weight. In 
contrast SC/82/1 did not show any weight loss although food intake was slightly 
reduced. Among the APR measured in both experimental groups, serum amyloid 
A concentrations showed a clear difference between the two isolates. Cortisol 
concentrations were raised at the early phase of infection with both isolates but 
after day 2, isolate SC/82/1 infected calves of Group II showed a lower cortisol 
response. Thyroxine concentration dropped in both groups but, the Group I 
calves showed a greater reduction than Group II. However, haptoglobin and the
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respiratory rate showed a similar response in both groups. It is probable that the 
differences observed, which show that SB/82/1 caused a more severe APR than 
SC/82/1, are related to the extent of the pulmonary pathology. The pulmonary 
score and the lung lesions showed a mark difference in the two isolates with 
isolate SB/82/1 having a more marked local and systemic response. Possibly 
SB/82/1 had a higher leukotoxic and\or endotoxic effect than SC/82/1. However, 
more controlled experiments are required to confirm this hypothesis. In future 
studies to compare different isolates in vivo it would be important to have less 
variations within the animal groups; i.e. use the animals from the same source, 
with similar pre-infection live weights and produce one infection at the same time. 
It is interesting that while most acute phase reactants gave a greater response to 
SB/82/1 (Group I) there were exceptions. Thus Hp and respiratory rates were 
raised to the same extent in both infected groups. The reason for these differences 
could be related to differential responses to the mediators of the inflammatory 
reaction but a full explanation would be the subject of further investigations.
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CHAPTER V
THE IMMEDIATE ACUTE PHASE RESPONSE IN 
BOVINE PNEUMONIC PASTEURELLOSIS: CYTOKINES, 
LIPOPOLYSACCHARIDE AND ACUTE PHASE PROTEINS
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5.1. Introduction
An understanding of cytokine action and the host responses to bacterial infections 
has been obtained from in vitro studies and from experiments using laboratory 
animal models in which a wide range of substances including live bacteria, 
lipopolysaccharide (LPS) and recombinant cytokines had been introduced directly 
into target tissue cultures or administered intravenously into animals. Although 
the effects of cytokines have been studied extensively in laboratory animals 
(Heinrich et al. 1990; Kunkel and Remic 1992) and man (Kishimoto 1989) very 
few studies have been carried out in cattle or in other domestic animals.
The cytokines interleukin-1 (a and p), interleukin- 6  and tumour necrosis 
factora are important early mediators of the acute phase response. In cattle, IL-1
activity in parturient paresis has been studied in relation to its ability to induce 
osteoclast activity (Goff et al. 1992). These workers demonstrated that an 
injection of IL-1 (3 to cows in late pregnancy reduced the incidence of parturient 
paresis. In another study, Collins et al. (1989) using a bovine thymocyte cell 
culture, measured IL-1 like activity in cattle with intra-mammary devices. Using 
recombinant bovine IL-1 as standards they showed that IL-1-like activity in 
mammary macrophages increased with the tissue damage caused by the devices. 
In a more recent study, Winstanley and Hckersall (1992), using a D-10 mouse T- 
lymphocyte mononuclear cell line, demonstrated EL-1 like activity in supernatant 
from bovine mononuclear cells stimulated with LPS and that the IL-1 like activity 
was dependent on the dose of LPS. In addition, these workers found that the 
bovine IL-1 like activity could be neutralised by anti-human IL-1 a  and IL-lp 
antibodies.
Stressful events such as parturition, lactation, nutritional deficiencies and 
environmental changes may induce immunosuppression and increase disease 
susceptibility in cattle (Griffin 1989). Administration of recombinant cytokines 
such as IL-1 or granulocyte colony stimulating factor (G-CSF) activates of 
lymphocytes as well inducing other cytokines required
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for stimulation of immune cells, emphasising their potential value as
immunomodulatory agents (Stabel et al. 1991). In a later study, Stabel et al.
(1993) injected recombinant bovine-IL-lp to 6  Jersey cows (166 ng of rb-IL-lp
per kg of body weight) at 8  hour intervals for 96 hours. Leukocytosis was
observed within 3 hours of rb-IL-ip treatment and peaked within 24 hours after
the first injection and returned to the base line after 72 hours. Within 24 hours of
the first rb-IL-lp injection, rb-IL-ip mRNA transcription in stimulated blood
mononuclear cell cultures was markedly increased, suggesting that rb-IL-lp
upregulates its own production in mononuclear cells. In another study (Shuster
et al. 1993) 6  cows had 10 |ig of E-coli LPS infused into 1 mammary gland.
Endotoxins caused udder oedema 1.5 to 2.5 hours after the infusion, high milk
somatic cell counts and all treated cows showed increased cortisol levels within
3-5 hours. High concentrations of IL-1 (10 - 600U m l1) and IL- 6  (2 to 22 U m l1)
were detected in milk of infused glands from 2.5 to 4 hours after infusion, whereas 
TNFa was undetectable. Systemic responses and the leukocytic influx into
endotoxin-infused glands developed concurrently with the initial cytokine activity. 
However, at present litde is known on the relationship between the acute phase 
response (APR) and IL-1 activity in vivo in cattle.
There have been a number of studies on bovine TNFa (Kenison et al.
1991; Pace et al. 1993; Espinasse et al. 1993). The in vitro release of TNFa from 
bovine peripheral blood monocytes and alveolar macrophages has been 
demonstrated following stimulation by E. coli LPS (Adams and Czuprynski
1990).
The concentration of tumour necrosis factor in the serum of calves after a 
challenge of S. typhymurium and LPS from E coli has been investigated by Peel 
et al. (1990). In this study TNFa levels began to rise 30 minutes after
administration of LPS, reached peak levels between 1-2 hours and returned to 
baseline by 4 hours after administration. However, calves infected with 
S. typhymurium failed to show a TNFa response in spite of demonstratable
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septicaemia. In another in vivo study Kenison et al. (1991) demonstrated a 
similar rise in TNFa following the administration of E-coli LPS. Recently, two
groups of workers reported conflicting results from experiments designed to 
study the systemic TNFa response in calves infected with P. haemolytica. Pace et 
al. (1993), using a bioassay, demonstrated an increase in circulating TNFa 
following intra-tracheal inoculation of P. haemolytica. The rise in the TNFa 
concentration was observed within 2 hours of challenge and lasted for 48-72
hours. In contrast to these observations Espinasse et al. (1993), using a 
radioimmunoassay, were unable to detect any increase in serum TNFa
concentrations in calves inoculated with P. haemolytica by combined intra- 
nasal/intra-tracheal route. In the latter study, the TNFa concentrations were
measured in serum collected at 6  hourly intervals over a period of 3 days after 
treatment.
Interleukin- 6  (EL-6 ) is another multifunctional cytokine which is known to 
play an important role in the early APR and is a major stimulant of the acute phase 
protein (APP) synthesis by hepatocytes. Furthermore, it stimulates the adrenal 
cortex to release glucocorticosteroids which also have an effect on acute phase 
protein production (Le and Vilcek 1989; Heinrich et al. 1990). However, there 
have been no reports of IL- 6  or DL- 6  like activity in bovine serum. Nakajima et al. 
(1993) monitored the APP response in calves following intravenous injection and 
continuous infusion of recombinant human IL- 6  (rh-IL-6 ). These studies
demonstrated an increase in serum haptoglobin and fibrinogen concentrations 
after rh-IL- 6  was infused over a long period but not when rh-IL- 6  was 
administered as a single intravenous injection.
Work described in Chapter 4 demonstrated that a wide-ranging systemic 
APR occurs during bovine pasteurellosis. However, to understand the initiating 
factors of the host's response to BPP it is necessary to study the immediate APR in 
order to determine the extent of cytokine involvement in this stage of the disease. 
The cytokines which initiate the APR are released immediately after the insult
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(Vogel and Hogen. 1990) and as these cytokines have a short half-life (Waage et 
al. 1992) frequent sampling during the early stages of the APR must be employed 
to detect peaks in the cytokine concentration (Peel et al. 1990).
The induction of an APR by Gram-negative bacteria is believed to be 
caused by stimulation of monocytes and macrophages by the LPS. The LPS of 
P.haemolytica has been characterised recently (Davis et al 1992) and shown to 
vary between field isolates. Hence this second in vivo study was undertaken to 
determine whether LPS from P.haemolytica was capable of stimulating cytokine 
release in vivo and initiating the immediate cytokine network and the subsequent 
systemic APR. In this experiment a single sublethal dose of LPS was administered 
intravenously and blood samples were collected at short intervals for the first 
10 hours after the challenge and then less frequently over the next 5 days.
The aims of the study
a) To determine whether the cytokines TNFa, IL-1 and EL- 6  are mediators of 
the immediate systemic acute phase response in bovine pasteurellosis.
b) To determine whether APP and haematological response occurs during 
the immediate APR after LPS administration.
c) To determine whether the LPS extracted from P. haemolytica type A 1 is
able to stimulate TNFa production in vivo in calves.
d) To determine whether intravenous challenge of LPS from P. haemolytica 
Al is capable of stimulating an acute phase response similar to that caused
by the whole bacterium when inoculated intra-tracheally.
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5.2. Materials and Methods
5.2.1. Animals and Experimental Design
All calves were housed in loose boxes and managed as described previously 
(section 4.2.1). Nasopharyngeal swabs were taken from all calves on several 
occasions prior to inoculation and examined for the presence of Pasteurella spp. 
as described in section 4.2.2.
Experiment I was performed to achieve aims a) and b) while Experiment II 
was designed to achieve aims c) and d). These studies were designed to add to 
our knowledge of the early stages of the APR and differed from the previous 
studies (Chapter 4) by the high frequency of blood collection over the first 10 
hours of the response and the use of a single inoculum of P. haemolytica to infect 
the animals.
Experiment I
A total of nine calves ( 6  male and 3 female) were used in this experiment. The 
animals were divided into two groups consisting of 5 calves in the control group 
and 4 calves in the infected group. The experimental design and the parameters 
examined are summarised in Table 5.1.
Each calf in the infected group was challenged intra-tracheally (Section 
4.2.2) with a single dose of a 3 hour log phase culture of a field isolate of 
P. haemolytica type Al (4 xlO12 cfu m l1; 20 ml calf1). The bacterial isolates used 
in this experiment are summarised in Table 5.2. All calves in the control group 
received 20 ml of sterile PBS by the same route.
Experiment II
In this experiment, 5 calves (4 males and 1 female) were infused intravenously 
with a single dose (10 ml) of LPS at 0.7 jLLg k g 1 extracted from 5 different field 
isolates of P. haemolytica type Al (Table 5.4). In a trial experiment with 1 calf 
(No. Al) LPS at 1 |ig k g 1 was used but found to be too high for subsequent use.
166
Table 5.1 Experiment I-The experimental design
Control Group Infected Group
No. of calves 5 4
Age 3 months 3 months
Body Wt.(Kg) 131 ± 6 127 ± 8
Infection procedure Sterile PBS(I/T) P. /z-bacteria (I/T)
Challenge (20 ml) per calf - 4 x 1012(cfu m l1)
Sampling interval, post-challenge -1,0,1, 2, 4, 6 , 8 , 10 -1,0,1, 2, 4, 6 , 8 , 10
hours
Clinical Examination Rec.Tem. Resp.Rate Rec.Tem. Resp.Rate
Cytokines measured IL-1; IL-6 ; TNFa IL-1; IL-6 ; TNFa
Acute phase proteins SAA; Hp SAA; Hp
I/T - intra-tracheal, SAA serum amyloid A, Hp haptoglobin, IL-1 interleukin-1, IL- 6  
interleukin-6 , TNFa tumour necrosis factor a. Rec.Tem.- rectal temperature, Resp.
Rate- respiratory rate, Organism- live P. haemolytica
Table 5.2. Details of bacterial isolates used in the Experiment I.
Calf no Isolate
33 S/C 82/1 Bovine
2 S/B 82/1 Bovine
197 vV/D 83/4 Bovine
16T FA 1 Bovine
All isolates belonged to serotype Al.
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Table 5.3 Experiment II - The experimental design
Control Group LPS Treated Group
No. of calves 5 5
Age 1 to 2  months 1 to 2  months
Body Wt. (Kg) 1 1 0  ± 6 113 ± 10
Challenging procedure sterile PBS I/V LPS I/V
Challenge dose 1 0  ml per calf 0.7 t^g kg*1
Sampling interval 0,1,2, 4, 6 , 8 ,10  hr 0,1, 2, 4, 6 , 8 , 10 hr
and 1-5 days and 1-5 days
Clinical examination + +
APP SAA; Hp; Fb SAA; Hp; Fb
Cytokine Assay TNFa TNF„
I/V - intravenous; SAA-serum amyloid A; Hp-haptoglobin, Fb-fibrinogen;
Table 5.4. Experiment II-Details of endotoxin extracts and the dosage per animal
Calf no/sex Body
(kg)
Wt. Strain Total LPS 
dose ( ^g)
i^g LPS kg*1 
B. Wt.
OX 1/M 1 2 0 PH 30 84 0.7
OX2/F 1 2 0 PH 8 84 0.7
21T/M 92 PH44 64 0.7
8 /M 78 PH 2 54.5 0.7
12T/M 155 B664 108.5 0.7
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Control calves (n=5) were infused with 10 ml of sterile PBS. The details of 
animals used and parameters examined are given in Table 5.3.
The animals used in this experiment were part of a pilot study for an 
associated project on the pathology induced by LPS from different field isolates of 
P. haemolytica in calves. The LPS samples were prepared by Drs. R.L. Davies 
and R. Parton, Department of Microbiology, University of Glasgow. The 
experiment was designed to study the APR of calves to different field isolates of 
LPS from P. haemolytica.
5.2.2. Blood collection
In Experiment I, jugular blood samples (10 ml) were collected from all calves one
hour prior to inoculation, and at 0, 1, 2, 4, 6 , 8 and 10 hours after inoculation. In
Experiment II, jugular blood (10 ml) was collected as in Experiment I but also at
24, 36, 48, 72, 96 and 120 hours after inoculation. Blood for measurement of
leukocyte counts was collected in 10 ml vacutainer tubes containing 0.38 mM 
EDTA. Blood for the determination of cytokines (TNFa, IL-1 and IL-6 ) was
collected in chilled, endotoxin free (Endo Tube ET) vacutainer tubes with no 
coagulant from Chromogenix AB (Taljegardsgatan 3, S-431 53 Molndal, 
Sweden.). Plasma samples for acute phase protein determinations were collected 
as described in section 4.2.2. All blood samples (except those for haematology) 
were centrifuged at 1600g for 20 minutes at 4°C, serum was harvested and stored 
at -20°C until assayed.
5.2.3. Clinical examination
Calves were observed hourly post-inoculation with P. haemolytica and following 
treatment with LPS. The details recorded at each clinical examination included 
observations on demeanour, rectal temperature, respiratory rate and character, the 
presence or absence of cough, nasal and ocular discharges and any other relevant 
clinical findings.
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5.2.4. Acute phase proteins
The concentration of SAA in serum was assayed by ELISA (Horadagoda et al. 
1993; Chapter 3 (Section 3.2.3.) and the haptoglobin concentration was assayed 
according to the method of (Conner et al. 1988b) described in Section 4.2.10.2. 
Fibrinogen was analysed as described in Section 4.2.10.3.
5.2.5. Analysis of cytokines
5.2.5.I. Radioimmunoassay for bovine Tumour Necrosis Factora
Bovine TNFa was measured using a competitive, sequential-saturation, non­
equilibrium radioimmunoassay. In order to increase the sensitivity of the assay 
non-equilibrium conditions were employed by delaying the addition of the 125I 
labelled antigen. The RIA was a modification of the method described by Kenison 
et al. (1990) and was performed under the supervision of Dr. J C. Hodgson at the 
Moredun Research Institute, Edinburgh.
Reagents
The TNFa used in the assay was recombinant bovine rb-TNFa which was
produced, cloned and expressed in E. coli and purified by HPLC. It was kindly
provided by Dr. Gary Entrican, Division of Immunobiology, Moredun Research
Institute through the courtesy of CIBA-GEIGY Limited, St. Aubin-FR, 
Switzerland. The rabbit anti-serum to bovine TNFa was raised against rb-TNFa
and was kindly provided by Dr. P. M. Preston, (Division of Biological Science, 
University of Edinburgh, Edinburgh). Donkey anti-serum to rabbit IgG and 
normal rabbit serum were from the Scottish Antibody Production Unit 
(Lanarkshire, Scotland). The Sephadex G-25 gel filtration column (PD-10) was 
obtained from Pharmacia (Uppsala, Sweden). Radiolabelled sodium [125I] iodide 
was purchased from Amersham International (Amersham, Bucks, UK). Iodogen 
(tetrachlorodiphenylglycouracil), bovine serum albumin and Tween 20 and other 
laboratory chemicals were from Sigma Chemical Company (Poole, Dorset, UK). 
Polyethylene glycol 6000 was from BDH Chemicals (Poole, Dorset, UK) and the
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polystyrene Rohren tubes used in the assay were obtained from Ciba Coming 
Diagnostic Limited (Halstead, Essex, UK).
Assay buffer
All antibody dilutions were prepared in assay buffer which consisted of 0.15M 
phosphate buffered saline, pH 7.4, with 1% (w/v) bovine serum albumin and 
0.1% (v/v) Tween 20.
First antibody
The first antibody was prepared by diluting the rabbit antiserum to rb-TNFa 1:250 
in assay buffer.
Second antibody
The second antibody was prepared by mixing 2 parts of a 1:40 dilution of the 
donkey anti-serum to rabbit IgG with 7 parts of a 6 % (w/v) solution of 
polyethylene glycol 6000 in assay buffer.
Iodination Procedure
An iodinated tracer of rb-TNFa was prepared by the iodogen method described 
by Elsasser et al. (1986). rb-TNFa (10 mg) was allowed to react with 0.5 mCi of
[ 125 I] in 95 ml of borate-buffered saline (pH 8.4) in a tube previously coated 
with 7.5 mg of iodogen. Unbound iodine was removed by passing the mixture 
through a Sephadex G25 gel filtration column pre-equilibrated with borate 
buffered saline containing 0.2% (w/v) bovine serum albumin and 5% (v/v) Tween 
20. The average specific activity of the tracer produced by this procedure was 
60 mCi mg-1; a dilution in assay buffer which yielded approximately 10, 000 CPM 
per 1 0 0  |il was used in the assay.
Standards
Standards were included in each assay and were prepared by diluting a stock 
solution of rb-TNFa to give concentrations of 500, 100, 25, 5, 1 and 0.25 ng m l1
in foetal bovine serum (FBS).
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Assay validation 
Quality Control Samples
A high (250 ng m l1) and a low (5 ng m l1) quality control sample of bovine TNFa 
were prepared by spiking foetal bovine serum with rb-TNFa and used to
determine intra-assay coefficients of variance. The limit of detection was 
calculated as the concentration of TNFa at two standard deviations from the zero
serum which was foetal bovine serum. The radioimmunoassay for TNFa, was 
performed according to the method described by Kenison et al. (1990; 1991) and 
was validated for the analysis of bovine plasma. In the present study, the limit of 
detection of the assay was 250 pg m l1 and the intra-assay coefficients of variance 
were 6% at 250 ng m l1 and 17 % at 5 ng m l1.
Assay procedure
The assay was performed in 75 x 11 mM Rohren tubes. Fifty microlitres of the 
standards, controls or test sera, in duplicate, were mixed with 50 |il of first 
antibody (1:250 dilution) and 50 pi of assay buffer in the assay tubes. After 
vortex-mixing the tubes were incubated at 4°C for 24 hours to allow antigen in 
the samples and the first antibody to react. At the end of this period, 50 pi of 
[125I]-labelled-rb-TNFa was added to all the tubes, vortexed and incubated for a 
further 18 hours at 4°C. Tubes with the labelled TNFa alone were incubated to 
provide the total count of tracer. The second antibody (200 pi) was then added 
to all the tubes, apart from the tubes for the total count of tracer, and incubated 
for 2 hours. To enhance pellet formation, 50 pi of 1% (v/v) normal rabbit serum 
was added to the tubes and the incubation continued for a further 30 minutes. All 
tubes were then centrifuged (12,000 g 6  min; Centra 3S, Damon/IEC), the 
supernatant aspirated and the radioactivity of the pellet measured in a gamma 
counter (Packard Auto-Gamma-5650, Pangboume, Berks, UK). The results were 
analysed using the S. A .S. immunoassay program 632014 written and supplied by 
Dr. P. Edwards, Dept, of Molecular Endocrinology, UCMSM, London, UK.
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5.2.5.2. Assay fo r Interleukin 1 (IL-1)
Biological basis o f IL-1 assay
EL-1 was estimated by a biological assay developed by Collins et al. (1989) using 
bovine thymocytes and with recombinant bovine IL-1 (rb-IL-1) (Collins, R.A. 
personal communication) as standard. In this assay, the bovine thymocyte cells 
depend on IL-I for proliferation which was low with control media but increased 
up to 10 fold in the presence of DL-I and by 4 fold when the mitogen 
concanavalin A was added at 5 fig m l1. The assay was performed at the Institute 
of Animal Health, Compton, (Newbury, Berks) under the supervision of Dr. R. 
A. Collins. The limit of detection of the assay was 0.1 pg m l1.
Reagents for the IL-1 assay
All reagents used were of the molecular biology grade. Recombinant bovine IL-1 
was kindly provided by Dr. R. A. Collins. Culture medium RPMI 1640 was 
obtained from Microbiological Associates, (Walkersville, MD). Concanavalin A 
(con. A) a mitogen and Histopaque for cell separation were obtained from Sigma 
Chemical Company (Poole, Dorset, UK). Foetal bovine serum and flat-bottomed 
microtitre plates were obtained from Gibco (Uxbridge, Middlesex, UK). 
^H-Thymidine (specific activity 5Ci mM1) was purchased from Amersham 
International (Amersham, Bucks, UK).
Preparation o f thymocytes
Thymus tissue was collected from a clinically healthy calf at slaughter. The 
thymus was initially cleaned of fatty or fibrous tissues before macerating in a 
"stomacher" (Institute for Animal Health, Compton, Berks) with 20 ml of 0.01M 
phosphate buffered saline (PBS; pH 6 .8 ). The resultant cell suspension was 
diluted further with PBS (1:4; v/v), transferred to 50 ml plastic universal tubes 
(Sterilin Ltd, Feltham, Middlesex, UK) centrifuged at 900 x g for 20 minutes at 
6 °C and washed three times with PBS. Thymocyte cell suspension (10 ml) at 
5 x 109 cell mb1 was layered over 8  ml of Histopaque (density 1.083) and 
centrifuged at 900g for 20 minutes at 4°C. After centrifugation, cells at the
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interface were collected with a sterile pipette, washed three times in 0.01 M PBS 
(15ml per wash) and resuspended at a concentration of 4 x 107 cell m l1 in tissue 
culture medium (TCM-1) which consisted of RPMI 1640 medium with 10% (v/v) 
heat-inactivated foetal bovine serum, Con A 0.2 mg ml -1, 50 mM 
2-mercaptoethanol, 2 mM glutamine, 27 mM sodium bicarbonate and ImM 
sodium pyruvate, 200 units m l1 penicillin and 100 mg m l1 streptomycin. The 
TCM-1 was filtered (0.22 Jim; Millipore filter) before use. Cell viability was 
determined by exclusion of 0.5% (w/v) trypan blue and was judged to be greater 
than 84% in the preparations used.
Calf thymocyte costimulation assay
Serial two fold dilutions of plasma samples were made in triplicate in microtitre 
plates using TCM-1 to achieve the following dilutions 1:2, 1:4, 1:8, 1:16, 1:32, 
1:64 and 1:128 in 100 fil volumes. A standard of rb-IL-1 was also serially diluted 
in triplicate to give a range of IL-1 from 0.1 to 100 pg per well. In each plate 
there were 4 sets of culture controls in triplicate as shown below (Table 5.5).
Table 5.5. Details of the culture controls
Control No TCM-1 Thymocytes Con.A LPS
1 + + - -
2 + + + -
3 + + - +
4 + + + +
LPS= 0.025 |ig m l1 lipopolysaccharide (LPS; 026 B6 ); Con.A= 5 |ig m l1
Calf thymocytes, isolated as described above, were cultured at 4 x 106 cells 
well1 in flat-bottomed, 96-well microtitre plates containing serial two-fold 
dilutions in TCM-1. Similarly test samples (plasma samples collected as described 
in 5.2.2.) and standards of rb-IL-1 (0.1-100 Units mb1 i.e. 0.1 to 1000 pg m l1)
I
I
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were diluted with TCM-1. Three quality control samples were used in the assay at 
high, (C-I) medium (C-II) and low (C-III) concentrations of rb-IL-1 (3 foetal calf 
serum samples were spiked with known concentrations of rb-IL-1 at 64.0 pg m l1; 
4.0 pg m l1; 0.2 pg m l1). Three serum samples from P. haemolytica infected 
calves were also spiked with 50 pg m l1 of rb-IL-1 and used in the assay as serum 
controls. The thymocytes were added in a volume of 100 |il per well to the 
diluted test samples or standards in the wells of the microtitre plate. Cultures 
were incubated for 72 hr at 37°C in a humidified atmosphere containing 5% C02. 
For the final 6  hours of culture 0.5 mCi [3H]-thymidine (specific activity 5 G  
mmol1) was added. The cultures were harvested on to glass fibre filters using a 
semi-automatic harvester (Skatron), and the incorporated radioactivity was 
measured using a liquid scintillation counter (LKB Wallac, Turak, Finland). 
Results were recorded as counts per minute (CPM) before conversion to pg mb1 
by comparison to the standard curve.
52.5.3. Bioassay for bovine Interleukin - 6 (IL-6) using B9 cell-line
Most bioassays for IL- 6  depend upon the proliferative effect of this cytokine. The 
present work used the assay developed by Aarden et al. (1987) which makes use 
of this phenomenon to measure the effect of human IL- 6  on a susceptible murine 
hybridoma cell line (B9). The assay was performed under the supervision of Dr. 
C. Lawrence, Department of Veterinary Pathology, Glasgow University 
Veterinary School.
Reagents
The B9 murine hybridoma cell-line was a kind gift of Dr. L.A. Aarden (Central 
Laboratory of the Netherlands, Red Cross Blood Transfusion Service, 
Amsterdam). Flat-bottomed microtitre plates were purchased from Costar 
(Cambridge, UK). Con A and RPMI 1640 (R 7755) medium from Sigma 
Chemical Company (Poole, Dorset, UK), FBS was from Gibco (Uxbridge, 
Middlesex, UK), [3H]-Thymidine (specific activity SCi.mM1) from Amersham
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International (Amersham, Bucks, UK). Methylthymidine and recombinant human 
IL- 6  (rh-IL-6 ) from Genzyme Corporation (Cambridge, UK).
Maintenance o f the B9 cell-line
The B9 cell line was in RPMI 1640 medium supplemented with 10% (v/v) FBS 
plus 1 U m l1 of IL- 6  (in tissue culture medium-2, TCM-2). Cultures were 
maintained at 37°C in a humidified carbon dioxide (5% C02) incubator. Cultures 
were split 1:5 to 1:10 every 2-3 days and using fresh TCM (with IL-6 ) until the 
cell density reached approximately 5x10s cells m l1.
Assay procedure
Cells were washed twice in RPMI 1640 medium by centrifugation at 250g for 
10 min and resuspended in TCM-2 to yield a concentration of 5X104 cells ml*1. 
The viability of the cells were determined by exclusion of 1% (w/v) trypan blue.
The assay was performed in 96 well flat-bottom polystyrene microtitre 
plates (Costar). Initially, 100 fil of TCM-2 was added to all 96 wells of the plate. 
This was followed by the addition of standards (100 (il of stock human IL- 6  in 
TCM-2 at 16 units ml*1) and test samples (100 p.1 plasma per well) in triplicate to 
the wells in the top row of the plate. Serial two-fold dilution of these were made 
to obtain a final DL- 6  standard range from 8  to 0.125 U ml*1. The final dilution of 
test sample was from 1:2 to 1:128. The assay negative control consisted of 100 jxl 
of TCM without IL-6 . In addition Con A at 0.2 p.g ml*1 in TCM-2 was added to 
three wells as a positive control. Three additional controls consisted of 2 culture 
supernatants from feline peripheral blood lymphocytes (5X106 ml*1) stimulated for 
24 hours with either 10 |ig ml*1 LPS (control 1) or 7.5 fig mF Con A (control 2) 
or one without any stimulant (control 3).
Finally, 100 fi.1 of the B9 cell suspension was added to each well and the 
plates were incubated for 72 hours at 37°C in a humidified C02 incubator. Cells 
were labelled by incubating for the final 4-6 hours with 25 |il [3H]-thymidine, at an 
activity of 0.5 mCi per well, prepared by adding 50 |il of a stock solution of 
1 mCi mF to 2.5 ml of TCM-2. Following incubation, cells were harvested and
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the radioactivity counted as described above. The results were expressed as the 
arithmetic mean ± SEM of counts per minute (CPM) incorporated per culture for 
each triplicate group. The IL- 6  concentrations in the unknown samples were 
derived by comparison with IL- 6  standards using probit analysis at the 50% 
response of the rh-IL- 6  standard.
5.2.7. Haematology
A complete haematological study was carried out as described in Chapter 4 for 
Experiment II.
5.2.8. Statistical Analysis 
Experiment I  and II
Results of the Pasteurella haemolytica infection and LPS treatment are presented 
as individual values for TNFa or group means plus or minus the standard error of
the mean (SEM). Comparisons between experimental and control groups were 
made using one way analysis of variance. Results from the analysis of variance 
were then used in the Newman-Keuls multiple range test to identify treatment 
differences.
These statistical analysis were conducted using the MINITAB statistical 
package (MINITAB Inc., State College, PA 16801-3008 USA) and ANIMAL 
DESIGNS 1, VI.21 5/6 (Data International Services, Glasgow) programmes on 
an IBM computer (Personal system/2, Model 30). Responses were considered 
statistically significant when P < 0.05.
5.3 Results
5.3.1. Experiment I
5.3.1.1. Clinical examination
The most marked clinical change observed following infection was the alterations 
in the respiratory rate. Figure 5.1a shows the variation with time in the mean 
respiratory rates of infected and control animal. Prior to infection the respiratory 
rates of animals in both groups were within the normal range (15-30 per minute).
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Following inoculation the calves in the control group showed a transient increase 
in the respiratory rate soon after the intra-tracheal inoculation of PBS which 
returned to the normal rate within 6 - 8  hours (Fig.5.1a). In contrast, the calves 
challenged with P. haemolytica showed a significant ( P< 0.001) increase of the 
respiration rate from a baseline rate of 26 ± 3.4 min1 to 6 6  ± 6.3 within 4 hours 
post-inoculation. At 10 hours the respiration rate was 80 min-1. Calves in the 
control group remained bright and alert throughout the experiment but infected 
calves became dull, lethargic, anorexic and tachypnoiec within 4 hours after 
inoculation.
Figure 5.1b shows the mean rectal temperatures of the infected and the 
control animals. Prior to infection, the rectal temperature of calves in both groups 
were within the normal range (38.2 - 38.6°C). Following inoculation the rectal 
temperature of the infected calves increased significantly (p<0 .0 1 ) from a baseline 
value of 38.4 ± 0.4 to 40.2 ± 0.6°C within 6  hours and remained elevated through 
out the experimental period. In contrast, there were no appreciable changes in the 
rectal temperatures of control animals.
5.3.1.2. The acute phase protein response
Prior to inoculation the serum SAA concentrations of calves in both the infected 
group and the control group were at or below the limit of detection of the assay 
(<3 |ig m l1). As illustrated in Fig.5.2a. the mean SAA concentration in infected 
animals increased markedly to 18 ± 3.2 mg mb1 at 10 hours post-inoculation. In 
comparison, the control group did not show any apparent changes in the serum 
SAA concentration during this period. The mean serum haptoglobin 
concentration did not show any significant change and remained within the normal 
range throughout the experiment in both groups.
5.3.1.3. Cytokines 
TNFa
The time-course of induced TNFa production following infection with 
P. haemolytica is depicted in Figure 5.2b. In all four infected calves, the serum
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Figure 5.1 Mean (±SEM) respiratory rates (Fig. 5.1a) and rectal 
temperatures (Fig. 5.1b) over 10 hours of calves infected intra-tracheally 
with the P. haemolytica A1 (n=4). The control calves received phosphate 
buffered saline intra-tracheally (n=5).
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Figure 5.2 Mean (± SEM) serum amyloid A concentrations (Fig. 5.2a) 
and the individual tumour necrosis factora concentrations (Fig. 5.2b) over 
10 hours of calves infected with P. haemolytica A l, intra-tracheally (n=4). 
The control calves received phosphate buffered saline intra-tracheally 
(n=5). In the control group for tumour necrosis factora only the mean
values are shown.
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TNFa concentration rose to a peak at 2 hours post-inoculation, ranging from
18-37 ng m l1, (mean ± SEM = 25.8 ± 8.7 ng m l1) and then declined rapidly to 
reach baseline values at 4-8 hours post-inoculation. TNFa was not detected in
serum samples from the PBS-treated control group or in animals prior to 
infection.
IL-l
Validation of the IL-l assay used in this study was described by Collins et al. 
(1989). The assay has been used to measure the IL-l concentration in synovial 
fluid, peripheral blood lymphocytes (PBL's), and in serum or plasma.
Figure 5.3a shows the IL-l standard curve for the incorporation of [3H] 
thymidine. Figure 5.3b. shows the IL-l content of the assay controls; blank - 
1840 CPM, Con. A positive - 5575 CPM and LPS positive - 292398 CPM. In 
addition, three rb-IL-1 spiked samples which were designated as control-1 
(123460 -CPM ), control-2 (35678 - CPM) and control-3 (10111 - CPM) were 
also used as quality controls in the assay. The values obtained for the IL-l assay 
standards and the controls agreed with values already established in the laboratory.
However, in the serum obtained from infected animals and in all dilutions, 
the incorporation of [3H] was at or around the counts obtained with the assay 
blank. So that the IL-l levels were undetectable. In order to rule out the 
possibility that inhibitors in serum were inactivating IL-l, three serum samples 
(IS-1; IS-2; IS-3) from infected animals were spiked with rb-IL-1 (50 pg ml*1) and 
measured in the assay. These samples gave counts which corresponded to an IL-l 
concentration of 50.4 pg ml-1; 49.6 pg ml*1; 51.0 pg ml*1 respectively (Fig. 5.3b).
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Figure 5.3a Standard curve for recombinant bovine IL-l from calf 
thymocyte proliferation assay. Reciprocal dilution of rb-IL-1 from 1000 
pg m l1 to 0.1 pg ml*1 in culture medium containing 5% foetal calf serum. 
IL-l concentration is proportionate to the [3H]-thymidine counts per 
minutes. Error bars represents the ± SEM of six standards at each point.
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Figure 5.3b Interleukin 1 bioassay controls and sample controls. 
Histogram represents three assay controls; blank (only the culture 
medium); Con.A control (culture medium with 5 pg ml*1 Con A) and 
LPS control (culture medium with 0.025 LPS). The culture medium 
controls with added IL-l include Control 1 (65 EL-1 pg ml*1), Control 2 
( 8  IL-l pg ml*1) and Control 3 (0.2 IL-l pg ml*1). Three P. haemolytica 
infected calf sera spiked with 50 pg ml*1 of rb-LL are represented as IS-1, 
IS-2 and IS-3. The IL 1 activity in the infected serum sample without 
spiking was below the assay sensitivity limit at 0.1 IL-l pg ml*1.
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IL-6
Bovine EL- 6  was not detected by the bioassay. The assay standards (Figure 5.4a) 
and the three controls (Fig.5.4b) with supernatants from cat PBL's stimulated by 
LPS, Con. A or without any stimulant gave 90; 38 and 17 Units per millilitre IL-6 , 
respectively. However, the wells containing bovine serum gave very low counts 
which were below the counts in the negative control and could not be interpreted 
using the standard curve.
5.3.2. Experiment II (10 hour duration)
The acute phase response in LPS-treated calves was monitored for the immediate 
response over the first 10 hours and the delayed response up to day 5 post 
infection. The results obtained were compared with Experiment I in this chapter 
in relation to the immediate response and the experiments described in Chapter IV 
in relation to the response over following 5 days.
The measurements of the respiratory rates and the rectal temperatures of 
the LPS-treated and control calves which received intravenous PBS over the initial 
10 hours are shown graphically in Figures 5.5a and 5.5b, respectively. None of 
the calves in the control group were tachypnoeic. On the other hand, LPS treated 
calves became depressed, anorexic, recumbent and showed a rapid increase in the 
group mean respiratory rate. In these animals the respiratory rates increased ffom 
a baseline value of 18 ± 1.2 per min to 70 ± 2.6 per min, after 1 hour. When 
compared to the control group there was a significant (P<0.01) rise in the 
respiratory rate but this lasted only about 4 hours and gradually dropped to 38 ±
1.2 per minutes. In contrast to temperature changes observed in Experiment I in 
which animals were infected with the organism, the calves treated with LPS 
showed only a slight febrile response which was not significantly different ffom the 
controls.
Administration of PBS (control group) did not cause any significant 
clinical change during the entire experimental period.
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Figure 5.4 Interleukin 6 standard curve (Fig. 5.4a). The histogram 
(Fig. 5.4b) indicates the IL 6 activity LPS, Con A and a blank used as 
controls.
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5.3.2.1 Acute phase proteins
Following LPS infusion there was a significant (P<0.05) rise in the SAA 
concentration within 6  hours post treatment and at the end of 10 hours the SAA 
had risen from a pre-treatment value of 3.5 ± 0.3 mg m l1 to 20.2 ± 0.9 mg m l1 
(Fig. 5.6a). The serum Hp concentration was 0.2 ± 0.23 mg mF before the 
treatment with LPS and showed a marginal rise to 0.45 ± 0.11 mg m l1 at the end 
of 1 0  hours.
5.32.2 Cytokines
Due to limitation on the resources for the TNFa assay sera from only 4 infected 
and 5 control calves were analysed for TNFa activity. The individual semm TNFa
concentration in the 4 calves treated with LPS are shown in Figure 5.6b. Of the 
4 calves 3 were treated with 0.7 |ig kg-1 of LPS while the fourth calf (A-l) 
received a higher dose of LPS (1 Jig k g 1). TNFa concentration started to rise
significantly (p<0.001) 1 hour after the LPS treatment and peaked at 2 hours 
ranging from 11.33 - 80.24 ng mF, (mean ± SEM concentration = 33.8 ± 15.0 ng 
mF). By six hours post-infection, TNFa levels fell rapidly to reach the 
pre-infection concentration, except for calf A-l which maintained detectable TNFa
in serum rll 10 hours post-treatment. Sera from control calves did not contain 
detectable amounts of TNFa at any time after the injection of PBS.
5.3.3. Experiment II delayed response 
5.3.3.I. Acute phase proteins
The mean SAA and Hp concentrations in serum taken over the following 5 days 
are illustrated in Figures 5.7a and 5.7b, respectively. The LPS-treated group and 
the control group had barely detectable levels of SAA and Hp prior to treatment. 
Over the 5 days after inoculation the mean SAA and Hp concentrations increased 
in the LPS treated group with the concentration of both proteins peaking around 
24 hours and then gradually declining thereafter. There was a two-fold rise in the 
fibrinogen concentration on the day of treatment. This fell to
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Figure 5.5 Mean (± SEM) respiratory rates (Fig. 5.5a) and rectal temperatures 
(Fig. 5.5b) of calves over 10 hours after intravenous administration of 
P. haemolytica LPS (0.7 pg kg- 1 in 10 ml PBS; n=5). The control calves received 
1 0  ml phosphate buffered saline intra-tracheally (n=5 ).
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Figure 5.6 Mean (± SEM) serum amyloid A concentrations (Fig. 5.6a) 
and the individual tumour necrosis factora concentrations (Fig. 5.6b)
after intravenous administration of P. haemolytica LPS (0.7 jig kg-1 in 10 
ml PBS. n=3); animal No. A1 received 1.0 fig kg' 1 P. haemolytica LPS. 
The control calves were given 10 ml PBS, intravenously.
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Figure 5.7 Mean (± SEM) serum amyloid A concentrations (Fig. 5.7a) 
and the haptoglobin concentrations (Fig. 5.7b) in calves over 5 days 
after intravenous administration of P. haemolytica LPS (n=5). The control 
calves were given 10 ml PBS, intravenously.
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1.5 times the control value on day 3 and further decline was found on day 5 post­
treatment (Figure 5.8a).
5.3.32. Haematology
In the haematological studies, the main changes observed were in the total 
leukocyte and neutrophil counts (Fig 5.8b). Before inoculation the total leukocyte 
counts in both groups were similar and within the reference range. Following LPS 
infusion there was a marked increase (PcO.OOl) in total leukocyte counts in the 
endotoxin-treated group which reached a maximum after 24 hours while in the 
control group leukocyte counts remained unchanged throughout the entire study 
(10.6 ± 1.0 to 10.8 ± 1.3 x 109 I*1). The leukocytosis reflected an increase in 
neutrophil counts, (from 2.8 ± 0.4 at pre-treatment to 11.3 ± 1.8 x 109 11; after 
24 hours; PcO.OOl). Monocyte counts gradually reduced after LPS injection from 
0.8 ± 0.03 to 0.45 ± 0.01 xlO9 l 1 after 6  hours and started to rise gradually 
reaching 0.75 ± 0.23 xlO9 11 after 24 hours but these were not significant changes. 
LPS also induced a decrease in lymphocyte counts from 7.3 ± 0.25 at the time of 
injection to 6.2 ± 0.3 x 109 l 1 after 6  hours with a recovery to 8.3 ± 0.4 after 
36 hours but again these were not significant changes (Fig.5.8b.).
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Figure 5.8 Mean (± SEM) serum fibrinogen concentrations (Fig. 5.8a) in 
calves over 5 days after intravenous administration of P. haemolytica 
LPS. The control calves received phosphate buffered saline intravenously 
(10 ml per calf; n=5;). Figure 5.8b shows the mean (± SEM) total 
leukocyte, neutrophil, lymphocyte and monocyte counts in calves over a 
5 day period after intravenous administration of P. haemolytica LPS.
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5.4. Discussion
The main objectives of this study were to determine the involvement of the 
cytokine network in the immediate APR in bovine pasteurellosis and to identify 
what role, if any, is played by LPS from P.haemolytica in the initiation of the 
systemic reaction to this infection. In these experiments blood samples were 
collected more frequently than in the studies described in Chapter 4 and were 
therefore more suitable to extending our knowledge of the onset of the APR in 
cattle.
The results of this study demonstrates that both P. haemolytica and LPS 
extracted from the bacteria stimulate an APR within a few hours of administration. 
The presence of a systemic APR was confirmed by the clinical changes which 
included a significant increase in respiratory rate (>60 min-1), associated with 
pyrexia and anorexia. These findings agreed closely with the observations 
reported by Gibbs et al. (1984) and demonstrated that the alterations produced 
during the APR to P. haemolytica could be instigated by LPS via the cytokine net 
work.
Previous studies by Conner et al. (1989) and Horadagoda et al, (1992) on 
BPP have demonstrated that an acute phase protein response is detectable 24 
hours after infection with P.haemolytica. This is the first study to observe the 
immediate acute phase protein response in BPP and to demonstrate a progressive 
increase in SAA concentrations during the first 10 hour period when Hp 
concentrations remained small and insignificant.
It is accepted that in man and other laboratory animals, the APR synthesis
seen during inflammation is regulated by several cytokines, particularly IL-l, IL- 6  
and TNFa (Evans and Whicher 1992; Koj 1985). However, controversy exists
regarding the quantitative and qualitative importance of these three cytokines. 
For example in human hepatocytes, SAA mRNA is increased modestly by IL-l
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while it remains constant or is decreased by IL-6 . In contrast, IL- 6  induces 
fibrinogen mRNA in a dose dependent manner whereas IL-l reduces this effect 
(Malawista et al. 1989; Moldawer et al. 1989; Playfair 1991).
The frequent sampling protocol adopted in the present study demonstrated 
a rise in circulating SAA as early as 4 hours after infection but Hp did not 
increase above the normal concentration during the 1 0  hours following infection. 
A possible explanation for the difference in the SAA and Hp responses observed 
in this study may be due to the difference in the induction of hepatic synthesis 
which may be related to sequential release of cytokines. Haptoglobin is a 
glycoprotein and its production is dependent on IL-6 , the cytokine primarily 
responsible for regulation of APP production by hepatocytes (Koj 1985). 
However, SAA is an apolipoprotein and IL- 6  is not the main mediator of SAA 
production (Playfair 1991; Hocke et al. 1992). Early investigations identified IL-l 
as the main inducer of SAA (Sipe et al. 1979; Vogal and Hogan 1990; Playfair
1991) but more recent in vitro and in vivo studies have demonstrated that IL-l is 
not the only cytokine that modulates acute phase SAA synthesis and have 
implicated TNFa as a major mediator of SAA (Sipe et al. 1987; Sipe 1990).
The question of whether the earlier stimulation of SAA production was a 
result of the sequential and differential stimulation by cytokines could be 
addressed by characterisation of the sequence of the cytokine response to 
infection. This was a further stimulus to provide suitable assay systems for the 
bovine cytokines IL-l, IL- 6  and TNFa However, despite the unsuccessful 
attempts to measure b-IL-1 and b-IL-6 , the availability of an RIA for b-TNFa has 
demonstrated an early TNFa response following post-infection which is in 
agreement with similar studies conducted in other species (Waage et al. 1987; 
Michieeftf/. 1988).
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The use of the specific radioimmunoassay for bovine TNFa to analyse the 
serum samples taken after P. haemolytica inoculation demonstrated that a TNFa 
response was induced as early as 1 hour after the inoculation and a peak 
concentration of 18 - 37 ng mF was achieved within 2 hours of inoculation with 
non-detectable levels restored by 6  hours. The rapid rise and fall in serum TNFa is 
compatible with the short half-life of serum TNFa reported for various species, 
for example 72-90 minutes in both humans and rats (Michie et al. 1988; Waage 
et al. 1992) and 6-7 minutes in mice (Beutler and Cerami, 1989). These results 
also confirm a recent report of a systemic TNFa response during experimental
bovine pasteurellosis (Pace et al. 1993). Nevertheless, there are qualitative and
quantitative differences between the two studies. Pace et al. (1993) identified low 
and high responding animals, with maximum serum TNFa concentrations in their
high responding calves of about 6  ng ml"1. The peak serum concentrations of 
TNFa reported in the present work were higher (18 to 37 ng ml'1) and occurred
2 hours post-challenge rather than 8  hours post-challenge as reported by Pace 
et al. (1993). These workers also reported a longer measurable TNFa response
(>72 hours). Differences between the results presented here and those of Pace 
et al. (1993) may be due to the cytotoxic biological assay which they employed. 
Biological assays are not specific for TNFa estimation unlike the RIA which was
used in this study. Both TNFa and TNFp are toxic to a range of tumour cells 
in vitro and cytotoxic assays are not capable of differentiating these forms of the
cytokine (Meager et al. 1989). Therefore it is possible that the bioassay used by 
Pace et al. (1993) could have measured TNFa along with TNFp which is known to
have a longer half life (Nelson et al. 1990).
The results of this investigation also disagreed with those of Espinasse et 
al. (1993) who employed a RIA similar to that described here, based on rb-TNFa,
to examine serum following experimental BPP infection. In this investigation the 
inoculum was administered as a single dose whereas Espinasse et al. (1993)
194
inoculated calves over 3 consecutive days. After the initial burst of TNFa release, 
the cells such as the alveolar macrophages, producing TNFa become resistant to 
the stimulating effect of LPS (Waage 1987) and the TNFa production begins to
fall. Therefore the inoculation regime of Espinasse et al. (1993) may have been 
too low and too extended to produce a detectable increase in TNFa. Additionally, 
transient accumulation of TNFa in the serum may reflect an acute over-production 
followed by a spillover phenomenon when local tissue binding sites have been 
saturated and or there has been temporary breakdown of natural inhibitors (Tracey
et al. 1989; Creasy et al. 1991).
Another reason for the inability of Espinasse et al. (1993) to detect TNFa
is likely to be because of the low frequency of bleeding as sampling once or twice 
daily would not allow a rapid peak to be detected. This combined with the 
multiple inoculation patterns used is most likely to be the main reason for the 
difference in detection of the TNFa response to BPP between the investigation
described here and that of Espinasse et al. (1993). Their assay system which was 
also based on the RIA of Kenison (1990; 1991) has successfully identified a TNFa
response in calves infected intravenously with E. coli (Peel et al. 1990) but 
following S. typhymurium infection they failed to demonstrate a TNFa peak.
Blood samples were again collected only once a day and this could easily cause a 
TNFa peak in the serum to be over looked (Peel et al. 1990).
Unfortunately, attempts to demonstrate the sequential stimulation of 
cytokines in BPP were unsuccessful due to the inability of bioassays for human 
IL-l and DL- 6  to quantify the bovine cytokines in the serum samples. In an earlier 
study, Winstanley and Eckersall (1992) measured bovine EL-1 like activity in the 
supernatant from bovine mononuclear cells stimulated with LPS and demonstrated 
that the D-10 cell line (Winstanley and Eckersall 1992) which has been used to 
measure human IL-l could be used to measure bovine IL-l in culture medium. 
However, in preliminary studies D-10 cells failed to proliferate with the bovine 
serum samples from animals infected with P.haemolytica. Therefore, an attempt
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was made to measure bovine IL-l like activity using an alternative method 
described by Collins et al. (1989). This assay was originally developed to measure 
IL-l activity in bovine macrophages collected from injured mammary glands and 
used a bovine thymocyte cell culture as the bioassay system.
However, the assay of serum IL-l activity in BPP using the calf thymocyte 
cell line was not successful and this could be attributed to at least two reasons. 
The first and most likely reason is that the IL-l response in pasteurellosis was too 
low for detection by this assay even though it had a limit of detection of 0 .1  pg 
mb1 of IL-l. The second possibility is that IL-l inhibitors or binding protiens 
present in the bovine serum may have inhibited a reaction in the IL-l bioassay. 
Such inhibitors have been identified in blood and other biological fluids (Larrick
1989). This possibility was tested by adding rb-IL-1 to serum from infected 
animals which resulted in no loss of activity of the cytokine added to the serum. 
Therefore the possibility of an inhibitory effect of bovine serum on the thymocyte 
response could be virtually eliminated. Various methods have been used to 
remove potential inhibitors of IL-l, including serial dilutions, chloroform 
extraction (Cannon et al. 1988) and treatment with PEG (Hopkins et al. 1990). 
These procedures however, were not attempted in the present assay of bovine 
IL-l but could be recommended for any further attempts to estimate IL-l by 
bioassay. To confirm the production of IL-l in BPP, alveolar macrophages 
obtained through bronchoalveolar larvage (BAL) may be a better source of 
material as these cells are likely to have a higher concentration of this cytokine and 
effects of serum inhibitors would be virtually eliminated. However, the dilution 
effect of lavage buffer would reduce the quantitative value of such an approach. 
Another alternative is to use peripheral blood lymphocyte's (PBL’s) which may be 
a better source than the serum. It is likely that detection of bovine IL-l in serum 
from infected animals will have to wait until an ELISA or a radioimmunoassay 
system has been developed for the bovine cytokine.
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Although IL-l like activity was not demonstrated in the serum of infected 
animals, clinical features such as fever, anorexia, pain and lethargy which are 
associated with IL-l in other species (Dinarello 1984b; Atkins 1989) were 
observed in the infected calves, suggesting a major role for IL-l in mediating the 
APR in bovine pasteurellosis.
In the present study the attempt to measure circulating bovine IL- 6  like 
activity using a bioassay was not successful. As in the case of the attempt to 
measure bovine IL-l by bioassay, this may be either because the assay was not 
sensitive enough or due to the interference of bovine serum with the bioassay.
Bovine serum ffom animals before and after experimental infection with 
P.haemolytica reduced the uptake of [3H]-thymidine in the B9 cell line below that 
of the negative control, indicating that cells were being inhibited rather than being 
stimulated. This was in contrast to the IL-l assay, where bovine serum had no 
effect on the basal metabolism of the bovine thymocytes. The effect on the IL- 6  
bioassay may to be due to a toxic effect of the calf serum but was not related to 
the infection as pre-infection serum had the same effect. The toxic effect 
decreased as the serum samples were titred out. This assay is in regular use for 
the measurement of feline IL- 6  in purified peripheral blood lymphocyte's (PBL's), 
serum and plasma ffom cats with feline infectious peritonitis (FIP) and this toxic 
effect has not been seen with any feline sera present at the same range of dilutions 
(Dr. C. Lawrence, personal communication). Whether the IL- 6  assay is sensitive 
enough for analysis of bovine serum will have to wait until the problem of the 
toxic effect of the serum is solved. Foetal bovine serum (10% v/v) was one of the 
constituents of the tissue culture media and therefore, FBS must not contain the 
component with the toxic effect on the cell line, whereas bovine serum ffom the 
3 months old calves used in the experiment appears to contain inhibitory factors. 
One possibility is foetal bovine serum is subjected to processing prior to sale 
which would destroy or remove the toxic factor. Initial attempts to remove the
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inhibition by heat treatment (56°C for 30 min) and the addition of PEG to the 
serum did not alter the B9 cell line response to bovine serum.
Studies in cattle have revealed that an acute phase protein response was 
observed after infusion of human-recombinant-IL- 6  (Nakajima et al. 1993) . The 
serum concentration of Hp and fibrinogen responded to rh-IL- 6  by increasing 
100-fold and doubling respectively. In the present studies (see Chapter 4) both 
SAA and Hp were raised in response to P. haemolytica infection and to treatment 
with LPS which suggests that IL- 6  like activity is a likely mediator of the APR in 
bovine pneumonic pasteurellosis, but confirmation of this postulate will require a 
suitable assay for measuring IL- 6  either by overcoming the toxic effect on the 
B9 cell line, by development of alternative cell lines not susceptible the toxic effect 
or by development of an immunoassay.
Investigation of the interaction between bacteria and host showed that a
distinct acute phase response was found after treatment of calves with LPS even
though LPS ffom 4 field isolates and different doses (0.7 and 1.0 |ig kg-1 body
weight) were used. The response was evident ffom the clinical signs, the acute
phase protein response, the haematological response and by demonstration of a 
TNFa response within 2 hours of infection. Indeed, few of the systemic acute
phase responses which occur in BPP were not mimicked by LPS treatment. 
Unfortunately it was not feasible to measure all the analytes studied in Chapter IV 
for their responses to LPS. It would be of particular interest to extend the 
investigation to cover hormone and trace element responses. During the 
immediate response, TNFa, Hp and SAA gave similar responses to LPS as that
seen in P.haemolytica (Experiment I). However, rectal temperature did not show 
a significant rise with LPS but the respiratory rate was much sharper with the LPS 
response. When the acute phase response to LPS was examined over 5 days a 
similar response to that obtained with the whole bacterium was found and there 
was little difference in the course of the response for these analytes. There were 
differences in the extent of the response in comparison to that shown by
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P. haemolytica infection (Experiment I), but these may only relate to the doses of 
LPS used in the experiment and further investigation with increasing doses of LPS 
are required to clarify this point. However, these initial studies demonstrate that 
most, if not all, of the systemic effects produced by P. haemolytica on the 
metabolism of the host can be caused by LPS and its interaction with leukocytes 
and the cytokine net work. It would be of interest to determine whether the 
systemic response is influenced more by LPS transferring from the site of infection 
in the lung to the circulation or by activation of alveolar macrophages and 
cytokine from the latter causing the systemic response. Evidence from this study 
indicates that LPS from P. haemolytica would be able to induce a rapid APR once 
it is in the circulation. Investigations to measure the serum LPS level in the early 
APR would help to answer this question.
Experiments carried out in mice indicate that in LPS-induced 
inflammation, the TNFa concentration in serum increased from 15 minutes after
LPS administration, reached a peak 85 minutes later and was not detectable 
200 minutes (Remick et al. 1987) after administration. There is strong evidence 
that the generation of TNFa is a principal mediator of the APR observed in vivo
following the administration of LPS. Recombinant TNFa given to rats by
intravenous infusion over 5 minutes at a dose of 3.6 mg kg-1 causes hypotension, 
metabolic acidosis, hyperglycaemia, hyperkalaemia and death. However, lower 
doses of TNFa are compatible with survival (Tracey et al. 1986). Monoclonal 
antibodies to TNFa are protective against potentially lethal doses of endotoxin
indicating the important role of this cytokine (Bagby et al. 1990). However, such
antibody treatment does not abolish all the inflammatory changes seen in
LPS-treated animals.
In the LPS experiment the time course of serum TNFa activity after
intravenous LPS administration was similar to that studied in other species (mice, 
chimpanzees) where a peak serum concentration occurring within 90 minutes of 
infusion and then returned to pre-infected levels 3-4 hr later (Morris 1992).
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However, in horses TNFa response time has been shown to be dependent on the 
method of stimulation (May et al. 1992). When animals were treated with a high
concentration of LPS from E coli (1 mg k g 1) there was a rapid increase in serum 
TNFa concentration with a rise seen as early as 2 hours post-treatment. However,
when smaller doses of LPS (30 ng m l1) were administered by the same route, a 
serum TNFa increase was detected only after 3 hours.
Lipopolysaccharide treatment of calves not only caused a peak of TNFa 
and initiated production of SAA and Hp, but also effected leukocyte concentration 
in circulation as did inoculation with the whole bacterium (Chapter IV). LPS 
induced a pronounced neutrophilic leukocytosis in all calves within 24 hours. 
Similar results have been reported by Bowersock et al. (1990) and Breider et al. 
(1990; 1991) in calves exposed to a mixture of LPS and crude leukotoxin of 
P. haemolytica. It is likely, that the concurrent increase in the circulating levels of 
cytokines contributed to this response because intravenous administration of either 
TNFa, IL-1 or DL- 6  gives rise to neutrophilia in several species ( Ulich et al. 1987;
van Deventer et al. 1991). IL-1 in particular, caused great peripheral neutrophilia 
and lymphopenia. The peripheral neutrophilia was characterised by an increase in 
circulating band forms (Ulich 1992). In this experiment a slight neutrophil rise 
was observed as early as 6  hours post-infection.
The migration of neutrophils from the pulmonary microvascular 
compartment into the pulmonary interstitium and alveolar space is an important 
immunopathological consequence, since this process is also accompanied by 
neutrophil activation. In the setting of enhanced vasodilatation and vascular 
permeability associated with the initial local APR, neutrophils must first adhere to 
endothelial cells, followed by diapedesis along established chemotactic gradients 
(Maheswaran 1993; Walker et al. 1985). Cellular communication via cytokine 
networks operating between immune and non-immune cells of the 
alveolar-capillary membrane may be essential for the generation of inflammation
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(Maheswaran 1993; Slocombe et al. 1990). The subsequent events of these 
cellular-humoral interactions are pivotal to the initiation and propagation of the 
inflammatory response leading to pulmonary injury. Both TNFa and IL-1 are 
necessary for the initiation of acute inflammation but whether TNFa or IL-1
participates in a pulmonary immune reaction is still unclear.
The use of LPS infusion in human volunteers has provided important 
evidence of the cytokine net work and the associated systemic response (Michie 
et al. 1988). This model, has provided relevant information concerning the 
cytokine cascade in the human, which has helped to interpret the complex data 
obtained from infected patients. Similarly studies of LPS treatment of calves will 
help to identify those biochemical changes dependent on LPS from the bacterium. 
In cattle, both intravenous administration of LPS and intra-tracheal inoculation of 
the bacteria induced the acute phase response. This supports the conclusion that 
LPS is an important mediator in the systemic icsponse to bovine pasteurellosis.
Increased knowledge of the cytokine cascade in man and other species has 
progressed to the point where therapeutic measures aimed at reducing mortality 
from bacterial infection by influencing cytokine action have been undertaken 
(Hannum et al. 1990; Silva et al. 1990; Eisenberg et al. 1991). Low 
concentrations of cytokines or their receptor antagonists have an important 
protective effects in host resistance (Havell 1989; Carter et al. 1990; Piguet et al.
1990) so that, with any anti-cytokine therapy, it will be important to avoid 
potentially harmful immunosuppressive effects. More research based on 
antibodies raised against bovine TNFs, interleukins and LPS from bovine 
pathogens would be beneficial to increase understanding of this complex network 
of interacting mediators.
In conclusion, this experiment has demonstrated that P.haemolytica 
infection and its LPS induces TNFa in vivo probably by activation of bovine
macrophages and monocytes. The acute phase response that developed is likely
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to be mediated by cytokines including TNFa. Tumour necrosis factor activates the 
hepatocytes to release APP either directly or via other members of the cytokine 
net work. Unfortunately suitable assay systems were not available to measure 
interleukins in the present study but the systemic reaction indicates the likely 
presence of other interleukins. This will be further elucidated when assays become 
available to detect bovine IL-6 , IL-1 and other cytokines.
CHAPTER VI
CONCLUSIONS
AND
GENERAL DISCUSSION
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6.1 Conclusions
Serum amyloid A (SAA) was the most responsive of the bovine acute phase 
proteins in an established animal experimental model for bovine pneumonic 
pasteurellosis.
Hydrophobic interaction chromatography and gel filtration were the 
method of choice to purify bovine serum amyloid A (b-SAA) which was used 
subsequently to quantify a pool of acute phase bovine serum as standard in an 
enzyme linked-immunosorbent assay to measure SAA in bovine serum.
Infection of calves with P. haemolytica Al caused a rapid fall in 
circulating zinc and non-haem iron, an immediate rise in cortisol but a fall in 
thyroxine concentrations, a marked neutrophilic leukocytosis, an increase in 
bilirubin concentrations and a fall in glutamate dehydrogenase activity.
The response of most of the acute phase reactants related to the extent of 
the pathological lesions which varied between the two field isolates used to 
inoculate calves.
P. haemolytica Al caused a transitory rise in circulating TNFa which
was also produced following injection of calves with lipopolysaccharide (LPS) 
from the bacteria.
Intravenous administration in calves of LPS from P. haemolytica Al 
caused an acute phase response closely resembling that induced by intra­
tracheal inoculation with the whole bacterium.
6.2. General Discussion
Studies described in this thesis and the investigations reported by Boosman et al. 
(1989) have demonstrated clearly that SAA is a major acute phase protein in 
cattle as it is in man and the horse (Pepys et al. 1989; Taktak and Lee 1991). At 
present SAA concentrations in man are used in clinical monitoring of 
inflammation and acute disorders such as myocardial infarctions and renal 
allografts (Yamada et al. 1993). Limited studies in domestic animals have also
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reported that SAA could be a reliable marker of inflammation and tissue injury in 
other species (Pepys et al. 1989; Boosman et al. 1989; Grays et al. 1993). 
Despite the wide usage of SAA as an acute phase reactant, the precise function of 
this protein remains unclear. Some workers have implicated SAA in reverse 
cholesterol transport and more recent studies have suggested that SAA plays a 
role in the transport of bacterial endotoxins. The availability of purified bovine- 
SAA offers an excellent opportunity to investigate the specific function of SAA in 
cattle either by in vitro or in vivo studies.
At present there are no reports on the structure of b-SAA and, although 
several isoforms have been described in other species (Steinkasserer et al. 1990; 
Raynes and Me Adam 1991) only one isoform of b-SAA has been described 
(Rossevatn et al. 1992). The purification of b-SAA using the methods described 
in this thesis creates opportunities to investigate the presence of isoforms and to 
determine the structure of b-SAA using advanced techniques such as 
crystallography. Additionally, it is now possible to determine the amino acid 
sequence of the purified protein and compare the homology of b-SAA with SAA 
from other species.
The b-SAA ELISA developed in this study is the first assay in which the 
purified analyte has been used to quantify the SAA concentration in SI units. 
Previous assays for estimating SAA in domestic animals expressed the 
concentration of SAA in arbitrary units (Boosman et al. 1989; Pepys et al. 1989). 
The ELISA described here has a number of other advantages over the ELISA 
developed by Boosman et al. (1989) to measure b-SAA. First the rabbit antibody 
to bovine amyloid A used by Boosman et al. (1989) is not specific to b-SAA and 
an additional absorption step is necessary before the assay of b-SAA can be 
performed. Prior absorption of antiseram is not required in the present assay as 
the rabbit anti-human antiseram reacted specifically with b-SAA in APbS on 
Western blots. In addition, the SAA antibody used in the present assay is 
commercially available making the assay widely available and
205
allowing the assay to be transferable to other laboratories:transfer would be much 
more limited with the antibody prepared and used by Boosman et al. (1989). 
Furthermore, the use of a calibrated acute phase bovine serum as standard for the 
assay has overcome the problems associated with the matrix and also reduced the 
demand for a constant supply of purified analyte to perform the assay.
The analysis of serum from calves experimentally infected with 
P. haemolytica Al (Chapters IV and V) or inoculated with LPS (Chapter V) 
demonstrated that SAA is a major acute phase protein in cattle comparable to and 
complementary with the assay for haptoglobin. In experiments performed to 
compare the acute phase response (APR) to isolates of P. haemolytica (Chapter 
IV), the SAA concentration reflected the magnitude of the APR observed while 
the haptoglobin concentrations failed to demonstrate such a difference. 
Furthermore, in the experiments which examined the immediate acute phase 
response to P. haemolytica infection (Chapter V) the SAA response was present 
as early as 4 hours post-infection while haptoglobin failed to respond within 
1 0  hours of infection.
The samples from clinical cases analysed for SAA in this study and those 
performed by Gruys et al. (1993) indicate that SAA measurements are reliable in 
detecting inflammatory conditions in cattle. Furthermore, the greater incremental 
range of SAA makes it a more sensitive assay when compared to haptoglobin to 
detect tissue injury caused by infection or trauma. Another application for 
measurement of SAA as an acute phase protein is as an antemortem test to 
identify animals with infections or inflammatory diseases which can be then 
examined further to assess whether the meat from such animals is fit for human 
consumption.
However, the use of SAA measurements in clinical practice or meat 
inspection will require a robust, rapid, inexpensive and efficient assay. The ELISA 
described here, in its present state, does not meet all of these criteria but attempts 
could be made to improve the assay in the future. Several options are
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available for this purpose and include developing a latex agglutination 
nephelometric immunoassay (Yamada et al. 1993) or sequence-specific 
monoclonal antibodies in an ELISA as described for human SAA (Casl and 
Grubb 1993).
In the experiments described in Chapter IV a bovine pneumonic 
pasteurellosis (BPP) experimental model was used to compare the APR of calves 
to two highly virulent field isolates of P. haemolytica. The isolates used for the 
infection demonstrated similarities in their LPS content but varied in their 
capacity to produce leukotoxin in vitro (Dr. R.L. Davis personal 
communication). Following inoculation, both isolates demonstrated many of the 
changes associated with the APR but there was a difference in the magnitude of 
the response produced by each isolate. Clinically the animals in Group I, which 
were inoculated with P. haemolytica isolate SB/82/1, demonstrated a more severe 
response in relation to demeanour, rectal temperature, respiratory rate, and food 
intake compared to animals in Group II inoculated with isolate SC/82/1. Other 
acute phase responses such as leukocytosis, mineral redistribution, acute phase 
protein response and endocrine changes were also more prominent in the 
animals in Group I compared to those in Group II. The findings of these 
experiments indicate that the APR can be used as a means of studying or 
comparing the in vivo responses of calves to different bacterial isolates without 
having to resort to post-mortem examination.
The findings of the present study demonstrate for the first time the 
presence of a trace mineral redistribution during the APR to P. haemolytica 
infection in cattle. The experiments demonstrated a 70 per cent reduction in the 
iron concentration and a 60 per cent reduction of the zinc concentration within 
24 hours of challenge. The redistribution of trace minerals by the host during the 
APR may play an important protective role by curtailing the multiplication of 
bacteria by depriving the microorganisms of essential trace minerals which are 
required for its survival and proliferation. Furthermore, the studies by
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Slocombe et a l (1990) suggests that the reduction of circulatory iron may 
decrease the leukocyte-derived toxic metabolites which apparently play a 
significant role in the initiation of the pulmonary lesions in BPP.
Only a few studies have examined the implication of endocrine changes 
with infection in domestic animals (Elsasser 1992). Indeed, the investigations 
reported in this thesis are among the first attempts made to study the endocrine 
changes associated with the APR in BPP. These studies demonstrated a significant 
rise in serum cortisol and a marked decline in thyroxine levels during the APR of 
infected animals. The mechanisms responsible for the hormonal changes are a 
subject of much debate. However, several in vitro and in vivo studies performed 
in laboratory animals have demonstrated a major role for cytokines, particularly 
IL-1, in direct and indirect stimulation of the adrenal cortex to release cortisol 
(Besadovsky et al. 1986; Salas et a l 1990a; 1990b). The specific cause for the 
reduction of thyroxine is unclear.
Chapter V describes experiments performed to determine the role of 
cytokines in the systemic response of bovine pneumonic pasteurellosis. As LPS of 
P. haemolytica is recognised as an important virulence factor, animals in one 
group were infused with LPS extracted from P. haemolytica while another group 
was infected with the whole live organism. Animals in both groups developed an 
APR which was characterised by pyrexia, anorexia, tachypnoea and an acute 
phase protein response. Furthermore, the infected animals and those infused with 
LPS demonstrated a rise in serum TNFa as early as 1 hour after inoculation and a
peak at 2  hours with no detectable levels by 6  hours.
The ability of LPS to generate an APR and a TNFa response in the present
study confirmed previous investigations in which LPS has been incriminated as a 
major virulence factor of P. haemolytica (Confer et a l 1990; Whiteley et a l
1992). In vitro and in vivo studies performed in laboratory animals and man have 
clearly demonstrated that LPS activates tissue macrophages and 
monocytes to synthesise and release a wide range of substances
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including the cytokines TNFa, IL-1 and IL- 6  (Sipe 1990 ). Furthermore, these 
studies have shown that TNFa is a key mediator of the APR which is characterised
by many pathophysiological alterations. Indeed, in man LPS is known to induce 
the sepsis syndrome (septic shock) in Gram-negative infections through TNFa
stimulation, which can result in multi organ failure and even death (Bone 1991). 
The results of the present study demonstrate a TNFa response which suggests that
this cytokine may play a pivotal role in mediating the APR in BPP following P.
haemolytica infection and after stimulation by LPS.
The precise origin of circulatory TNFa in the APR following
P.haemolytica or LPS stimulation is unclear. Whiteley et al. (1990) using 
immunohistochemical techniques, demonstrated the presence of P. haemolytica 
LPS in the intra-vascular, interstitial and alveolar macrophages (AMO) following 
intra-tracheal inoculation of the organism. These findings suggest that the LPS in 
BPP could cross the alveolar wall to stimulate pulmonary intravascular 
macrophages (PIM) in addition to the AMOs to produce TNFa. This postulation
however, needs to be confirmed by demonstrating circulatory LPS in BPP. 
Studies conducted in the rats have also shown that the LPS administered 
intra-tracheally crosses the alveolar wall to disseminate into visceral organs 
(Freudeberg et al. 1984). In contrast, investigations in sheep using radio-labelled 
P. haemolytica LPS have noted that the LPS does not cross the alveolar wall and 
was restricted to the alveolar macrophages, suggesting that alveolar macrophages 
are the main source of TNFa. The active role of alveolar macrophages in
restricting LPS may partly explain the reason for the inability to experimentally 
establish pneumonic pasteurellosis in conventional sheep (Personal communication 
Dr. J C.Hodgson).
The demonstration of TNFa in the APR of BPP have implications on 
studies related to the pathogenesis of the disease and suggest the need for
investigations on the use of therapeutic alternatives such as the use of low doses 
of recombinant-TNFa, IL-1 receptor antagonist, anti-TNFa and anti-LPS which
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are being actively studied and used in human medicine to minimise the deleterious 
effects of LPS in Gram-negative infections (Wong and Goeddel 1988; Carter et al. 
1990; Waage et al. 1992). However, at present this may not be a feasible 
proposition under field conditions, but with the development of sequence-specific 
monoclonal antibodies it may be a therapeutic approach worth considering in the 
future.
Experimental studies in other species have shown that clinical signs such as 
fever, anorexia, pain and lethargy in the APR are associated with IL-1 activity 
(Dinarello 1984a; 1984b). The presence of comparable clinical signs during the 
APR in BPP suggests a role for IL-1 although the bioassays used in this study 
failed to demonstrate the presence of this cytokine. One reason for not detecting 
IL-1 activity may be the low serum concentration in BPP which was perhaps 
below the assay detection limit. IL-1 is produced by numerous cells therefore 
future attempts may be made to circumvent the problem associated with the low 
serum concentrations by the use of an alternative source for IL-1 measurement 
such as peripheral blood lymphocytes or alveolar macrophages obtained by 
bronchoalveolar lavage. Furthermore the use of cells as a source for IL-1
estimation will overcome the effect of IL-1 inhibitors in plasma such as
corticosteriods, a-melanocyte stimulating hormone and PGE2  which can interfere 
in bioassays (Larrick et al. 1989). The measurement of IL-1 activity in serum 
would be more convenient, but this may have to wait till the development of a 
suitable ELISA or RIA.
IL- 6  is recognised as a potent inducer of acute phase protein response in 
man and laboratory animals (Gauldie et al. 1987; Kishimoto et al. 1992), and 
experiments performed by Nakajima et al. (1993) have demonstrated that
recombinant human IL- 6  has a similar effect in cattle. The results of the acute
phase response of BPP investigated in this study have demonstrated an acute 
phase protein response characterised by an increase of several acute phase 
proteins including SAA, fibrinogen and haptoglobin which suggest a major role
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for EL- 6  activity. However, the human and feline IL- 6  bioassay used here to 
measure bovine IL- 6  activity failed to demonstrate the presence of this cytokine 
in serum. These observations indicate the need for development of species
specific assays for estimating bovine IL- 6  activity in the APR.
In the experiments described in Chapter V the TNFa response was
examined after a single inoculation of P. haemolytica LPS. Studies in man 
(Granowitz et al. 1993) using a continuous LPS infusion have provided an 
opportunity to study the sequential release of cytokines in the APR. Such an 
experimental procedure in the future will provide a clear insight to relative 
cytokine production which could be correlated with changes present during the 
APR. The experiments described in this thesis have concentrated on the 
cytokines responsible for the induction of the APR however, future studies 
should not overlook the role of cytokines such as IL-4 and IL- 8  which are 
implicated in the down regulation of the APR. At present cytokine research in 
domestic animals is at an early stage but there are considerable scope for such 
investigations in order to understand the host responses which are now 
recognised to have a major role in disease processes.
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Appendix 2.1
Stock solutions, SDS-PAGE buffers and gel mixes 
Stock Acrylamide
acrylamide 29 g
methylene-bisacrylamide 1 g
dH20  100 g
SDS-PAGE resolving gel
stock acrylamide 1 0 .0  ml
1M Tris-HCL (pH8 .8 ) 5.0 ml
dH20  4.6 ml
10% SDS 200 Hi
10% APS 100 nl
TEMED 10 p.!
SDS-PAGE resolving gel
stock acrylamide 2.5 ml
1M Tris-HCL (pH6 .8 ) 2.5 ml
dH20  8.0 ml
10% SDS 200 Hi
10% APS 100 Hi
TEMED 10 Hi
SDS-PAGE tank buffer
glycine 14.4 g
Tris base 3.1 g
SDS 1.0 g
dH20  1 litre
Treatment buffer (sample buffer)
2.5% SDS
2.5 % dithreioerythriol 
0.1 M Tris-HCL (pH6 .8 )
1 0 % glycerol
0 .0 1 % bromophenol blue
Coomasie Blue staining solution
Coomassie blue 0.5g
methanol 300 ml
glacial acetic acid 1 0 0  ml
dH20  to 1 litre
Destaining solution
methanol 300 ml
glacial acetic acid 1 0 0  ml
dH20  to 1 litre
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Appendix 4.a
Composition of Cortisol radioimmunoassay buffer 
Reagents
Sodium dihydrogen orthophosphate NaH2P 0 4.2H20  2.18 g l 1 
Disodium hydrogen orthophosphate Na2HP0 4 12.21 g I 1
Sodium azide (NaN3) 0.50 g l 1
Adjust pH to 7.4
Add 1.0 g of gelatin per litre of assay buffer before use.
Appendix 4.b 
Preparation of thyroxine for T4 assay accuracy
To measure accuracy a thyroxine sample with a known concentration was 
prepared using L-thyroxine (FW 888.9) sodium salt pentahydrate crystalline 
(Sigma Chemical Company T 2126). 88.9 mg of thyroxine was weighed out and 
dissolved in 100 ml of a propylene glycol: distilled water (1:1) solution [A] which 
was adjusted to pH 9 by dropwise addition of 1 M NaOH. Then 0.4 ml of [A] 
was added to 4 ml of 0.04 M NaOH in duplicate and 0.4 ml of propylene 
glycol:distilled water solution was added to 4 ml of 0.04 M NaOH used this to 
blank the spectrophotometer. Absorbance was measured at 325 nm, the e for 
thyroxine is 6,200 the spectrophotometer readings for blank was = 0; [A] = 0.545 
and 0.528 in the duplicate samples, from this the concentration of [A] was 
calculated and was 0.95 mmol l 1.
Solution [A] was further diluted twice as follows 1 ml of [A] in 50 ml of 
barbitone (pH 8 .6 ) buffer (Sigma) solution [B] which was 19.0 and 1 ml of [B] 
was again diluted with 20 ml of the same buffer (pH 8 .6 ) to make a solution [C]. 
The concentration of 30 jllI of [C] is 27.4 nmol l 1. Take known amounts (30 |il, 
20 pi) of [C] and mix with 1 ml of serum and analyse the thyroxin concentration.
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Appendix 5.1
RPMI Tissue Culture Medium
Sterile distilled water 431.5 ml
RPM1 1640 500.0 ml
glutamine (200mM) 5.0 ml
penicillin (5000 U ml Ostreptomycin/SOOO fig m l1 5.0 ml 
Sodium bicarbonate (7.5%) 13.5 ml
GLOSSARY
AGP a-acid glycoprotein
AFC affinity chromatography
APbS acute phase bovine serum
apo AI apolipoprotein-AI
apo All apolipoprotein-AII
APP acute phase protein(s)
APR acute phase response
apo apolipoprotein(s)
BAL bronchoalveolar lavage
BCA bicinchoninic acid
BPP bovine pneumonic pasteurellosis
BSA bovine serum albumin
b-AA bovine amyloid A
b-SAA bovine-serum amyloid A
°C centigrade (celsius)
Ci curie
cm centimetre
Cp ceruloplasmin
cpm counts per minute
CRP C-reactive protein
Cu copper
Da Dalton
DEAE diethylaminoethyl
dH20 distilled water
dl decilitre
EDTA ethylenediaminetetra-acetate
ELISA enzyme link immunosorbent assay
FBS foetal bovine serum
Fe iron
FPLC fast protein liquid chromatography
g gram
GF gel filtration
Hb haemoglobin
Hct haematocrit
h hour
HRP horseradish peroxidase
HDL high density lipoprotein(s)
HIC hydrophobic interaction chromatography
Hp haptoglobin
IHA Indirect haemagglutination test
IL-1 Interleukin-1
IL- 6 Interleukin- 6
IL-8 Interleukin- 8
k kilo
kD kilo Dolton
1 litre
LDL low density lipoprotein(s)
mg milligram
min minute(s)
ml millilitre
mm millimetre
mM millimole
mmol millimole
mRNA messenger ribonucleic acid
Mr molecular radius
N normality
ng nanogram
nm nanometre
nmol nanomole
OD optical density
PBS phosphate buffered saline
PBST phosphate buffered saline with Tween 20
PPD p-phenylenedi amine
RIA radioimmunoassay
rpm revolutions per minute
SAA serum amyloid A
SD standard deviation
SEM standard error of mean
SDS sodium dodecyle sulphate
SDS-PAGE SDS-polyacrylamide gel electrophoresis
t 4 thyroxine
TBS tris-buffered saline
TCM tissue culture medium
TSB trypticase soy broth
TEMED N',N',N',N’,-tetramethylenediamine
TNFa tumour necrosis factor- alpha
TNFp tumour necrosis factor- beta
UF ultra centrifugation
P micro
Pg microgram
Pi microlitre
jimol micromole
v/v by volume
w/v by weight
Zn zinc
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